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Within the field of nanoscience there is a growing interest in the use of biological molecules 
such as proteins, peptides and nucleic acids, to create materials with complex structure and 
function.  These molecules self-assemble to form a huge variety of functional nanoscale 
structures in biological systems. Through the work of supramolecular chemistry there is now 
a greater understanding of how to control the assembly of molecules into functional entities. 
The aim of this thesis is to combine the fields of biology and supramolecular chemistry to 
increase the repertoire of available protein building blocks for use in bionanotechnology. 
Three proteins have been selected due to their ability to self assemble in nature, Lsr2, the N-
terminal domain of Lsr2 (Nterm-Lsr2) and human peroxiredoxin 3 (HsPrx3).  
Lsr2 is a small DNA binding protein that has the innate ability to self-assemble in vivo via a 
number of routes. This makes it an ideal candidate as a biological building block for forming 
nanomaterials in vitro. The truncated version of Lsr2 (Nterm-Lsr2) oligomerises into linear 
chains via anti-parallel β-sheet formation between the extended N-termini of neighbouring 
dimers. This process was facilitated in vitro using low concentrations of trypsin which 






, allowing an inter-dimer anti-parallel 
β-sheet to form. Using trypsin to initiate assembly led to unwanted proteolysis at additional 
lysine and arginine residues within the polypeptide chain. A novel and more controlled 
method of initiating assembly was developed by replacing three N-terminal residues with an 
enteropeptidase recognition site. Enteropeptidase cleaves specifically at Lys
4
 leaving an 
identical sequence to the native protein when treated with trypsin but without additional 
fractionation. This allows the formation of an ordered network of “spaghetti-like” fibres. The 
structures alternate between a tetramer and high molecular weight oligomers in response to 
variations in pH. Further control is exerted over the system by exploiting the open symmetry 
of the assemblies. Increasing and decreasing the protein tecton concentration leads to the 
formation of larger and smaller structures respectively. 
Wild type HsPrx3 has been shown to assemble into one dimensional tubes at acidic pH (pH 
4.2). By incorporating the N-terminal histidine tag and linker sequence (HsPrx3-6his) into the 
current assembly system, a number of novel oligomerisation routes were developed. The 





which higher ordered structures can form. The increased pH sensitivity of HsPrx3-6his 
allows the formation of tubes at pH 7.4. The size of the assembly was further controlled by 
small changes in pH, with the tube length increasing with decreasing pH values. It is 
proposed that electrostatic interactions at the ring interface are driving the assembly. 
Increasing the salt concentration, thereby disrupting these electrostatic interactions, caused 
the tubes to dissociate into single rings. Increasing the histidine content within the tag led to 
the formation of longer tubes, suggesting that the presence of the non-native histidine 
residues is the origin of the pH sensitivity. The metal-binding imidazole side groups of the 
histidine tag were also utilised to stabilise stacks of HsPrx3-6his through coordination to 
Ni
2+
. The switch from high molecular weight stacks to low molecular weight rings was 
achieved with the addition of chelating agents to the solution.  
Throughout this study, novel protein building blocks have been developed that assemble and 
disassemble in a controllable manner in response to variations in environmental conditions. 
The assembly system of an existing protein tecton (HsPrx3-WT) has been enhanced, creating 
a protein building block that associates within the physiological pH range. These new routes 
towards controlled protein oligomerisation could be utilised in future work to form protein 










Chapter One: Introduction 
Overview 
Proteins are emerging as attractive tools in nanotechnology for the formation of functional 
and responsive materials. The methods developed in supramolecular chemistry have been 
incorporated with the innate self-assembly ability of biological molecules to create a new 
field of science known as bionanotechnology.  The following chapter will discuss how the 
field of bionanotechnology has advanced over the last 20 years to develop complex self-
assembling structures such as nanotubes [1], layers [2] and cages. [3]  The proteins used in 
this study will also be described in detail to explain how they may be used as novel protein 
building blocks.  
 
1.1 Nanoscience 
1.1.1 What are nanomaterials? 
Nanomaterials are generally defined as materials that have at least one dimension between 1 - 
100 nm although there is still some debate over this classification. [4, 5] In comparison to 
bulk materials, nanomaterials have a large fraction of surface atoms per unit mass [6] which 
means that they exhibit size dependent characteristics and properties that are intrinsically 
linked to their small dimensions. [5, 7, 8] The stark increase in surface area in comparison to 
the bulk material means that the inter-subunit forces are far greater than those of gravity and 
inertia.  This leads to the formation of particles that are thermodynamically unstable or 
metastable and one of the big challenges in the field of nanoscience is developing particles 
that do not grow in size. 
The field is widely interdisciplinary due to the unique properties that these materials offer 
with areas of research in optics, electronics and materials science.[8, 9].  Because of this there 
has been a marked increase in interest in the field of nanoscience in recent years. [10] 
 




1.1.2 Top-down and bottom-up approach 
There are two main approaches to form nanomaterials, these are the top-down and bottom-up 
approach.  The top-down approach involves the reduction in size of physical bodies until they 
reach nanoscale dimensions. [6]  This can be achieved through a variety of different methods 
such as nanolithography, where surfaces are etched on the nanoscale using atomic force 
microscopy (AFM). [11] Due to the nature of the methods used, this particular approach 
brings with it inherent problems.  The lack of accuracy, that can sometimes be an issue when 
using the top-down approach, can lead to imperfections on the surface of the material. [6]  As 
there is a large fraction of surface atoms per unit, any imperfections can have a profound 
effect on the properties and characteristics of the final product. 
The bottom-up approach describes nanomaterials formed through the assembly of units of a 
lower order. [12] While the materials formed from this method tend to have fewer surface 
imperfections, [6] there are still problems relating to the metastable nature of many 
nanoparticles which can make it difficult to prevent continued aggregation.  To be able to 
control the assembly and form functional and finite nanomaterials in a bottom-up manner it is 
essential to understand the routes by which these structures are formed.  
 
1.2 Self-Assembly 
Self-assembly is the process by which ordered structures are formed from separate 
components in a disordered system. The process is driven by interactions between the 
components. These interactions are non-covalent or weak covalent interactions [13] such as 
van der Waals, hydrogen-bonding, electrostatic, hydrophobic and amphiphilic interactions 
and metal-ligand coordination. The combined interactions need to be strong enough to 
overcome the decrease in entropy which occurs when the system becomes more ordered.  To 
be able to design components that can assemble in a controllable manner it is important to 
understand and predict the interactions that take place.  This field of science is classified as 
supramolecular chemistry. 
 




1.2.1 Supramolecular chemistry 
In the past decade a lot of work has been done in the field of supramolecular chemistry to 
explain the mechanisms by which molecules self-assemble. [13, 14] Supramolecular 
assemblies are often kinetically reversible, this allows for the components to assemble and 
disassemble until a thermodynamic minimum is reached. [14, 15]  The mechanism of self-
organisation can be dictated by specific recognition sites on the subunits and the environment 
in which the assembly takes place.  For example, hydrogen bonding may be disrupted in the 
presence of water whereas a hydrophobic interaction will be favourable. [16]  Steric factors 
also play a significant role in driving assembly with units binding in the order of least steric 
hindrance. Metal-ligand coordination can be used to drive the formation of products with 
specific geometries. [17-21] This is particularly useful when designing 3D supramolecular 
assemblies such as cages as the geometry can be manipulated by the metal centre and the 
conditions in which the coordination is taking place. [22] While there is some exceptionally 
progressive research in designing synthetic molecules that can assemble in a tailorable 
manner, many are still looking to nature as the peak of complex supramolecular chemistry. 
 
1.2.2 Supramolecular self-assembly in nature 
“When searching for a parallel assembly technique for atoms and molecules one is well 
advised to look at the methods of nature.”[23] 
In nature there is an abundance of examples of self-assembly, from a bacteria swarm or a 
school of fish to dynamic self-assembly within the living cell. Even the cell itself is 
comprised of subunits such as fatty-acids, amino-acids and sugars which associate in a 
complex manner to form the basic unit of life. 
There is a huge array of biological molecules that utilise non-covalent bonding to self-
assemble.  Phospholipids use amphiphilic interactions to assemble into lipid bilayers which 
form the cell membrane.  These essential biomolecules are comprised of a hydrophilic head 
and a hydrophobic tail which aggregate into their functional component when exposed to 
water. [24] Single strands of DNA self-assemble via a complex system of hydrogen bonding 
interactions and hydrophobic stacking which contribute to the double helix structure, 
discovered by Watson and Crick in 1953. [25] The three dimensional (3D) structure of these 
molecules give stability to the DNA which is essential for its continued function. [26]    




The self-assembly of proteins is an ideal illustration of how nature forms functional, 
nanoscale devices within living systems [9] using the bottom-up approach. [27]  There are 
three levels of protein assembly that are all intrinsically linked to the function of the protein.  
The protein assembly is dictated by the molecular composition of the primary sequence. This 
is a chain of covalently linked amino-acids which make up the polypeptide chain. Secondary 
structure describes the first mode of protein self-assembly.  It is the initial folding of the 
chain into small 3D conformations. Tertiary structure depicts the interactions of the 
secondary structural elements which give the protein its geometric shape. Quaternary 
structure is the interaction between multiple protein subunits to form what is known as a 
protein oligomer. All three modes of assembly are essential for the protein structure and 
function. 
An example of this in action is the self-assembly of collagen, the most abundant protein in 
mammals. It is formed through a hierarchical self-assembly process. [28] The basic unit of 
collagen forms from three polypeptide chains which self-assemble into a triple helix 
structure.  These then assemble into microfibres which continue to combine into strong and 
tough collagen fibrils in vivo. [29] The electrostatic interactions between the repeating 
sequence of 3 amino acids, Gly-X-Y (where X and Y can be any amino acid but are often 
proline (Pro) or hydroxyproline (Hyp) respectively),drive oligomerisation and allow for the 
formation of tough fibrils. [30]  These fibrils are found in many connective tissues such as 
muscles, tendons and ligaments and therefore their strength is integral to their function. [31] 
As in the formation of the cell, proteins can interact with other molecules in complex 
assemblies which are directly linked to the function of the product. A prime example of 
proteins forming hybrid complexes is biomineralisation, the formation of biominerals within 
living tissue. [32]  There are many different types of biominerals found across all forms of 
life, silicates in algae, carbonates in invertebrates and calcium phosphates and carbonates in 
vertebrates, and they are formed for uses as wide as shells in sea creatures to bones in 
mammals.  Their formation is a hierarchical bottom-up process and displays the interplay 
between organic and inorganic composites. [32]   
Proteins can also self-assembly to form sophisticated molecular-machines such as ribosomes 
[33] and ATP-synthase. [34] Both are comprised of multiple protein subunits that combine 
via a series of complex non-covalent interactions to generate nanomachines that are essential 
to life. 





1.2.3 Harnessing the power of nature to design objects with specific structure and 
properties 
Through studying how molecules assemble in nature it is possible to design self-assembling 
nanomaterials from biologics.  Furthermore, it is possible to use biological building blocks 
that have been specifically functionalised via chemical modifications to create materials for a 
specific task in vitro. [35, 36] The materials can be made from multiple different organic and 
inorganic tectons, as seen in nature, to make hybrid materials that would be difficult to design 
purely synthetically. [37, 38]  Over all, this relatively new field of materials science is known 
as bionanotechnology. [39] 
 
1.3 Bionanotechnology 
Bionanotechnology is an interdisciplinary field of science that uses biological molecules to 
generate nanostructures with specific functions and properties. [39] In the natural world, 
biological molecules are assembled in a bottom-up approach through non-covalent and weak 
covalent interactions between components which drive the formation of supramolecular 
structures. [9, 40, 41] Unlike entirely synthetic molecules, biological molecules already 
contain the necessary elements which allow them to interact in a specific way to generate the 
desired product. [42]  As previously discussed, many of these structures have dimensions on 
the nanoscale and therefore have unique physicochemical properties that are not present in 
classical materials and systems.  
 
1.3.1 DNA and RNA 
Some of the earliest work in the field of bionanotechnology utilised the specific interactions 
between DNA base pairs to direct the assembly of nanoparticles of specific size and function. 
[8, 38, 43, 44]  Units of DNA can be combined using a “sticky end”, a single strand of DNA 
at the end of the double stranded helix. [45]  These single strands can be used like Velcro 
when different “sticky ends” have complementary arrangements of nucleotide bases with the 
assembly being driven via hydrogen bonding between the base pairs. [45] The strands are 
designed so that the final product is the most thermodynamically stable. However, in many 




cases there are different conformations that have very similar energy which can lead to a low 
product yield, due to self-assembly errors, and a heterogeneous mixture of species. [44, 46] 
One of the most well researched areas of DNA nanomaterials is [47] the formation of 2D and 
3D structures via DNA origami. [44, 48-50]  DNA origami is the anti-parallel folding of a 
long, single stranded DNA (~7 kilobase) scaffold onto a set of specifically sized, parallel 
double helix oligonucleotides  (20- 50 nucleotides) that have been aligned to fit a certain 
geometric shape. [50] These scaffold DNA arrays [50] can be organised into many different 
shapes (squares, disks, 5-pointed stars) which can then be arranged into larger assemblies. 
[49, 50]  Fu et al. formed nanoscale bioreactors using DNA origami scaffolds.[51]  A “sticky 
end” was added to different edges of a rectangle DNA scaffold to form nanoribbons and long 




Figure 1.1: Structures formed from DNA origami arrays.  The scaffold arrays 
have been organised into 3D structures using a “sticky end” moiety. [51]  Permission 
granted 
 
Another 3D shape formed from DNA is the tetrahedron.  A one-pot method for constructing a 
high yield (~ 95 %) of these shapes was discovered by Goodman et al. in 2005. [44] This was 
a breakthrough in the field of DNA nanotechnology due to the high yield and speed at which 
the structures formed. The tetrahedron is formed from four rigid DNA helices covalently 




joined at one vertex. [44] The rigid strands make up the edges with more flexible branch 
points at the vertices (fig. 1.2). [44]   
 
 
Figure 1.2: DNA tetrahedron formed from four strands of DNA.  The rigid DNA 
helices are covalently linked one vertex with the flexible branch points at the other 
vertices. [44] Permission granted  
 
Ke et al. further developed the idea of the DNA tetrahedron by combining the methods of 
DNA origami and the protocol developed by Fu et al. to produced tetrahedral containers with 
closed faces, something that could not be achieved using the rigid strand and “sticky end” 
method alone. [43] 
The structures formed from DNA can be further functionalised by the addition of components 
bound to the DNA scaffold. For example, thiolated DNA can be utilised to position gold 
nanoparticles (AuNP) in an ordered array on the DNA scaffold. [38]  It is also possible to 
anchor enzymes to the DNA scaffold which Fu et al. showed can lead to an increase in the 
enzymatic efficiency when compared to the enzymes freely dispersed in solution.[51] 
Ribonucleic acid (RNA) is another biological molecule that can be used to form 
nanomaterials. [52-55] The nucleotide primary structure can fold via both canonical Watson-




Crick and non-canonical H-bonding into a range of 3D architectures that are believed to be 
related to the many cellular functions of RNA. [52, 55]  By studying the architecture of 
naturally occurring RNA it is possible to rationally design novel RNA motifs that assemble 
into a specific shape. [52] For example, the stabilisation of the kink turn (K-turn) motif, 
found in double stranded RNA (60 
o
), [56, 57]  by the addition of L7Ae protein to form rigid 
RNA complexes shaped like equilateral triangles (fig. 1.3). [54]  RNA is able to form a 
variety of 3D structures in vivo that are influenced by their environmental conditions (salt 
content, metal ions) making it an attractive target for the development of biologic-based 
nano-building blocks. [52]   However, materials formed from both RNA and DNA tend to be 
rigid in nature and lack the dynamics and in-built functionality afforded by other biological 
molecules. [52, 55]  
 
 
Figure 1.3: RNA equilateral triangle. The K-turn motif is stabilised by L7Ae 
protein to form a rigid RNA-protein complex. [54] Permission granted 
 
1.3.2 Peptides  
Peptides offer a range of routes towards self-assembly into ordered structures due to the 
variety of functional groups available.  Specific amino acids can be chosen for the non-
covalent interactions they afford. These have been tailored for the design of an array of 
different structures for example, fibrils, [58, 59] layers, [60, 61] 2D tapes [62] and tubes. [63] 
Cyclic peptides have been used since the early 90s to make 1D hollow nanotubes known as 
cyclic peptide nanotubes (CPN).[64]  These nanotubes have been utilised to develop a variety 
of functional materials from trans-membrane ion channels to drug delivery vehicles and 
more. [65, 66]  While their remarkable stability and the exact driving force behind the 




assembly remains unclear it is believed that they interact via hydrogen bonding of the peptide 
backbone to form anti-parallel and/or parallel β-stacks.  The dimensions and surface 
properties of the tubes can be manipulated by the primary amino acid sequence. In a study by 
Hourani et al. [67] a 3-amino-2-methylbenzoic acid was incorporated into a D, L-α-
alternating sequence of a cyclic peptide.  This allowed for surface functionalisation from the 
benzyl group and also reduced the tube diameter due to the methyl, hydrophobic group, being 
directed into the interior of the ring. The side chains of the amino acids can also be selected 
to direct modes of assembly. For example, Qu et al. [68] used computational methods to 
study the difference between two cyclic peptides, cyclo[(L-Phe-D-Ala)4] and cyclo[(L-Ala-D-
Ala)4].  Steric hindrance and electrostatic repulsion between the phenyl groups on cyclo[(L--
Phe-D-Ala)4]  in parallel stacking models are reduced when the anti-parallel model is selected.  
This is not seen for the cyclo[(L-Ala-D-Ala)4]. This demonstrates how the assembly 
mechanism can be manipulated by changing the amino acid make-up. 
Peptides have been designed to form tapes, ribbons, fibrils and fibres via hierarchical systems 
that are mimetic to proteins in nature. [59, 69] Many peptides are designed to promote β-
strand formation which allows for the control assembly into amyloid fibrils. [70]  The idea 
originated from the β-sheet structure seen in misfolded, insoluble proteins in pathological 
diseases such as Alzheimer's. [71] Aggeli et al. developed two 11 amino acid peptides that 
differed in their side chain content (P11 – I –glutamine polar side chains, P11-II phenylalanine 
and tryptophan aromatic side chains). These small variations in the primary peptide sequence 
allowed for a different response to peptide concentrations, with P11-II readily forming 
ribbons, fibrils and brittle hydrogels upon increasing peptide concentrations. [59]  The 
hierarchical assembly of collagen has also been used as a basis for peptide amino acid content 
to form collagen like fibres. [69, 72] As described above, collagen forms from three amino 
acid chains which self-assemble into a triple-helix.  These chains then assemble to form 
fibres which grow both linearly and laterally.  By using the repeating amino acid sequence of 
Pro-Hyp-Gly,  O’Leary et al. was able to develop peptides that would mimic this process in 
vitro to form hydrogels (fig. 1.4). [72] The nucleation of the fibres was further probed by 
Sarkar et al. and it was found that large nucleation domains undergo rapid fibre formation 
which leads to gelation or precipitation. [69] 
 





Figure 1.4: Peptides derived from the collagen sequence (a)  The repeating amino 
acid sequence, Pro-Hyp-Gly (b), enables the hierarchical assembly of peptide fibres 
that form hydrogels. [72] Permission granted 
 
A study by Valery et al. showed that peptide sequences derived from β-continuous interfaces 
of  homo-oligomeric proteins were ideal candidates for forming peptide nanomaterials.[73] 
Four peptides, 7 – 8 amino acids in length, were made from the protein interfaces of bovine 
peroxiredoxin 3 homodimer, bovine β-lactoglobulin homodimers, Mycobacterium 
tuberculosis diaminopimelate decarboxylase homotetramer and E.coli umud’ protein 
homodimers. 
All four peptides formed birefringent hydrogels from complex nanostructures ranging from 
bundles of nanofibrils, single nanofibrils and nanoribbons.  Circular dichroism and ThT 
assays confirmed the presence of β-sheet arrays and, interestingly, the self-assembly was 
reversible, with the degree of oligomerisation being sensitive to the peptide concentration.  
The nanoribbons made from peptides derived from the dimer interface of bovine 
peroxiredoxin 3 (BtPrx3) have been further studied and it was found that they can be utilised 
to encode the assembly of perylene imide based organic semiconductors. [62]  This is an 
elegant example of the types of hybrid materials that can be formed using the natural 
propensity of biological molecules to self-assemble in a controllable manner.   
Structures formed from peptides tend to be more stable than protein structures as they can 
withstand physicochemical conditions that would denature most proteins. [74]  However, 
they are expensive to synthesise on a large scale and also lack the surface functionality that 
proteins display. 





Proteins in biological systems form a diverse array of 3D structures with a wealth of 
functionalities. [39] They undertake a number of cellular roles for example protein synthesis, 
[33] chromosomal replication, [75] regulated membrane channels, [76] and catalysts for 
various different reactions. [77] The architecture, physical properties and mesoscopic size are 
all related to the function of the protein meaning that there is the potential to form functional 
nanomaterials by utilising protein building blocks that already have a unique inbuilt function. 
[78] The challenge now is to develop designer protein nanomaterials of specific size, shape 
and function by either mimicking nature directly or using computational methods to design 
novel proteins or protein-protein interactions. [79]  As there are no changes to the covalent 
structure of a polypeptide during folding there is a wide range of possible 3D conformations a 
disordered polypeptide chain can take. [80] This makes it difficult to specifically design 
novel proteins that assemble in a predictable manner in vitro.   A solution to this is to modify 
naturally occurring proteins to mimic the highly precise hierarchical self-assembly seen in 
nature to develop novel protein structures in vitro.[74]  Proteins are particularly attractive 
tools in nanoscience due to their ability to undergo bottom-up synthesis of biochemical 
materials with atomic level features inbuilt into the design. [81]  To be able to program the 
assembly of protein building blocks it is imperative to have a good understanding of the 
interactions that drive this process in order to control it.[81] 
 
1.4 Protein as building blocks for nanotechnology 
1.4.1 Protein sequence and folding 
Primary sequence 
The primary sequence of a protein is made up of covalently bonded, naturally occurring 
amino acids.  The amino acids are joined together via peptide bonds that are formed by a 
polymerisation reaction that occurs within the ribosome. [33]  The amino acid content and the 
order in which they are placed dictate the spontaneous folding of the protein which nucleates 
the final protein conformation. [82] Therefore, the protein shape and function is encoded 
within the primary amino acid sequence. [27] This can be used to predict how changes in the 
amino acid sequence will influence the final protein structure. [37, 83, 84]  





Protein folding is a fundamental example of biological self-assembly. [71] It is the process by 
which the polypeptide chain folds in to its native, stable conformation. Almost all native 
protein folded states are the most thermodynamically stable states under physiological 
conditions. [71, 80, 85]  Local folding of the chain is known as the secondary structure of the 
protein. The most common protein folds are the α-helix and β-strands, both of which are 
stabilised by hydrogen bonding between the amide and carbonyl groups on the polypeptide 
backbone. The α-helix is the most common protein secondary structure (around 40 %). [71]  
It has 3.6 residues per turn, and the average length is around 10 residues. [86] It is almost 
always right handed in proteins with all hydrogen-bonds pointing in the same direction. [87] 
β-Sheets are composed of nearly fully extended polypeptide chains known as β-strands. 
Interactions via hydrophobic and electrostatic forces are believed to drive the formation of 
this secondary structural conformation. [27] There are two main types of strands; anti-parallel 
and parallel (fig. 1.5). [88] 
 
 
Figure 1.5: The two main types of β-strands. 
  
Secondary protein folding is a crucial factor that affects the overall structure and function of 
the protein. [88]  This can be seen when misfolding leads to the formation of non-native 




protein aggregates such as amyloid fibrils. [71, 89] These are seen in disorders such as 
Alzheimers and Parkinson’s disease. [27, 71]  Furthermore, by mimicking these secondary 
structural elements at the protein-protein interface, interactions in protein oligomers can be 
stabilised. [87] 
Tertiary structure 
Tertiary structure is the overall shape on the protein, (globular, rod-like, sheet-like).  The 
geometric structure is often related to the function of the protein for example the formation of 
active sites for enzymes[90] or the 3D structural elements that enhance protein-protein 
interactions to form biological “nanomachines”. [33] It is important to have an idea of the 
tertiary structure of the protein as the molecular information for assembly can be encoded 
within the protein’s 3D structure. [91] 
Quaternary structure 
“Proteins in biological systems rarely act in isolation.” [90] 
The quaternary structure describes the oligomerisation of multiple protein subunits to form 
the native oligomeric state.  The process is driven by molecular recognition, one of the most 
important chemical events occurring in biological systems. [92] For protein-protein 
interactions to occur there needs to be complementary surface residues on the separate 
protein units.  Hydrophobic interactions bury non polar residues within the interface (away 
from aqueous surroundings) which can be further stabilised by Van de Waals interactions. As 
well as Van de Waals interactions between residues there is an increase in Gibbs free energy 
due to the expulsion of water from the interface. Electrostatic interactions occur between 
charged residues on the protein subunit interface that can combine due to complementary 
charge stabilisation and the formation of salt-bridges. Hydrogen-bonding can occur at the 
subunit interface via bonding along the backbone of the polypeptide chain. This can be in the 
form of β-sheets and α-helices, mimicking the secondary structural elements described above. 
Covalent interactions can also develop in the form of disulfide-bonds.  Many protein-protein 
interfaces have a combination of these interactions which ensures stability.   
 
 




1.4.2 Manipulating the protein-protein interface 
Naturally oligomerising proteins can be the inspiration for the formation of novel assemblies.  
With an understanding of how these form and function in nature it is possible to derive 
functional nanomaterials by manipulating and modulating how these supramolecular 
assemblies aggregate in vitro. [81] The features that instigate oligomerisation are already 
encoded in the protein sequence and the goal is to be able to control the aggregation in a 
programmable manner by varying environmental conditions and/or site specific mutations. 
Interface surface area 
Many proteins’ interfaces are bound together by relatively weak non-covalent interactions. 
The stability of multi-subunit complexes is often derived from the large surface area of these 
interfaces. A recent study completed by Chen et al. showed the direct correlation between the 
binding affinity of 113 heterodimers and the interfacial buried surface area.[93] They 
concluded that increasing the area of the buried surface leads to an increase in the binding 
affinity between the proteins. Within the study it was also noted that there is a decrease in the 
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[93] This agrees with the idea of hot-spots within the buried surfaces with the fraction of the 
surface residues that make energetic contributions decreasing with an increase in total surface 
area. [93] Alanine scanning mutagenesis is used to analyse hot spots at protein-binding 
interfaces.  Substituting a “hot-spot” residue for an alanine results in a drop in the binding 
constant of the protein. [94] These sites, when identified, could be targeted for the promotion 
of oligomerisation. 
Site specific mutations 
Site specific mutations can be used to further stabilise native interfaces, produce switchable 
oligomers or even drive the assembly of non-native interfaces. An example of this in action is 
the addition of cysteine residues to the top and bottom of the ring shaped protein HcpI.  This 
allows the formation of protein nanotubes via a “non-native” ring-interface, stabilised by 
covalent disulfide bonds. [95]  The interfaces can be switched “on and off” with the addition 
of reducing agents that break the thiol-thiol interactions.   




Metal-directed oligomerisation can be utilised by substituting in a residue with a metal 
coordinating side group, for example, histidine.  This coordination is frequently utilised to 
stabilise protein-protein interfaces. [22, 83, 96-99]  The addition of a ligand to a potential 
protein-protein interface has been shown to drive the assembly of a native monomeric 
protein, the four helix bundle haem protein cyt cb-526, into 1D tubes and 2D sheets via 
coordination of the histidine side group imidazole, which has been placed to optimise 
assembly with Zn
2+
. [96] The resulting assemblies are exceptionally stable and can be used as 
a template for the formation of Pt
0
 nanocrystals. [97]  Additional control over the geometry of 
the protein oligomers can be gained by analysing the geometry, specificity and affinity of the 
metal ion-ligand coordination [100, 101] which gives an extra level of protein nanomaterials 
design. 
Histidine residues have also been utilised as pH responsive residues at protein-protein 
interfaces.[102] The pKa of the imidazole side group can vary but is generally around the 
physiological pH range.  The subsequent protonation at pH below the pKa can lead to 
beneficial [103] or detrimental electrostatic interactions [102] at the interface. 
Symmetry factors 
Symmetry in quaternary structures arises from repeating protein units known as protomers.  
There can be no inversion centre or mirror symmetry in the oligomer as this will disrupt the 
chirality of the protein. [104] Padilla et al. showed that structures with complex symmetries 
can be developed using units with only two distinct symmetry elements. [105] They used this 
idea to generate self-assembling protein cages, layers, crystals and filaments.  By fusing 
together protein A, a self-assembling dimer, to protein B, a self-assembling trimer, they 
developed bespoke nanohedral particles (fig. 1.6). The symmetry of the protein units is fixed 
by linking the domains with amino acids that prefer an α-helical conformation, giving the 
linker rigidity. [105] This can be seen as a cut and paste route towards protein assembly. 





Figure 1.6: Structures with complex symmetries developed from units with only 
two symmetry elements. Subunits from a dimer and trimer (a) are linked together 
by a ridgid α-helix to (b and c) to create a tecton that can form sheets (d) and cages 
(e). [105] Permission granted. 
 
1.4.3 Examples of protein nanomaterials formed from naturally occurring proteins 
Protein cages 
An ideal example of utilising a naturally occurring protein to form a functional nanomaterial 
is the use of the cage protein, ferritin.  Ferritin cages in nature are used to store iron in a 
microcrystalline non-toxic form. The size of the protein cage controls the size of the non-
particulate iron. This knowledge was utilised by Allen et al. to design a protein cage that 
produced cobalt oxide nanomaterials.  The ferritin like protein from Listeria innocua, a 12 
subunit cage with a 5 nm interior, was employed to synthesise size-controlled cobalt 
minerals. [3] The composition of the mineral could be further manipulated by the temperature 
in which the reaction took place.  It was hypothesised that the acidic residues on the surface 
of the cage interior were able to mimic biomineralisation nucleation sites found in nature. [3] 
 





Proteins have also been used to form 2D arrays of layers.  One such example was derived 
from a Class I fungal hydrophobin which self-assembles in nature into amphiphilic 
monolayers at hydrophobic – hydrophilic interfaces. [2] This protein was use to facilitate the 
reverse wettability of hydrophobic and hydrophilic surfaces. [2] Coating hydrophobic single 
walled carbon nanotubes (SWCNT) with a hydrophobin I enables the tubes to be suspended 
in an aqueous solution.  Sonication of SWCNT with EASΔ15 (truncated Class I hydrophobin 
from Neurospora crassa) in water resulted in a clear black solution whereas sonication with 
SWCNT in water alone led to the production of visible particles. 
Amyloid fibrils 
Protein fibres and amyloid fibrils: make up some of the fundamental building materials of life 
(structural proteins- collagen, elastin, keratin and spider silk). It is believed that all proteins 
have the ability to form amyloid fibrils. [71]  This can be seen in the lack of similarity 
between the native structures of amyloid forming proteins. [89] The fibrils tend to have a 
high β-sheet content and are stable in harsh conditions. [106]  Due to the variety in the amino 
acid sequences of proteins, there is the potential for surface chemical modification of these 
fibrils, a possible route towards functionalisation. [42, 106] 
Amyloid fibrils are believed to be formed from partially unfolded protein intermediates that 
polymerise into elongated fibrils. [71]  This can be achieved under harsh denaturing 
conditions e.g. acidic pH (pH 2) and heat (80 
o
C) and the subsequent nucleation of the 
denatured protein over time at room temperature. [42] Sasso et al. used the dairy industry by-
product, whey protein isolates, to form amyloid fibrils in this manner. [106] The fibrils were 
functionalised via two surface chemical modifications, biotinylation – used for enzyme 
attachments and thiolation – to anchor the fibrils to a gold surface.  Using the biotin-
streptavin interaction they were able to successfully anchor both fluorescent quantum dots 
and glucose oxidase to the amyloid surface.  TEM and AFM showed that the amyloid fibrils 
bound to a gold surface after thiolation using Traut’s reagent.  This study is an elegant 
example of how protein nanomaterials can be engineered for a specific function.  
Protein rings and nanotubes 
Protein rings provide ideal building blocks for the formation of a range of different protein 
nanomaterials due to the regular symmetry and high surface area of the ring-ring interface. 




[107] These can be used as single rings, stacks, tubes, cages and cantenanes. The rings can 
either be the native oligomeric state or be created by designing non-native interfaces. For 
example, Bai et al. utilised a rigid dimer, Schistoma japonicum gluthanione S-transferase 
(sjGST) to form ordered ring structures through metal-ion coordination and non-covalent 
interactions. [101]  By placing an extra histidine, perpendicular to the C2 axis and adjacent to 
a native histidine, they were able to use the geometry of Ni
2+
 coordination to imidazole to 
join the dimers in a V-shape, so that they assembled into a ring. Through computational 
modelling, they identified key residues at the inter-dimer interface that were mutated to form 
non-covalent electrostatic interactions, further stabilising the ring form.  In fact, the geometry 
of the ring could be manipulated by disrupting or enhancing these electrostatic interactions by 
varying the salt content of the solution in which they were formed. [101] 
Human peroxiredoxin 3, a naturally occurring ring shaped dodecamer made up of 12 subunit 
monomers, can be assembled into tubes at acidic pH (pH 4.2) (fig. 1.7). [108, 109]  
 
 
Figure 1.7: TEM image of HsPr3-WT tubes formed at pH 4.2 Lowering the pH 
induces the structural changes needed to facilitate interactions at the R-type interface. 
[110] 
 
Phillips et al. utilised cryo-EM imaging to generate 3D models of the tubes into which they 
docked the crystal structure of a double stacked peroxiredoxin decamer [110] to identify the 
points of contact that were stabilising the ring-ring interfaces. [109] In accordance with the 
100 nm




information in the literature [110, 111]  and the residues that were in close enough proximity 





 on α2 of one subunit in the base ring with His
164
’ on α6 of the subunit 
directly above.  These contacts are facilitated by the local unfolding of the first turn of the α2 
helix and the increased disorder of the C-terminus. Lowering the pH induces these structural 
changes which brings the interacting residues closer together [110] and therefore enables the 
electrostatic contacts that stabilise the ring-ring interface. [109] 
 
1.4.4 Good building block  
The aim of this thesis is to select proteins that have an innate ability to form elaborate 
quaternary structures through self-associating interfaces. [104] This can be achieved using 
naturally oligomeric proteins and experimenting with varying conditions to drive the non-
native formation of highly ordered nanoscale materials. The three proteins selected have the 
capacity to do this and therefore work was done to further control their assembly to form the 
desired protein nanostructures. 
 
1.5 Lsr2 and Nterm-Lsr2 
Lsr2 is a nucleoid associated protein (NAP) found in mycobacteria and related actinobacteria. 
[75, 112-114] It has been shown to have a range of functionalities such as modulating 
chromatin organization, compaction and global gene expression. [115] It can also protect 
mycobacteria against reactive oxygen intermediates. [116] Being a highly conserved protein 
that is found in all sequenced mycobacteria, also makes it a target for the treatment of 
pathogenic diseases. [117, 118] It belongs to a group of proteins known as histone-like 
proteins which silence foreign DNA in bacteria. These transcription regulator proteins have 
the ability to bind selectively to AT rich chromosomal DNA and share similar mechanisms 
and functions but have little sequence and structure homology. [113, 114, 119, 120] Lsr2 is 
comprised of an N-terminal, dimerisation (and possible polymerisation) domain [75] and a C-
terminal DNA binding domain. [113]  It was selected in this study due to the specific way it 
can oligomerise via the N-terminal region and the ability to bind to DNA, forming large 
protein-DNA oligomers. [118]  Both of these attributes make Lsr2 an attractive candidate for 
protein nanotechnology, providing a self-assembling tecton with potential in-built function.  




1.5.1 Lsr2 physiological roles 
Histone-like proteins exist in prokaryotes and perform similar functions to their eukaryotic 
counterparts, silencing, organising and regulating chromosomal DNA. [112] While there is 
little sequence homology between these proteins, they share many of the same physical 
attributes, namely their small size and high positive charge. [121]  Lsr2 has been identified as 
a histone-like protein not only due to its low molecular weight and alkaline pI, but also its 
ability to bind to DNA, [68]  and its broad down regulating activity. [118] 
Lsr2 has been identified as a primary silencer of DNA acquired by horizontal gene transfer. 
[114] Horizontal gene transfer is the act of transferring genetic material between free living 
bacteria. [122] The process can be both beneficial, adaptation to new environments, and 
problematic as it can lead to the inappropriate expression of a foreign gene. [119] Xenogenic 
sequences, DNA that has been acquired from a foreign source, display a higher adenine (A) 
and thymine (T) content than the host genome. [123] There is an abundance of evidence that 
Lsr2 binds to AT rich (and conversely, GC deficient) DNA. [68, 112-114, 119, 124]  This is 
one reason why it is believed that this protein plays a crucial role in silencing and regulating 
xenogenic DNA. [114, 119] 
The bacterial chromosome is ordered into a compacted structure known as the nucleoid.  The 
nucleoid is comprised of topologically independent loops that are compacted together by 
nucleoid associated proteins (NAPs). [121]  Histone-like nucleoid structuring protein (H-NS) 
is known to complete this task in E. coli and Lsr2 has been shown to have a similar role in 
mycobacterium. [124]  The means by which this occurs is believed to be via DNA bridging, 
whereby two DNA binding C-terminal domains associate with two strands of DNA and the 
bridging occurs through the N-terminal dimerisation domain. [68, 119, 124]  In fact, it has 
been shown that both of these domains are essential for Lsr2 function in vivo. [124] 
Furthermore, AFM studies in vitro display the ability of Lsr2 to compact relatively non-
specific regions of DNA. [124] 
Lsr2 has been identified as a global transcription regulator due to its ability to regulate gene 
transcription [125, 126] and its apparent non-specific binding to DNA sequences. [113] This 
capacity to regulate gene transcription has been shown to be integral to the antibiotic 
response of Mycobacterium tuberculosis (M. tuberculosis).   A strain containing an increase 
in Lsr2 expression was more resistant to the antibiotic, ethanbutol (EMB). [118] Furthermore, 




Lsr2 knockout cell lines (Δlsr2) showed up-regulation of antibiotic induced genes indicating 
that Lsr2 acts as a silencer to down-regulate these genes. [118] 
During transfer into a host, pathogenic bacteria are subjected to stress conditions.  This can 
range from the change in temperature to the attack of the parasitic cell by the host immune 
responses.  One such immune response is the attack by reactive oxygenated species (ROS).  
In Mycobacterium smegmatis (M. smegmatis) Lsr2 has been shown to protect DNA from 
ROS, with deletion of the lsr2 gene leading to more susceptibility to the detrimental effects of 
H2O2 DNA damage. The role of protection was demonstrated in vitro by the direct binding of 
Lsr2 to the pUC19 plasmid DNA under stress conditions. [116]  For a pathogen to survive 
transfer into a host, there needs to be a degree of adaptation to the new environment.  One 
significant change is the level of oxygen as the pathogen passes from the atmosphere into the 
host. The ability of M. tuberculosis to adapt to changing oxygen availability is one key reason 
for its success. [125]  Lsr2 deletion leads to a decrease in this ability indicating that it is 
needed for adaptation to the new oxygen environment. [125]  However, unlike M. smegmatis, 
there is no difference to a knockout mutant that has been subjected to ROS stress under 
normal oxygen conditions.  This indicates that the protein is more likely to have a 
transcription regulation role rather a direct DNA protection role in M. tuberculosis. Due to 
the virulence of M. tuberculosis and its tolerance to antibiotics, proteins that are involved in 
host adaptation are key targets in the defence against pathogenic diseases. 
1.5.2 Lsr2 structure 
C-terminal DNA binding domain 
The structure of the C-terminal DNA binding region was solved by Gordon et al. using 
nuclear magnetic resonance (NMR). [113] It was found that the C-terminal DNA binding 
domain binds to the minor grove of the DNA double helix. [113, 119] The C-terminal domain 
is comprised of residues 77 – 137 and exists as two α-helices joined together by a loop.  It is 
unique to other histone-like proteins in the fact that the helices are ordered perpendicular to 
one another and stabilised in this conformation via hydrophobic interactions (fig. 1.8). [113]   
 





Figure 1.8: C-terminal domain of Lsr2.  Two α-helices are arranged perpendicular 
with respect to each other, stabilised in this arrangement by the hydrophobic core 
(blue). Aromatic between Trp86 and Tyr108 (orange) adds additional stabilisation. 
 
The key residues involved in DNA binding were identified by chemical shift changes when 










 interact with the sugar phosphate 





 completely disappears in the presence of DNA indicating an intermediate 
exchange with DNA on the NMR time scale.  Furthermore, the DNA binding is diminished 




 for alanine [114] showing that these residues are 
integral to the DNA binding. The mechanism of binding was described as an AT-hook like 
motif, similar to that seen for H-NS even though the roles of this two proteins do diverge [68, 
114] and there is little structure and sequence homology between them. [114]  
N-terminal dimerisation domain 
The N-terminal domain of Lsr2 has been shown to be integral to function.[124]  In vitro 
testing of increasing amounts of Lsr2 to DNA shows that Lsr2 can not only bridge DNA 
through the dimerisation region but can also form bundles of DNA, presumably through the 
N-terminal oligomerisation region. [124] [68] It was this particular function that identified 
Lsr2 as a H-NS like protein, with the potential to structure the bacterial chromosomal DNA 
into a nucleoid. [68]  
α1
α2





Figure 1.9: N-terminal domain of Lsr2. Dimerisation occurs between β2 on each 
subunit.  Additional oligomerisation at β0 allows the dimers to associate into long 
protein chains.  
 
In a study by Summers et al. the crystal structure of Nterm-Lsr2 (the truncated N-terminal 
domain of Lsr2) showed a simple dimeric structure comprised of two α-helices, surrounding 
a four stranded β-sheet, with the dimerisation occurring between two anti-parallel β-strands 
(fig, 1.9). [75] During the study, it was noted that Nterm-Lsr2 was able to form large 
oligomers via the disordered N-terminal residues.  Closer inspection of the crystal structure 






 were absent, presumably due cleavage by 
contaminating proteases. [75] The remaining residues in the disordered N-terminus 
(KVTVTLV) are well suited for the formation of an inter-dimer β-strand. [73] The 
oligomerisation can be initiated in a more controlled manner using trace amounts of trypsin 
(1:500, trypsin:Nterm-Lsr2). The oligomers formed, using this method, are remarkably 
stable, being visible on both SEC and TEM. [75, 127]  Full length Lsr2 and DNA were 
analysed on DNA agarose electrophoresis in the presence and absence of trypsin.  The 
addition of trypsin leads to the compaction of DNA suggesting the oligomerisation of a 
DNA-protein complex where the C-terminal region binds to DNA and the N-terminal region 
oligomerises into larger assemblies, compacting the DNA. [75]  This could provide evidence 
around the mechanism by which Lsr2 acts as an NAP. [75] Indeed, the residues within the 
oligomerisation region are remarkably well suited to form inter-subunit β-interfaces [73] 












1.5.3 Lsr2 as a tecton in bionanotechnology 
It was noted in a study by Colangi et al. during [112] electrophoretic mobility shift assays, 
that Lsr2 appeared significantly larger than would be expected (12 kDa).  [118]  This 
indicated the presence of DNA-protein complexes, bound by Lsr2 in a non-specific manner. 
[118] A further study by Qu et al. elucidated a possible mechanism by which Lsr2 is able to 
perform its physiological roles. [68] Not only can Lsr2 bridge DNA [124] but it can also 
stiffen both unfolded and folded DNA into a nucleoprotein filament. [68]  Steric confinement 
due to high protein concentration was ruled out by studying the integration host factor (IHF) 
protein, which binds to DNA as a dimer but did not have the same stiffening effect as Lsr2 at 
equal concentrations. [68] This knowledge combined with the fact that the N-terminal 
domain of Lsr2 has the capacity to oligomerise into large structures (fig. 1.10) [75] and also 
its behaviour  as a NAP, organising and shaping DNA, [113] means this protein has the 
potential to be used in a controlled manner to form specifically designed nucleoprotein 
complexes in vitro.  This would join the bionanotechnology fields of bespoke DNA 
organisation and protein oligomerisation with Lsr2 being used to build functional, nanoscale 
biological materials.  Furthermore, a greater understanding of the behaviour of Lsr2 could be 
beneficial to the design of protein targeted pharmaceuticals for the treatment of virulent 
pathogenic bacterial infections such as M. tuberculosis. 
 
 
Figure 1.10: Assembly of Nterm-Lsr2 upon the proteolytic cleavage of three N-
terminal residues. Removal of these residues allows the formation of an inter-dimer 
β-strand. 
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Peroxiredoxins (Prx) are a class of peroxidases that exist in all forms of life. [128]  Their 
primary role is to protect the cell against oxidative stress by reducing hydroperoxides, organic 
hydroperoxides and peroxynitrite within the cell. [129] Unlike other peroxidases, Prx does 
not contain a redox active metal centre but instead uses a cysteine residue at the active site, 
conserved in all species. [128] In addition to their peroxidase activity, Prxs are believed to 
adopt a number of other roles under physiological conditions. For example, as molecular 
chaperones or intercellular regulators of levels of the H2O2 molecules that are involved in 
redox signalling. [129, 130]  There are a variety of different oligomeric states that Prxs can 
adopt, from oblique dimers, rings of decamers and dodecamers, stacks and tubes and cages. 
The aggregation of the subunits is dependent on the classification of the Prx and there is 
strong evidence that the oligomeric state is linked to the protein function. [131] Due to the 
variety of highly ordered, supramolecular complexes that Prxs can form, this class of 
enzymes has been identified as an ideal candidate for protein nanotechnology. [109]  Because 
of the apparent innate ability of these enzymes to form high molecular weight (HMW) 
structures, it is proposed that there are further routes towards assembly that are yet to be 
explored. These routes have the potential to be manipulated to develop tailorable biological 
nanomaterials in vitro. 
1.6.1 Catalytic cycle 
Unlike other peroxidases, Prx does not contain a redox active metal centre; instead, it 





The active site is organised in a way that allows the binding of peroxides in a conformation 
for an SN2 substitution reaction. [132] The environment of the active site lowers the pKa of 
the peroxidatic cysteine (Cysp) side group which gives a fully negatively charged thiolate.  
This attacks the peroxide to form a sulfenic acid. A resolving thiol, either from the Prx itself 
or another small molecule, attacks SpOH, releasing water and forming a disulfide bond.  For 
this to occur, there needs to be a degree of local unfolding at the active site which brings SP-




OH out of the protected, fully folded active site pocket. The formation of the disulfide bond 
effectively locks the locally unfolded (LU) conformation of the reaction intermediate.  The 
disulfide bond is reduced by a thiol group from another protein or small molecule. [133, 134]  
Many Prxs incorporate thiorodoxin or a thiorodoxin like protein for this role.  Once the 
disulfide bond is broken, the fully folded (FF) active site conformation is renewed allowing 
the protein to be ready to bind to another peroxide substrate. It is possible for SpOH to react 
with another peroxide before the resolution step occurs.  This leads to formation of a sulfinic 
acid which cannot react with the resolving cysteine, leaving an inactive form. However, the 
overoxidised cysteine can be recycled back to its active form via an ATP-dependent reaction 
with sulfiredoxin (Srx). The overoxidation of the peroxidatic cysteine is believed to be one of 
the ways that Prx can be involved in additional physiological processes. [135] 
 
 
Figure 1.11: Peroxiredoxin catalytic cycle. 1: Cysp reacts with the peroxide 
substrate to form sulfenic acid. 2: Local unfolding of the active site proceeds attack 
by Cysr to form a disulfide bond which releases water. In some cases another 
peroxide can react with the sulfenic acid to form a sulfinic acid. Disulfide bond 
formation locks the LU unfolded conformation. 3. Disulfide bond is reduced by 
thioredoxin or another thiolate-bearing reductant which renews the FF active site 
conformation. 




1.6.2 Peroxiredoxin classes 
Until relatively recently Prxs were grouped into three main classes of, typical 2-Cys, atypical 
2-Cys and 1-Cys.  2-Cys Prxs have two cysteine residues that are involved in the catalytic 
cycle, the peroxidatic cysteine - Cysp and a resolving cysteine -Cysr, which regenerates the 
reduced form of Cysp. [77]  In the typical form, Cysr is located on the adjacent subunit of the 
oblique dimer. Atypical 2-Cys Prxs, however, form intra rather than intermolecular disulfide 
bridges in the reaction intermediate. [77]  1-Cys Prxs have only one enzymatic cysteine and 
require another small molecular or protein to donate the resolving cysteine. [77] 
The issue with this classification is that it only describes one aspect of the Prx roles and many 
Prxs that have the same 1-Cys, 2-Cys, typical or atypical classification vary hugely in both 
sequence and physiological behaviour. [136] For this reason, a bioinformatics approach 
called active site profiling was adopted to analyse the sequences of segments situated near to 
the active site of 29 well characterised Prxs. [137] This information was then extrapolated to 
identify ~3500 known Prx sequences and the enzymes were classified as described in the 
table on page 28 (Table 1.1). [136] The protein used in this study is a typical 2-Cys Prx from 
the Prx1 subfamily. It is found in the human mitochondrial matrix and has been labelled as 






































B-type dimers,  (α2)5 
decamers (and rare 
(α2)6 dodecamers) 
through A interface 












B-type dimers,  some 
(α2)5 decamers 

















































Table 1: The 6-subfamilies of Prx. Table from Poole et al. describe the different 
Prx subfamilies and how they are classified. [136]  Many contain a mixture of typical 
and atypical 2-Cys and 1-Cys Prxs which is why a new classification method was 
needed to prevent the over-annotation of newly discovered Prxs. [136, 137]  
 
1.6.3 Peroxiredoxin monomer  
The Prx monomer is globular protein that has a common core tertiary structure that is based 
on the thioredoxin (Tpx) fold. [77, 131, 139, 140]  The Tpx fold is based on a central twisted 
β-sheet which contains a 4 stranded β-sheet (2 strands parallel, 2 stands anti-parallel) 
surrounded by 2 α-helices (fig. 1.12 A). In addition to N-terminal and C-terminal extensions, 















Prxs have a central twisted 5 stranded β-sheet comprised of β5- β4- β3- β6- β7.  The sheet is 
sandwiched between β1- β2-α1 on one face and α2, α3 and α5 on the other (fig. 1.12 B).  In 
the fully folded conformation, Cysp is in the first turn of the α2 helix.  For successful 
function, the active site needs to be stable in both FF and LU conformations.  In a 
comprehensive review by Hall et al. this stabilisation was described as a “cradle” from other 
secondary structural elements with β3 and β4 acting as the base and α3 and α5 acting as the 
walls of the cradle. [131]  This tertiary fold is highly conserved across the Prx family and 
therefore has great significance. 
 




Figure 1.12: Tpx fold and Prx monomer. (A) Thioredoxin is comprised of a central 
twisted β-sheet surrounded by two α-helices. The Tpx fold bakes up the Prx common 
core tertiary structure. Image generated using Pymol with coordinates from 
PDB:1X0A [140] (B) The peroxiredoxin monomer with the key secondary structural 
elements labelled. Images generated using Pymol with coordinates from PDB:4MH2 
[143] 
 
1.6.4 Active site 
The active site contains three amino acids which are absolutely conserved[136], these being 
the peroxidatic cysteine, a proline and an arginine residue.  In addition there is also the highly 
conserved threonine, which is replaced with a serine in some Prxs.[77, 131, 136] The 
PXXXTXXCp residues make up the Cp loop with arginine being positioned so that it can 
reduce the pKa of the cysteine thiolate via hydrogen bonding stabilisation (fig. 1.13). [77, 




138]  The hydrophobic proline protects the active site pocket from water and the fully folded 
active site allows for the positioning of the peroxide substrate to undergo a SN2 reaction 
during the peroxidatic step. [132, 141]  In typical 2-Cys Prxs, the active site undergoes a local 
unfolding event that allows Cysp and Cysr to adjust position so that they are close enough to 
form a disulfide bond.   
 
 
Figure 1.13: Prx active site. The conserve residues are in green.  The Cysp thiolate 




 shields the active site from water.  
The fully folded active site positions the peroxide substrate for a SN2 reaction. 
Images generated using Pymol with coordinates from PDB:1QMV [142] 
 
This involves the unwinding of the α2 helix and the disordering of the C-terminus. [143] 
Additional variations at the opening of the active site have been identified as selective for 
different forms of peroxide substrate.  For example, some Prxs contain hydrophobic residues 
from the dimer partner that create a hydrophobic collar at the active site. This helps to 
increase binding efficiency and therefore improve the Prxs rate of reaction with organic 










1.6.5 Peroxiredoxin dimer 
Although there are known Prx monomers, the only active forms of which are found in the 
BCP subfamily, [134] most Prxs form more complex quaternary structures. [131]  The 
smallest of these is the Prx dimer.  Prxs have two potential dimerisation interfaces, the B-type 
interface, so called due to its β-sheet structure and the A-type interface, alternative or ancient 
interface. 
B-type interface 
The B-type interface is formed by anti-parallel interactions along β7 on two monomeric 
subunits to form a 10 stranded β-sheet. [134]  The interaction is stabilised by hydrogen 
bonding and the burying of hydrophobic residues along the interface (fig. 1.14).  In typical 2-
Cys Prxs, Cysr is located across the B-type interface at the C-terminal end of the subunit 
partner. [145] Upon the unfolding of the first turn of α2, a disulfide bond forms at this 
interface producing an exceptionally stable dimer that buries around 30 residues per 
monomer. [146] Prxs that adopt this dimerisation do not disassociate under physiological 
conditions. [128] 
 
Figure 1.14: B-type interface.  The dimer associates along β7 of each subunit to 
form a 10 stranded β-sheet.  This is stabilised by both H-bonding and hydrophobic 
interactions. Images generated using Pymol with coordinates from PDB:4MH2 
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The A-type interface is comprised of a tip-tip association of chains between β1 and β2’ and 
the loops proceeding α2, α3 and α4. The interface incorporates a mix of hydrogen bonding 
and hydrophobic interactions for stabilisation. The crystal structure of Plasmodium 
falciparum antioxidant protein (PfAOP), displays a dimer that associates along the A-type 
interface.[147]  The researchers noted 5 regions of interaction between subunits (numbering 
from PfAOP); 
0- residues 11 – 14 and 34 
1- residues 54 – 57 
2- residues 8-100 
3- residues 110 -113 
4- residues 127 – 134 
 
 
Figure 1.15: A-type interface. [146]. Region 1 (red) precedes the Cp loop and 
interacts with region 2 (yellow) through hydrophobic contacts.   Regions 3 (blue) and 





 believed to the key involved residues.  The crystal structure of 
BtPrx3 is used in this figure as it shares 93 % sequence homology with HsPrx3 and 
the same four regions of contact at the A-type interface as PfAOP. Images generated 
using Pymol with coordinates from PDB:4MH2 
 




There are three main clusters.  Clusters I and III are located on the periphery of the interface 
with region 0 and 3 on one subunit interacting with region 4 of the adjacent unit (fig. 1.15).  




’.  The other cluster, II, makes 
up the core of the A-type interface.  The cluster is located around the 2-fold axis and 
therefore the same residues from each subunit, from region 1 and 2, interact with each other.  
The interface is comprised of both hydrophobic interactions and hydrogen bonding between 
the residues within these regions. [147] [148]  
When compared to other Prxs that associate in this way, Sarma et al. found that the 
interacting regions were conserved across many subfamilies, with the exception being the 
interactions of region 0, which is an N-terminal extension specific to PfAOP. [147]   Due to 
the conservation of this site across many Prxs and the increased frequency in comparison to 
the B-type interface, it is believed that the A-type dimer interface was the ancestral interface 





















1.6.6 Peroxiredoxin toroids 
Many Prxs utilise both the A-type and B-type interfaces to oligomerise into toroids 
comprised of 8, [149] 10, [141] or 12-Prx  monomers (fig.1.16). [109] The dimer-toroid inter-
conversion is redox, concentration and pH sensitive with the toroid being stabilised when the 
active site is reduced, the protein concentration is high and the pH is relatively low.  
Interestingly, the overoxidised sulfinic acid form of Cysp is also a stable, if slightly less 
compact, toroid that can only be disassembled upon reduction with Srx. [150]   
 
 
Figure 1.16: BtPrx3 dodecamer. [142] The dimers associate via the A-type 
interface to form a toroid. Images generated using Pymol with coordinates from 
PDB:4MH2 
 
The Prx used in this study is human Prx 3 (HsPrx3), a mitochondrial Prx found in the matrix, 
exists as a dodecamer.  [109]This is relatively unusual among the known typical 2-Cys Prxs. 











In many typical 2-Cys Prxs the quaternary structure is influenced by the redox state of Cysp. 
[148, 151, 152]  The reduced form exists as a stable ring whereas the disulfide bonded moiety 
can form a range of different oligomeric states depending on protein concentration and pH. 
By studying the crystal structure of disulfide bonded AhpC and comparing it to other known 
structures of Prx rings and dimers, Wood et al. were able to pin-point key regions that 
associated at the A-type interface and identify the potential molecular “switch” that dictated 
the quaternary structure. [148] Unlike other non-reduced 2-Cys Prxs, which crystallised as 
oblique dimers, the crystal structure of AhpC showed a meta-stable toroid of 10 subunits. It is 
believed this was due to the high concentration needed for crystallisation which was above 
the critical range for toroid formation.   
Comparisons were drawn between regions 1-4 (above) on the structures of non-reduced 
AhpC and those of the oxidised dimer – HBP23 and the reduced ring structure of Tpx-B with 
AhpC being cited as the intermediate of the two forms.  It was found that in the reduced state, 
the Cp loop is less mobile as it is packed against the fully folded α2 helix.  Upon oxidation, 
the α2 helix begins to unfold so that in AhpC the Cp loop is more mobile and therefore there 
are less interactions in region 1.  In the locally unfolded structure of HBP23, the active site 
has collapsed as Cysp has vacated the pocket to bind to Cysr. This leads to the uncoupling of 
the Cp loop to region 1 which completely destabilises the A-type interface.  A later study by 
Matsumara et al. showed that rearrangement of the active site helix led to changes in the 
positions of key hydrophobic residues at the A-type interface. [152]  It was postulated that 
this could lead the steric clashes at the dimer-dimer interface, further destabilising the 
toroidal form upon intermolecular disulfide bond formation. The fact that the protein is 
sensitive to the redox activity that takes part in the catalytic cycle suggests that the oligomeric 
state of the protein is integral to its physiological function. [77, 128, 133, 145]  It has been 
shown that the final recycling step is more successful when the protein is in the dimeric form. 
[131] However, the specific reasons behind the toroid form are still unknown as Prx dimers 
are fully active.   
pH 
It has long been noted that lowering pH can improve the stability of the Prx 2-Cys ring. [145, 
151, 153]  Even small variations between pH 7 – 8 have been shown to influence the 
quaternary structure. [153] Until recently, the specific mechanism that governed this switch 




was unknown.  Morais et al. set out to answer this question by studying the crystal structure 
of the disulfide bonded Leishmania braziliensis Prx 1 (LbPrx1m), at both basic and acidic 
pH.  It was noted that, at pH 4.4, the Cp-loop is locked into a closed conformation due to 




. In addition, there is a 
hydrogen bonding network that further stabilises this conformation, the positioning of which 
allows key hydrophobic residues to interact at the inter-dimer A-type interface, helping to 
sustain the decameric form (fig.1.17 A). [103]  At pH 8.5 the protein is in the dimeric state. 
His
113
 is no longer protonated, removing the key electrostatic interaction with Asp
76
 (fig.1.17 
B) and allowing an open Cp-loop conformation, seen in many other disulfide bonded typical 
2-Cys Prx dimers. [109, 131, 133, 148]  
 
A: pH 4.0                                                           B: pH 8.5 
 





 and a H-bonding network (green residues) lock Cp in a closed 
conformation. This facilitates hydrophobic interactions (blue residues) at the A-
type interface. (B) At pH 8.5 His
113
 is deprotonated. There is no longer an 
electrostatic interaction with Asp
76
 and therefore the Cp loop is open. This 
conformation displaces the hydrophobic residues at the A-type interface and the 
decamer dissociates into dimers. Images generated using Pymol with coordinates 










The solution studies showed that the changes in quaternary structure occurred between pH 7-
8, with the pKa of His
113
 being around 7.37. [103] This is consistent with the hypothesis that 
the protonation of the histidine was critical for the stabilisation of the decamer in non-
reducing conditions.  The key residues identified in this study are conserved in many other 
Prx1 typical 2-Cys Prxs, suggesting that a similar mechanism could be the origin of toroid 
stability for these proteins as well. [103]  Furthermore, the small range of pH that is necessary 
to facilitate this change suggests that it could play a role in vivo, aiding Prx to switch between 
different physiological roles. 
N-terminal tags and extensions 
It has been shown in a number of structural studies that additional N-terminal residues can 
have a profound effect on the quaternary structure of Prx. [141, 151, 154-156]. In a study by 
Cao et al. on the recombinant, histidine tagged Bovine Prx 3 (BtPrx3), it was found that the 
presence of a tag is enough to keep the ring intact even in non-reducing conditions.[151] A 
similar effect is seen in solution studies for Myc tagged Tsa1. [154] Wild-type, human PrxIV 
has a native N-terminal sequence, around 30 residues long, and this human Prx isologue is 
also a redox stable decamer.[141]  Initially it was believed that a cysteine in the N-terminal 
portion of the polypeptide sequence was stabilising the ring though covalent disulfide 
bonding to adjacent dimers. However, even the mutation of this cysteine to alanine is not 
enough to diminish the toroid stability. [141] The influence of varying N-terminal residues on 
typical 2-Cys Prxs was perhaps most dramatically displayed by Gretes et al.[155] Small 
changes within this region on Plasmoddium yoelii Prx 1 (PyPrx1a) are enough to cause a 
“slip” at the B-type interface that leads to variations in the angle perpendicular to the dimer 
C2-axis, at the inter-dimer interface. This is enough to change the geometry of the ring, with 
the tagged construct (PyPrx1a
N*
) oligomerising as an octamer instead of a decamer.[155] 
While these effects are not seen in all Prxs [157] they are a common enough occurrence to 








1.6.7 High molecular weight oligomers and other physiological roles 
In addition to peroxidatic activity, Prxs have been shown to have a variety of different 
physiological roles. [129, 134, 145]  This is perhaps unsurprising due to the apparent 
redundancy in the number of isologues found in many species. Humans, for example, have 6 
different Prx isologues. The role that Prx adopts is intrinsically linked to its quaternary 
structure, with tubes, stacks and cages being noted in the literature. [109, 110, 158, 159] Only 
the physiological roles of typical 2-Cys from the Prx1 subfamily will be elaborated upon 
here. 
Overoxidation of Cysp 
There are a number of studies that have described the formation of HMW oligomers in vivo 
and in vitro in response to a range of different conditions.  One of the most well studied is the 
overoxidation of the Cysp which can lead to toroid stabilisation and, in some cases, the 
formation of HMW structures. [133, 149, 160-162]   
Prxs in prokaryotes tend to be more resistant to overoxidation than those found in eukaryotic 
cells. [145] A common sequence has been found between Prxs that are more sensitive to 
overoxidation, this being the YF motif in the C-term extension. This packs against α2 helix, 
stabilising the fully folded active site [163] and allowing the persistence of the conformation 
needed for an additional peroxide attack. [132]  In fact, in a recent study by Cao et al. the 
Phe
190
 from the YF motif in BtPrx3 was substituted for Leu to form a motif similar to those 
found in some bacterial Prxs that are more robust. [143]  While the peroxidatic activity was 
not diminished, the sensitivity towards overoxidation was lowered, highlighting the 
importance of this motif with regards to overoxidation.  The YF motif is highly conserved in 
many eukaryotic typical 2-Cys Prxs suggesting that the sensitivity to overoxidation has an 
important physiological role. [129, 143, 145] The overoxidised form can be reduced by 
sulfiredoxin (Srx). [129]  Organisms that do not contain Srx have more robust Prxs [129] 
further suggesting that Cysp-SO2
-
 has a physiological significance and is not just an artefact 
of in vitro testing. 
There are a number of hypotheses explaining why overoxidation is able to occur. [135]   A 
number are related to stress and non-stress peroxide signalling. [160, 162]  One such example 
of non-stress peroxide signalling is the “floodgate” mechanism whereby the inactivation of 
the Prx, due to localised H2O2 build up, leads to a further increase in H2O2 levels that are 




utilised downstream. [162] The stress response is thought, in part, to be related to the ability 
of Prxs to act as a holdase chaperone, [150] preventing the aggregation of partially unfolded 
proteins under cell stress conditions. [157, 160, 164]   
Chaperone 
One of the many physiological roles of Prx is its ability to act as an ATP-independent holdase 
chaperone. [110, 145, 160, 164]  For many years it has been suggested that the overoxidation 
of Prxs initiates the structural changes needed for chaperone holdase activity in both the 
LMW and HMW oligomers. [111, 150, 160, 165, 166] There are a number of examples 
where typical 2-Cys Prxs have been shown to have chaperone activity or at least have the 
capacity to behave as a putative chaperone.[131, 164] The chaperone activity is not directly 
linked to the peroxidatic activity, [164] with Cysp and Cysr non-active mutants both 
exhibiting the capacity to function as a chaperone. [157] However, the quaternary structure is 
important, with only the toroid or HMW oligomers displaying chaperone activity.[164] In 
this way, it can be described as a redox regulated chaperone as a disulfide bond between the 
active site cysteine residues (non-reduced) generally leads to disassembly of the toroid into 
its dimeric state. [148]  The switch from peroxidatic function is not well understood, but it is 
believed to be in response to cellular stress for example, high temperature, [164] high [H2O2], 
[160] and changes in pH, [110] where Prxs switch between the dimer, LMW and HMW 
forms. [153] There is ongoing research into the structural differences between the two forms. 
[108, 111, 150]  Understanding the structural changes may give insight not only into how the 
function diverges but also why 
pH 
Saccoccia et al. solved the crystal structure of a double stacked Schistosoma mansoni Prx1 
(SmPrx1) at pH 4.2. [110] The HMW oligomer is comprised of 20 Prx subunits arranged as a 
double stack of decameric rings.  The rings are rotated 18 
o
 with respect to each other around 
the 5-fold symmetry axis to form “cog-wheel” like interactions.  The interactions at the ring 
interface (R-type interface) are predominantly polar, with the contacts between the carbonyl 




 on α6’on the subunit directly above (fig. 





the β2-strand in the bottom ring with the equivalent residues on β2’ in the adjacent subunit in 
the top ring (fig. 1.18 between chains B and C). 






Figure 1.18: pH stack. Chain A has contacts with both chain B and chain C on the 





 from α6 interact with the backbone carbonyl oxygen atoms on α2 




 on the β2 
(chain A and C). 
 
By studying the differences in folding between the HMW and LMW crystal structures, they 
were able to identify possible changes that led to the stacking, namely the local unfolding of 
α2, the disordered C-terminus and the proximity of α6 to C-terminal Phe
161
. These 
differences are specifically due to the acidic pH and more work will need to be done to 
compare this to the overoxidised structure.  
Temperature 
Mitochondrial tryparedoxin-peroxidase (mTXNPx) from Leishmania infantum has been 





C, change in temperature from insect to mammalian host) with the knockout strain 
producing a phenotype that has an increased sensitivity temperature. [164]  In vitro studies of 
mTXNPx showed that the reduced decameric protein (mTXNPxred) is able to decrease the 
degree of luciferase aggregation in response to an increase temperature while the oxidised, 
dimeric form (mTXNPxox) is not.  Unlike other studies, [157, 160] the overoxidation of Cysp 
was not needed to initiate chaperone activity, rather the increase in the surface 
hydrophobicity of mTXNPxred upon increasing temperature was believed to aid the switch to 










decamer with electron density in the lumen that was not visible in the absence of the substrate 
protein suggesting that the holdase activity of this enzyme is derived from holding the 
partially heat denatured protein substrate within the toroid lumen. 
 
1.6.8 Peroxiredoxins as tectons in nanotechnology 
The evidence in the literature suggests that there are a number of routes towards forming 
HMW structures from Prxs.  In fact, there have been a number of examples where this has 
occurred, through site-directed mutagenesis, changes in pH, the overoxidation of Cysp, metal 
ion coordination to the N-terminal histidine tag and the introduction of crowding agents. [98, 
109, 111, 159, 160]  These structures range from rings and stacks, to catenanes, cages and 
tubes, all within the dimensions necessary to qualify as nanomaterials. 
Catenanes 
The first crystal structure of BtPrx3 (93% sequence homology with HsPrx3), published in 
2005, showed that mutating Cysr (C168) to a serine led to the formation of a previously 
unseen catenated conformation of dodecameric Prx toroids. [167] The points of contact 
between two basic dimeric units on alternating rings were identified as the residues that may 

















’).  The catenated 
structure was seen again for BtPrx3-F190L with similar points of contacts between the rings. 
[143] Furthermore, the mutation of C168S for HsPrx3 also leads to a mixture of single and 
catenated rings as seem on TEM. [109]   While the physiological relevance and exact mode 
of assembly remains unclear, mutations at the C-terminal region of this Prx do appear to be 
involved at least under crystallographic and TEM conditions.  The HMW weight structures 
formed have a high surface area and a number of potential points for surface modification 
which could be utilised to form functional materials such as biosensors.  
Cages 
Prx decamers have been shown to assemble in dodecahedron cages under the conditions 
needed for TEM analysis. Meissner et al. used both crowing agents (polyethylene-glycol, 
PEG) and a TEM negative staining  procedure that promotes 2D crystallisation (ammonium 
molybdate and trehalose) to form dodecahedral cages from human erythrocyte Prx2 (Prx-2).  




[159] The structures formed can be varied by changing the TEM grid preparing. This 
includes adjusting the PEG concentration and the assembly time.  For example, the samples 
with a low PEG concentration (0.05 %) only displayed single rings and some small clusters. 
At medium PEG (0.2 %) concentration and a short incubation time (~ 5 min) Prx-2 had 
partially assembled into cage-like structures but there was still a high proportion of single 
rings.  Optimal conditions for cage formation were found to be 0.2 % PEG (w/v), 3 hour 
incubation time, 5 % (w/v) ammonium molybdate and 0.1 % (w/v) trehalose.  The crystal 
structure of Prx-2 was docked into a 3D reconstruction of the cages to give a 16 Å resolution 
pseudo-atomic structure (fig. 1.19).   
While the resolution is low it is clear that the cages are comprised of 12 Prx decamers and 
that the α6 helices are in close enough proximity to potentially aid cage stabilisation.  The 
interior of the cage has the potential to be used to form size controlled nanoparticles. 
 
 
Figure 1.19: Prx cage. The crystal structure of Prx-2 was docked into a 3D 
reconstruction of the cages to give a 16 Å resolution pseudo-atomic structure of the 
cages formed from human erythrocyte Prx-2. [158] Permission pending 
 
Tubes 
Tubes from can be formed by utilising the N-terminal histidine tag as a ligand to coordinate 
to divalent metal ions.  The crystal structure of SmPrx1 has shown that the protein has the 
ability to stack into double decamers. [110]  The oligomerisation can be amplified by 
increasing the R-type interface stability via coordination of divalent metal ions to the N-
terminal histidine tag. [98]  Aridni el al demonstrated that gold nanoparticles (AuNP), with 






 anchors, were able to coordinate to the histidine tags within minutes and tubes with 
conjugated AuNPs formed within hours.  The tubes can be dissembled with addition of 
chelating agents such as imidazole or EDTA. [98] 
As was described in section 1.4.4, HsPrx3 assembles into elongated 1D nanotubes at acidic 
pH.  This is believed to be due to the protonation of Cysp and the subsequent local unfolding 
of the active site and C-terminal region. [109]  A further study by Radjainia et al. elucidated 
the pseudo-atomic structure of these tubes to ~7 Å by mapping the crystal structure of BtPrx3 
onto the electron density map of the HsPrx3 cryo-EM reconstruction (fig. 1.20). [108]  By 
doing this they were able to confirm that the points of contact were indeed through the α2 and 
α6 helix plus additional contacts were noted between the partially resolved C-terminus and 
α2’ and α3’/4’.  This is different from the crystal structure of double stacked SmPrx1 due to 
the increased ordering of the C-terminus, possibly a result of the incorporation of the YF 
motif in HsPrx3 that is not seen in SmPrx1. [108, 110, 143]  They also noted significant 
differences in the ring diameter when compared to the BtPrx3 crystal structure.  These 
changes were attributed to changes at the A-type interfaces which appears to control the 
curvature of the toroid. Overall, the tubes show helical symmetry, with parameters 48.82 Å 
for the axial and azimuthal rotation angle of 8.06 
o
.  Helical symmetry is open, meaning that 









Figure 21:~7 Å ryo-EM reconstruction of a HsPrx3 tube at pH 4.2.  The crystal 
structure of BtPrx3 is docked into the electron density map to show specific points of 
contacts between the rings. [108] 
 
It is clear from the examples above that Prx is an ideal candidate for the formation of protein 
nanomaterials.  By combining the pH sensitivity of HsPrx3 with the metal chelating 
efficiency of the poly-6-histidine tag, further routes towards assembly will be explored.   
  
1.7 Conclusion 
The field of nanotechnology has grown immensely over the past 30 years. [5]  Within this 
field there is a growing interest in the use of self-assembling biological molecules to form 
bespoke and functional nanomaterials. [37]  Due to their 3D shape and the wealth of surface 
functionalities available, two  proteins have been selected for study in this thesis to further 
progress the field of bionanotechnology by exploring new routes towards controlled self-
assembly. 
Lsr2 has been chosen due to its innate ability to self-assemble into long fibres and its DNA 
binding function. The N-terminal domain of this protein will also be examined in isolation to 
improve the enzymatic switch which aids assembly 




HsPrx3-6his has been identified as an ideal tecton for the formation of protein nanotubes. 
[109]  This thesis strives to add to the previous work by discovering new routes towards 
controlled assembly and utilising the histidine tag as not only an oligomerisation trigger but 
also the potential source of functionalisation. 
Overall, this work will describe how these proteins have been used to form novel 
nanomaterials, the routes by which these materials are formed and suggest possible 
functionalities that may be utilised in future work. 
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Chapter Two: Materials and methods 
The following chapter describes the methods and materials used throughout this study.  
2.1 Materials 
2.1.1 Chemical reagents 
All chemical reagents were purchased from Sigma Aldrich (St. Louis, MO) unless otherwise 
specified. Tryptone media was purchased from Oxoid (United Kingdom) and yeast extract 
was purchased from Bacto-BD (United States). Plasmids were synthesised by Epoch 
Lifescience Inc (Sugar Land, TX) or GenScript (Piscataway, NJ). 
 
2.1.2 Bacterial strains 
BL21(DE3)* 
BL21(pRARE)Rosetta 




Each plasmid was engineered to have a particular antibiotic resistance (Table 2.1).  Solutions 
of antibiotics were prepared at the following concentrations: 
 










50 mg/mL 50 μg/mL 
Chloramphenicol Cam EtOH 35 mg/mL 35 μg/mL 
Table 2.1: List of antibiotics used during protein expression (AppliChem, Darmstadt, 
Germany). Growth solutions and agar plates were supplemented with the antibiotic relating 
to the plasmid resistance. 





Type Plasmid Resistance Chapter 
Nterm-Lsr2  











HsPrx3 WT – 6 his  




Amp + Cam 
Amp + Cam 
 
4 + 5 





Kan + Cam 
Kan + Cam 
 
5 
R-interface mutants  
pET151 D-TOPO-hsPrx3 K23A 
pET151 D-TOPO-hsPrx3 K23H 
pET151 D-TOPO-hsPrx3 K23R 
 
 
Amp + Cam 
Amp + Cam 
Amp + Cam 
 
4 








Kan + Cam 
Kan + Cam 
Kan + Cam 
Kan + Cam 
Kan + Cam 
 
5  




Table 2.2: List of the plasmids used in this thesis. Lsr2 and Nterm-Lsr2 were synthesised 
in-house at the University of Waikato, Ent-Nterm was synthesised by GenScript (Piscataway, 
NJ), R-interface mutants were developed in-house from the commercial HsPrx3-WT plasmid 
at the University of Auckland and all other peroxiredoxin plasmids were synthesised by 











Enteropeptidase (Applied Biological Materials (ABM) Inc, Canada) 
Tobacco Etch Virus (TEV) protease (in-house) 
 
2.1.5.2 Restriction enzymes 
NdeI – digest in buffer H 
NcoI – digest in buffer K 
XhoI – digest in buffer H 
 
For double digests a universal buffer was used 
All enzymes (10 U/μL) and buffers purchased from Invitrogen (Carlbad, US)  
 
2.1.5.3 Peroxiredoxin peroxidise assay 
Horse Radish Peroxidase (HRP)  
 
2.1.6 Media 
All media and media containers were sterilised by high pressure saturated steam (121 
o
C) for 
20 minutes prior to use. Media could be stored at 4 
o
C for up to two days if not used 
immediately. 
 
2.1.6.1 Lysogeny broth (LB) 
Lysogeny broth was used to grow all E. coli batches unless otherwise stated. The media 
contained tryptone (Oxoid, United Kindom), yeast extract (Bacto-BD, United States) and 
sodium chloride at 1%, 0.5% and 1% respectively in deionised water.   




2.1.6.2 Lysogeny broth agar (LA) 
The media was prepared as above with the addition of 1.5% agar (Bacto-BD, United States).  
This was dissolved into the media through the autoclave process. Appropriate antibiotics 
were added to the mix once the solution had cooled to 45
o
C and the plates were poured under 
sterile conditions [1] with ~ 20 mL per plate. 
 
2.1.6.3 Auto-induction media 
Auto-induction provided a means to grow bacteria without the need for manual induction. [2] 
The media consisted of 10 g of Tryptone and 5 g of yeast extract, dissolved in 960 mL MilliQ 
water. The media was autoclaved before the addition of 20 mL 50 x 5052 stock (25 % 
glycerol, 2.5 % glucose and 10% lactose), 20 mL 50 x M stock (1.25 M Na2HPO4, 1.25 M 
KH2PO4, 2.5 M NH4Cl and 0.25 M NaSO4), 1 mL 2 M MgSO4, 200 µL trace metals (50 mM 
FeCl2, 20 mM CaCl2, 10 mM each of MnCl2 and ZnSO4, 2 mM each of CoCl2, CuCl2, NiCl2, 

















All buffers were made using the reagents listed in the table, with the weight measured to ± 
0.01 g. The samples were incubated at the appropriate temperature before the pH was 
analysed. At this point the buffers were vacuum filtered through 0.2 μM filter paper.  
 
2.1.7.1 Lsr2, Nterm-Lsr2 and Ent-Nterm buffers 
Buffer Composition 
Lysis 20 mM imidazole, 200 mM NaCl, 50 mM NaPi, pH 7.4 
IMAC elution 1 M imidazole, 200 mM NaCl, 50 mM NaPi, pH 7.4 
Storage/proteolysis 200 mM NaCl, 50 mM NaPi, pH 7.4 
High salt 1 M NaCl, 50 mM NaPi, pH 7.4 
pH 9.0 200 mM NaCl, 200 mM Tris base 
pH 8.0 200 mM NaCl, 200 mM Tris base 
pH 6.0 200 mM NaCl, 200 mM NaPi 
CD 20 mM NaPi 
Table 2.3 NaPi relates to the ratio of NaH2PO4 and Na2HPO4 that has been calculated to 
achieve the correct pH. [3] 
 
2.1.7.2 Buffers for Prx purification (all at pH 8.0) 
Buffer Composition 
Lysis 20 mM imidazole, 150 mM NaCl, 20 mM HEPES 
IMAC elution 500 mM imidazole, 150 mM NaCl, 20 mM HEPES 
Storage – reduced 10 mM EDTA, 150 mM NaCl, 20 mM HEPES, 2 mM TCEP 
Storage – non-reduced 10 mM EDTA, 150 mM NaCl, 20 mM HEPES 
Table 2.4 




2.1.7.3 Buffers for assessing the locked toroid structure of Prx 
Buffer Composition 
Non-reduced 150 mM NaCl, 20 mM HEPES 
Reduced 150 mM NaCl, 20 mM HEPES, 2 mM TCEP 
EDTA chelation 
(red/NR) 
10 mM EDTA, 150 mM NaCl, 20 mM HEPES, ± 2 mM TCEP 
Imidazole chelation 
(red/NR) 
20 mM imidazole, 150 mM NaCl, 20 mM HEPES, ± 2 mM 
TCEP 
EDTA + imidazole 
chelation (red/NR) 
10 mM EDTA, 20 mM imidazole, 150 mM NaCl, 20 mM 
HEPES, ± 2 mM TCEP 
Table 2.5 (NR – non-reduced, red - reduced) 
 
2.1.7.4 Buffers for metal directed oligomerisation of Prx 
Buffer Composition 
Association buffer 20 mM imidazole, 150 mM NaCl, 20 mM HEPES, pH 8.0 
Coordination buffer 150 mM NaCl, 20 mM HEPES, pH 8.0 
Association buffer 
(Ardini) [4] 
20 mM imidazole, 150 mM NaCl, 30 mM MOPS, pH 7.6 
Coordination buffer 
(Ardini) [4] 
150 mM NaCl, 30 mM MOPS, pH 7.6 
Chelation buffer 50 mM EDTA, 150 mM NaCl, 20 mM HEPES, pH 8.0 
Table 2.6 




2.1.7.6 pH variation buffers for the oligomerisation of Prx 
Buffer Composition 
pH 7.8 – 7.0 red/NR 150 mM NaCl, 50 mM HEPES, ± 2 mM TCEP 
pH 9.0 150 mM NaCl, 50 mM Tris base 
pH 4.0 150 mM NaCl, 50 mM citrate 
High salt A 800 mM NaCl, 20 mM HEPES, pH 8.0 
High Salt B 800 mM (NH4)2SO4, 20 mM HEPES, pH 8.0 
High salt C 300 mM  NaCl, 50 mM HEPES, pH 7.4 
High salt D 600 mM NaCl, 50 mM HEPES, pH 7.4 
High salt E 1.2 M NaCl, 50 mM HEPES, pH 7.4 
No salt A 20 mM HEPES, pH 8.0 
No salt B 50 mM HEPES, pH 7.4 
 Table 2.7 
 
2.1.7.5 Peroxidase activity assay buffer 
Buffer Composition 










2.1.7.5 TEV purification and cleavage buffers 
Buffer Composition 
Lysis buffer 
20 mM imidazole, 20 mM NaH2Pi, 500 mM NaCl, 0.3 mM 
TCEP, pH 7.5 
Elution buffer 
500 mM imidazole, 20 mM NaH2PO4, 500 mM NaCl, 0.3 mM 
TCEP, pH 7.5 
Storage/cleavage buffer 
20 mM NaH2PO4, 150 mM NaCl, 1 mM TCEP, 1 mM EDTA,  
pH 7.5 
Table 2.9 NaPi relates to the ratio of NaH2PO4 and Na2HPO4 that has been calculated to 
achieve the correct pH. [3] 
 
 
2.2 Molecular biology and microbiology methods 
2.2.1 Preparing competent cells 
The frozen glycerol stocks of BL21(DE3)*or BL21(pRARE)Rosetta cells were applied to an 
agar plate containing either no antibiotic (BL21(DE3)*) or chloramphenicol 
(BL21(pRARE)Rosetta) (Table 2.1) (Chapter Two at 2.1.6.2) using a sterile loop. [1] The 
plates were incubated overnight (O/N) at 37
o
C at which point a single colony was picked for 
a 10 mL LB seed culture. The seed culture (± chloramphenicol) was grown O/N with shaking 
at 37 
o
C. 1 L of LB media (Chapter Two at 2.1.6.1) was inoculated with seed culture (1 %) (± 
chloramphenicol) and grown at 37 
o
C until the optical density at 600 nm (OD600) reached 
between 0.3 – 0.4. The solution was cooled to 4 
o
C on ice and the cells were harvested via 
centrifugation (3000 x g, 15 mins, 4
o
C). At this point the cells were prepared for either 
electroporation or chemical transformation. [5] 
 




2.2.1.1 Electrocompetent cells 
After centrifugation the supernatant was decanted and the pellet resuspended in 1 L of ice 
cold, sterile water. The cells were harvested from the suspension via centrifugation (3000 x g, 
15 mins, 4
o
C). The supernatant was removed and the pellet resuspended in 500 mL of ice 
cold, sterile water. The cells were harvested using centrifugation. These wash steps are 
essential as they remove any salts from the pellet that may interfere with the electroporation 
process. Again, the cells were resuspended in 20 mL ice cold 10 % glycerol and the 
centrifugation process was repeated. At this point, the supernatant was removed and the cell 
pellet was resuspended 4 mL ice cold 10 % glycerol. The suspension was separated into 
aliquots of 100 μL, frozen in liquid nitrogen and stored at – 80
o
C until use. 
 
2.2.1.2 Chemically competent cells 
After centrifugation the pellet was resuspended in 400 mL, ice cold, sterile MgCl2 solution 
(100 mM). The cells were harvested via centrifugation (2000 x g, 15 mins, 4
o
C). The 
supernatant was discarded and the pellet resuspended in 200 mL of ice cold, sterile CaCl2 and 
incubated on ice for 20 minutes. Again, the cells were harvested via centrifugation (2000 x g, 
15 mins, 4
o
C) and the supernatant removed. The pellet was resuspended in 50 mL ice cold, 
sterile chemically competent cell storage solution (85 mM CaCl2, 15 % glycerol w/v). The 
centrifugation step was repeated again but at a slower velocity (1000 x g, 15 mins, 4
o
C). The 
supernatant was discarded and the cells resuspended in 2 mL of the chemically competent 
cell storage solution. The suspension was separated into aliquots of 100 μL, frozen in liquid 
nitrogen and stored at – 80
o
C until use. 
 
2.2.2 Competent cell transformation 
2.2.2.1 Electrocompetent cells 
100 μL of frozen cells were thawed gently on ice (4
o
C). 1 μL of plasmid solution was added 
to the cells and mixed gently by tapping the Eppendorf and the mixture was incubated on ice 
(4
o
C) for 30 minutes. The mixture was transferred to a pre-chilled, sterile 1 mm 
electroporation cuvette and placed into the elctroporator (BioRad Gene PulserTM). It was 
essential that the cuvette was cleaned thoroughly prior to transformation to prevent unwanted 




DNA contamination. The sample was subjected to a 2.5 kV pulse and 900 μL of sterile LB 
(no antibiotic) was added immediately. The mixture was incubated at 37
o
C for one hour. 
Agar plates, containing the appropriate antibiotics (Table 2.1 and 2.2) were inoculated with 




2.2.2.2 Chemically competent cells 
100 μL of frozen cells were thawed on ice (4
o
C). 1 μL of plasmid solution was added to the 
cells and mixed gently by tapping the Eppendorf. The mixture was incubated on ice for 30 
minutes before heat shock at 42 
o
C for 1 minute. The cells were immediately put back on ice 
for a further 2 minutes. At this point, 900 μL of sterile LB media was added to the aliquot and 
the sample was mixed by pipetting and the mixture was incubated at 37 
o
C for one hour.  
Agar plates, containing the appropriate antibiotics (Table 2.1 and 2.2) were inoculated with 




2.2.3 Bacterial culture storage 
2.2.3.1 Long term storage 
Glycerol stocks were made for long term culture storage. 10 mL of LB (Chapter Two at 
2.1.6.1), + the appropriate antibiotic (Table 2.1), was inoculated with a single colony of 
transformed cells under sterile conditions. [1] This was grown O/N at 37
o
C with shaking (180 
rpm). 2 mL of seed culture was diluted 50:50 with sterilised glycerol solution (50 %) for a 
final glycerol concentration of 25 %. The mix was split into aliquots (1 mL), flash frozen 




2.2.3.1Short term storage 
The cells were grown on agar plate prepared using the protocol described in 2.1.6.2. The 
plates were incubated O/N at 37
o
C until mature colonies formed (~16 hours). The sealed 








2.2.4 DNA manipulations 
2.2.4.1 Plasmid extraction 
Reagents Composition 
glucose-Tris-EDTA (GTE) 50 mM glucose, 25 mM Tris-HCl, 10 mM EDTA, pH 8.0 
NaOH/SDS solution 0.2 M NaOH, 1% SDS 
potassium acetate solution 5 M CH3O2K  
Isopropyl alcohol (IPA) ACS reagent ≥ 99.5% 
Ethanol (EtOH) ACS reagent grade 
Tris-HCl-EDTA (TE) 10 mM tris-HCl, 1 mM EDTA, pH 7.5 
Table 2.10 
 
Plasmid extraction was performed to ensure correct transformation and to replenish any low 
plasmids stocks. The methods used were based those developed by Birnboim et al. [6] 10 mL 
LB (Chapter Two at 2.1.6.1) seed culture with the corresponding antibiotics (Table 2.1) was 
grown O/N at 37
o
C, with shaking. 1 mL of the seed culture was centrifuged (13, 000 x g, 
4
o
C) and the supernatant discarded. 100 μL of GTE buffer was added to the cell pellet. The 
solution was mixed gently to resuspend the pellet. At this point 200 μL of NaOH/SDS 
solution was added to the mix and the Eppendorf was inverted 6 – 8 times. As soon as this 
was completed 5 M potassium acetate solution was added to neutralise the NaOH and 
precipitate the genomic DNA. To separate out the genomic DNA, the suspension was 
centrifuged for 2 minutes (13,000 x g, 4 
o
C, Eppendorf). The supernatant was transferred into 
a new Eppendorf tube, taking care not to transfer any white flakes. The plasmid DNA was 
precipitated with the addition of 0.5 mL of IPA. The mix was incubated on ice for 10 minutes 
and then centrifuged for 2 minutes (13,000 x g, 4 
o
C). The supernatant was discarded and the 
sample was left for a few minutes to allow the remaining IPA to evaporate. The pellet was 
resuspended in 0.5 mL EtOH and the sample was again centrifuged for 2 minutes. The 
supernatant was discarded and the sample left to air dry, on ice, for 15 minutes. At this point, 
the pure plasmid was dissolved in 20 μL TE buffer and stored at -20
o
C until further use.  




2.2.4.2 Restriction digest 
Restriction digest was used to confirm the plasmids base pair count. The DNA (1 μg) was 
digested with the appropriate restriction enzymes and corresponding restriction buffers 
(Chapter Two at 2.1.5.2). The products were analysed on agarose electrophoresis (Chapter 
Two at 2.2.4.4)  
 
2.2.4.3 DNA concentration 
The concentration of DNA samples was analysed using NanoDrop 3300 spectrometer 
(Thermo Fisher Scientific Inc) using the automatic function: 
Concentration = (A260 / Ɛ260) * l 
A260 = absorption at 260 nm (AU) 
Ɛ260 = wavelength dependent extinction coefficient at 260 nm (ng/cm/μL) 
l = path length 
The software calculated the concentration from the average extinction coefficient for single 
stranded DNA which is around 50 ng/cm/μL. 
 
2.2.4.4 Agarose gel electrophoresis 
50 X Tris-Acetate EDTA (TAE) buffer ~ pH 8.5, 1L 
Tris-base 242 g 
Glacial acetic acid 57.1 mL 
EDTA (0.5 M, pH 8.0) 100 mL 
Table 2.11 
 
Gel electrophoresis was carried out to check DNA purity, identify DNA contamination from 
purified Lsr2 and to ensure the presence of the correct primers. Agarose gels were prepared 
by adding 1 % agarose (w/v) to 1 X TAE buffer and dissolving by gentle heating, ensuring 




the solution did not boil. Upon cooling to < 50
o
C, 5 μL of SYBR® Safe dye (Thermo fisher 
Scientific, Waltham US) was added and the gel was set in a gel caster, which included a 10 
well comb. Once the gel had set the cassette was placed into an electrophoresis chamber 
(Mini-sub Cell GT Cell, Bio-Rad, Hercules, US) and covered with 1 X TAE buffer until the 
liquid just filled the wells. DNA samples were mixed with a 1/6 volume of 6 x DNA loading 
dye (Life Technologies, Carlsbad US) to a total volume of 12 μL. 10 μL of this mix was 
loaded into the wells, taking care not to load any air bubbles. 5 μL of DNA ladder (various 
lengths, Life Technologies, Carlsbad US) was loaded into the remaining well and the sample 
was run at 120 V for 1 hour. The loading buffer contained a fluorescent dye and the bands 
corresponding to DNA base pairs were visualised under UV light. 
 
2.2.4.5 DNAse digest 
10 X DNase buffer pH 7.6 
Tris-HCl 100 mM 
MgCl2 25 mM 
CaCl2 5 mM 
Table 2.12 
 
DNAse was used to digest the DNA that co-purified with Lsr2. [7] 3 μL of 10 X DNAse 
buffer was added to 25 μL protein sample (1 mg/mL) and 2 μl of RQ1 DNase (1 U/μl, 
Promega) was mixed in to a total volume of 30 μL. The digest was left for 90 minutes at 
room temperature and the products were analysed on agarose gel electrophoresis (Chapter 
Two at 2.2.4.4) 
 




2.3 Recombinant protein production 
2.3.1 Protein expression 
Agar plates (Chapter Two at 2.1.6.2), supplemented with the appropriate antibiotic (Table 2.1 
and 2.2) were inoculated with ~ 2 μg of glycerol stock culture under sterile conditions. [1] 
This was spread evenly across the plate using a sterile loop. The plates were incubated O/N at 
37
o
C until established colonies appeared. A single colony was used to inoculate a 10 mL LB 
seed culture, supplemented with the correct antibiotics (Table 2.1 and 2.2). This was grown 




2.3.1.1 Isopropyl β-D-1-thiogalactopyranoside (IPTG) induction 
Lysogeny broth (LB) was prepared using the methods in 2.1.6.1. Either 1L (Lsr2, Nterm-
Lsr2, Ent-Nterm) or 400 mL (HsPrx3 and its derivatives) was inoculated with 1 % seed 
culture + the appropriate antibiotics (Table 2.1 and 2.2). The broth was incubated at 37
o
C, 
with shaking (180 rpm). The optical density at 600 nm (OD600) was monitored on a Specta 
Max MS multi-mode microplate reader at set time points until it reached between 0.4 – 0.6. 
At this point, the culture was cooled to room temperature and IPTG was added to a final 





2.3.1.2 Auto induction 
Media was prepared following the methods in 2.1.6.3. 1 L of media was inoculated with 1 
mL of seed culture + the corresponding antibiotics (Table 2.1 and 2.2). The broth was grown, 
with shaking (180 rpm), for 4 hours at 37
o
C. At this point the temperature was reduced to 30 
o
C and the culture was grown for a further 16 hours with shaking (180 rpm). 
 
2.3.1.3 Cell harvest by centrifugation 
The cell culture was harvested via centrifugation (8000 x g, 20 minutes, 4
o
C). The pellet was 
weighed and lysis buffer (Table 2.3 and 2.4) was added at a ratio of 5 x w/v. Once 
resuspended, the mixture was either lysed immediately or stored at – 80
o
C for up to 2 weeks. 





2.3.2 Protein extraction and purification 
2.3.2.1 Small Scale Lysis 
Small scale lysis was completed to confirm successful protein expression. 1 mL of the cell 
culture was harvested by centrifugation (8000 x g, 5 mins, RT). The pellet was resuspended 
in 200 μL of lysis buffer (Table 2.3 and 2.4) by gentle pipetting. 20 μL of 10 x lysozyme (10 
mg/mL) was added to the crude lysate along with Triton X-100 ASR (detergent) to a final 
concentration of 0.1%. The mixture was incubated in a water bath, with shaking, for 30 
minutes at 37
o
C. To aid cell lysis the lysate was subjected to a freeze thaw cycle (freeze in 
liquid nitrogen and thaw at 37
o
C for 15 min). Once fully thawed, 20 μL of 10 x DNase (1 
mg/mL) and 20 μL of 10 x MgSO4 (1 M) were both added and the sample was shaken at RT 
for 15 minutes. The insoluble and soluble fractions were separate by further centrifugation 
(10 000 x g, 5 mins, 4
o
C). The concentration of the soluble crude was analysed using 
nanodrop (Chapter Two at 2.4.1.2) and the presence of the target protein was confirmed by 
SDS-PAGE (Chapter Two at 2.4.2). 
 
2.3.2.2 Large Scale Lysis 
The resuspended pellet was cooled on ice to 4
o
C. To this mix, lysozyme was added to aid the 
lysis process (1 mg/mL). Cells were lysed on ice using sonication (0.5 amplitude, 40 %, 5 
minutes x 4) with one minute resting between each step. This was to allow the sample to cool 
to 4
o
C and prevent over heating which could denature the protein. 
 
2.3.2.3 Soluble protein extraction 
To separate the soluble proteins from the insoluble proteins and cell debris the sample was 
hard spun at 4
o
C (18000 x g, 30 minutes). At this point the soluble crude fraction was 
separated from the insoluble pellet, filtered through a 0.22 μm syringe filter, and kept on ice 
for further purification. 
 




2.3.2.4 Protein extraction by immobilised metal ion chromatography (IMAC) 
All constructs had an N-terminal or C-terminal 6-histdine tag. This allowed for IMAC 
purification. The target protein binds to immobilised Ni
2+
 within the column via the histidine 
imidazole side chain (~10 mg/mL, protein/column volume (CV)), and is released upon an 
increasing external imidazole concentration. The filtered soluble crude fraction was loaded 
onto an IMAC column (HisTrap FF Crude 5 mL column, GE Healthcare) equilibrated with 
lysis buffer (Table 2.3 and 2.4), at a flow rate of 2 mL/min. The column was then washed 
with 10 x CV or until all of the non-bound or weakly bound protein had eluted (absorbance at 
280 nm returns to baseline level). Any flow through (unbound protein) was collected to 
ensure the target protein had coordinated to the column. The target protein was eluted by 
applying a linear or stepwise gradient of an elution buffer (Table 2.3 and 2.4). Eluted 
fractions were collected in a 96 well plate and the absorbance signal at 280 nm was used to 
identify the location of the target protein. Fractions containing the target protein were pooled 
and concentrated to 5 mL using a 3 or 10 kDa molecular weight cut off concentrator 
(Centrifugal Concentrators Vivaspin 20 3.000 or 10.000 Cut Off), depending on the calculate 
MW of the protein.  
 
2.3.2.5 Buffer exchange by desalting column 
Isolated target protein from IMAC was passed through a desalting column (HiTrap Desalting 
5 mL column, GE Healthcre), equilibrated with protein storage buffer, (Table. 2.3 and 2.4) to 
remove excess imidazole. Eluted fractions were collected in a 96 well plate. The exchange of 
buffer was confirmed by measuring the conductivity and absorbance at 280 nm. A peak in the 
conductivity relates to the eluted salt. In successful buffer exchange there was no cross over 
between the conductivity peak and 280 nm absorbance peak. 
 
2.3.2.6 Size exclusion chromatography (SEC) 
SEC was used during the purification as a final finishing step and in some cases, as a buffer 
exchange step. (GE Healthcare HiLoad 10/16 Superdex 200 prep grade , MW 10 – 600 kDa) 
Due to the large volume of the column, up to 5 mL of sample could be loaded (< 3 % CV) [8] 
and the Superdex matrix allowed for high resolution separation which made this column ideal 
for purification purposes. [9] Blue dextran was eluted through the column to assess the void 




volume (V0), calculated to be 46.1 mL. Before sample analysis and purification, the column 
was calibrated using commercially available standards of a known MW (Table 2.13). The 
partition (Kav) was calculated from the standard elution volumes (equation 2.1).  
Kav = (Ve – V0)/(Vc-V0) 
Ve = elution volume 
V0 = void volume (46.1 mL) 
Vc = column volume (120 mL) 
Equation 2.1 
 
Log(MW) was plotted against Kav to give a calibration curve from which an unknown MW 
could be calculated (equation 2.2). 










Table 2.13: Elution volumes of calibration standards of a known molecular weight. Log(MW) is 
plotted against Kav to give the HiLoad 10/16 Superdex 200 prep grade calibration curve. 
 













Protein MW  
(Da) 
Ve Log(MW) Kav 
     Thyroglobulin  670,000 45.622 5.826075 -0.00647 
γ-globulin  158,000 64.003 5.198657 0.24226 
Ovalbumin  44,000 81.326 4.643453 0.476671 
Myoglobin  17,000 92.699 4.230449 0.630568 
Vitamin B12 1,350 112.138 3.130334 0.893613 





The column was equilibrated with storage buffer (Table 2.3 and 2.4) and the sample was 
loaded and run at 1 ml/min. The absorbance (280nm) was measured to allocate protein 
elution volumes. [8] The MW of the eluted fractions was calculated using the calibration 
curve. [10] All fractions were analysed on SDS-PAGE (Chapter Two at 2.4.3) to confirm the 
presence of target protein/the absence of impurities. Fractions containing isolated target 
protein were stored at 4 
o
C (short term, 1 week) or flash frozen in liquid nitrogen (5 – 10 %) 
and stored at -80 
o
C until use.  
 
2.3.3 Histidine tag removal by Tobacco etch virus (TEV) digest  
2.3.3.1 TEV expression and purification 
TEV was produced in-house using the plasmid design (pRK793) derived from Blommel and 
Fox 2007. [11] An affinity tag, poly-6histidine, followed by a maltose binding protein (MBP) 
was added to the C-terminus of the target protein by expression vector. This allowed ease of 
purification and increased protein solubility. [11] There was a TEV recognition site between 
the MBP and histidine tag which allowed for self-cleavage of the MBP during the 
purification process. E. coli (BL21 RILP) was transformed with the plasmid and the cells 
were grown on agar plates supplemented with kanamycin and chloramphenicol. The protein 
was expressed in auto induction media (Chapter Two at 2.1.6.3) using the protocols from 
section 2.3.1. [2] The cells harvested using centrifugation, resuspended in lysis buffer (Table 
2.9) and lysed on ice via sonication (Chapter Two at 2.3.2.2). The cell debris and insoluble 
protein was removed by centrifugation (Chapter Two at 2.3.2.3). Before any further 
purification, the sample was left to incubate at 4 
o
C for at least 3 hours to allow for the self-
cleavage of MBP. [11] Target protein was isolated from the soluble crude fraction using 
IMAC (Chapter Two at 2.3.2.2) and eluted upon increasing elution buffer concentration 
(Table 2.9). SEC was used a final purification step and to exchange the protein into 
storage/cleavage buffer (Table 2.9). Isolation of the target protein was confirmed by SDS-
PAGE (Chapter Two at 2.4.3). 
 




2.3.3.2 TEV fusion tag cleavage 
TEV cleavage was used to remove the histidine tag from HsPrx3-6his. The protein had a 
TEV recognition site which allowed for the removal of the non-native residues at the N-
terminus. A small scale digest using a range of TEV:HsPrx3-6his ratios was completed to 
determine the optimal conditions for tag removal 
HsPrx3-6his was transferred into the cleavage buffer (Table 2.9) using a desalting column. 
The protein was then mixed with TEV at ratios 1:1, 1:10, 1:20, 1:50 and 1:100. The samples 
were incubated O/N at 4 
o
C. The extent of digest was analysed using SDS-PAGE (Chapter 
Two at 2.4.3). Successful digest at 1:20 TEV:HsPrx3 was confimed by a single band at 20 
kDa (cleaved protein MW).  2 mL of HsPrx3-6his (8 mg/mL) was transferred into cleavage 
buffer using a desalting column.  The eluted protein was diluted to 2 mg/mL and split into 
aliquots of ~ 2mL. TEV was added to a final ratio of 1:20 and the samples were incubated 
O/N at 4 
o
C. At this point, the aliquots were combined and cleaved protein was isolated from 
the tag and TEV using IMAC that had been charged with Co
 2+
. The pass through was 
collected and further purified using SEC. This was also the desalting step whereby the 
cleaved protein was transferred into storage buffer (Table 2.4). The purity of the cleaved 
protein was confirmed using SDS-PAGE. 
 
2.4 Protein characterisation 
2.4.1 Determining protein concentration 
2.4.1.1 Bradford assay 
Reagents for Bradford assay 
Dye Bio-rad Protein Assay Dye Reagent 
concentrate (Bio-Rad) 
Protein standard Bovine Serum Albumin (BSA) (Gibco) 
Table 2.13 




Bradford assay was used to determine protein concentration following procedures developed 
by Marion M. Bradford. [12] BSA standards were prepared in dH2O with a concentration 
range from 0.50 – 0.063 mg/mL. The protein samples were analysed at 100%, 50 % and 10 % 
dilution. The upper limit of the wavelength with the Bradford reagent is 0.5 mg/mL, anything 
above this will not be accurate and therefore the dilutions are needed to ensure accurate 
measurement. Samples were prepared in a 96 well, clear bottom plate (Jet Biofil). 10 μL of 
the protein dilution was added to each well and then mixed with 200 μL of 1 x Bradford 
reagent (Biorad, Hercules, CA). All standards and protein dilutions were prepared in 
triplicate. The plates were left to stand for at least 5 minutes but no longer than hour, at room 
temperature to allow the dye to develop. The concentration was analysed using a Specta Max 




For samples with a low volume, nanodrop was used to gain an accurate concentration. This 
was compared to the bulk sample to ensure method consistency. The nanopdrop ND 100 
spectrophotometer was equilibrated with 2 μL of filtered dH2O and the equipment was 
blanked using the appropriate buffer. The protein was loaded on the reader and measured the 
260/280 nm using the protein extinction coefficient calculated from ExPASy. [13] 
 
2.4.2 Differential scanning fluorometry 
DSF reagent 
50 X dye 2 μL 5000 X SYPRO orange (Invitrogen) 
198 μL dH2O 
Table 2.14 
 
The 50 X dye was prepared and centrifuged (12, 000 rpm, 1 min, Eppendorf) directly before 
use. The protein sample (40 μL, ~ 1 mg/mL), dH2O (50 μL) and 50 X dye (10 μL) were 
mixed to a final volume of 100 μL. The mixture (25 μL) was added to a 96-well thin wall, 
PCR plate (Bio-Rad) in triplicate. A buffer blank was also prepared to generate the thermal 




shift base line. The plates were sealed and heated on a Biorad, CFX connect Real Time PCR 
Detection System (Bio-Rad) from 20 to 95 °C in increments of 0.5 °C, with 30 s dwell time. 
The melting temperature was calculated by plotting the negative derivative of the relative 




2.4.3 Sodium Dodecyl Sulfate Polyacrylamide gel Electrophoresis (SDS-PAGE) 
 
SDS-PAGE reagents 
4 x Loading buffer 
Novex® Sharp Pre-stained Protein Standard 
(Life Technologies) 
10 x reducing agent 500 mM DTT 
Molecular weight ladder (MWL) 
Novex® Sharp Pre-stained Protein Standard 
(Life Technologies) 
Gel 
NuPAGE™ Novex™ 4-12% Bis-Tris Protein 
Gels, 1.0 mm, 10-well (Life Techonolies, 
NP0321) 
Electroporesis tank buffer 
NuPAGE® MES SDS Running Buffer (20X) 
(Life Technologies) 
Table 2.15: List of reagents, buffers and equipment needed for SDS-PAGE 
 
SDS-PAGE analysis was used routinely to determine protein molecular weight and to probe 
the stability of oligomers. [14] Samples were prepared with 5 μL 4x loading buffer, 2 μL 10 x 
DTT, protein solution to a final concentration of around 250 μg/mL and dH2O to a final 
volume of 20 μL.  To ensure protein denaturation, the aliquots were placed in nearly boiling 
water (95 
o
C) for 5 minutes and then centrifuged before analysis.  The 20 μL samples were 
loaded onto the gel and run at 200 mV for 35 minutes.  The gel was washed in warm dH2O 3 
times to allow any SDS to defuse from the gel and stained with simply blue stain (60 – 80 mg 




G250) for at least 2 hours or until clear bands began to appear. Destaining was achieved 
through O/N rinsing in dH2O. 
2.4.4 Matrix assister laser ionisation (MALDI)-time of flight (TOF) mass spectrometry 
 
Solutions for MALDI-TOF MS 
Matrix diluent (1 mL) 
500 μL acetonitrile 
500 μL uH2O 
1 μL triflouroacetic acid 
Sample/standard diluent (1mL) 
300 μL acetonitrile 
700 μL uH2O 
1 μL triflouroacetic acid 
Matrix HMW Sinapinic acid 
Matrix LMW α-cyano-4-hydroxycinnamic acid (CHCA) 
Cal 1 LMW (100 μL) 
(Applied Biosystems) 
6.5 μg Angiotensin I 
10.5 μg Adrenocorticotropic Hormone 
(1–17 clip) (2094Da) 
9.3 μg Adrenocorticotropic Hormone 
(18–39 clip) (2464 Da) 
27.5 μg Adrenocorticotropic Hormone 
(7–38 clip) (3659 Da) 
50.2 μg Insulin, bovine (5733 Da) 
 
Cal 2 HMW (100 μL) 
(Applied Biosystems) 
7.1 μg Insulin, bovine (5733 Da) 
80.0 μg Thioredoxin, E. Coli (11674 Da) 
170.0 μg Apomyoglobin, horse (16,952 Da) 
Table 2.16 
 
The MW of Lsr2, Nterm-Lsr2 and Ent-Nterm pre and post-proteolysis was ascertained using 
MALDI-TOF mass spectroscopy. For the proteins pre-proteolysis the HMW standard and 
matrix were used and for the proteins post-proteolysis the LMW matrix and standards were 
used. The matrix (HMW or LMW) was mixed in 1 mL of matrix diluent directly before use. 




Undissolved matrix crystals were removed by centrifugation (12, 000 rpm, 5 mins, 
Eppendorf). The sample matrix and protein sample/calibration standard were mixed at a 5:1 
ratio. 1 µL of this mix was spotted in duplicate onto the MALDI-TOF sample plate (192 well, 
Applied Biosystems) and air dried before analysis.  
Spectra was obtained on an AB SCIEX 5800 MALDI TOF/TOF at Victoria University, 
Wellington in the positive ion linear mode. The parameters were as follows: 
Detector voltage – 1.95 kV 
Pulse rate – 400 Hz 
Time delay – 200  - 300 ns 
Mass range – 2000 – 30,000 Da 
 
2.4.5 Liquid Chromatography Mass Spectroscopy (LCMS) 
LCMS was used to determine the protein MW for constructs > 20 kDa. The protein was 
exchanged into a LCMS buffer using the desalting column.  0.5 mL aliquots of ~2 mg/mL 
protein sample were transferred into a 1 mL glass vial in preparation for analysis. The mass 
was obtained on a maXis 3G ultra high resolution time of flight tandem mass spectrometer 
(Brucker, Billerca, US).  All data collection and analysis was completed by Dr Amelia 
Albrett at the University of Canterbury. 
 
2.4.6 Western blot immunodetection 
Western blot immunodetection was used to identify bands on SDS-PAGE that related to SDS 
stable target protein oligomers. The 1
o
 antibody (anti-mouse) binds to the histidine tag 
sequence [15] and a 2
o
 antibody is applied which binds to the 1
o
 and the chromogenic dye 
which allows for tagged protein detection. The samples to be analysed were run on SDS-
PAGE (Chapter Two at 2.4.3). All solutions were part of the anti-mouse iBlot chromogenic 
western detection kit (Invitrogen, Carlbad, US) The diluent mix (10.5 mL of diluents + 4.5 
mL of additive) was prepared and split into three aliquots 5 mL prior to protein transfer. 
 




2.4.6.1 Protein transfer 
The protein from the gel was transferred to a PVDF membrane using an iBlot transfer system 
(Invitrogen, Carlbad, US) The PVDF membrane was placed on a copper anode (bottom 
stack). The SDS-PAGE gel was removed from the cassette and placed on top of the PVDF 
membrane followed by a sheet of filter paper, soaked in dH2O, and a copper cathode (top 
stack). Air bubbles were gentle removed using a roller and a sponge was placed on top of the 
cathode.  the lid was closed to complete the circuit. Program 2 (23 V, 6 mins) was selected to 
apply an electric field which transferred the charged protein to the membrane.  
 
2.4.6.2 Blocking 
The PVDF membrane was washed with dH2O and then placed back on top of the copper 
anode. The equipment was set up as described above with a blank matrix (soaked in 5 mL of 
diluent mix) in place of the filter paper. Program 9 was selected which ran in three stages: 
1. 20 V, 2 mins 
2. 5 V, 3 mins 
3. 5 V, 3mins 
While the first blocking step was running a new matrix was soaked in 5 mL of 1
o
 antibody 
mix (5 mL diluent mix + 5 µL 1
o
 antibody). The 1
o
 antibody matrix replaced the blank matrix 
and the second stage for program 9 was run. A new matrix was soaked in 5 mL 2
o
 antibody 
mix (5 mL diluent mix + 5 µL 2
o
 antibody) and the procedure was repeated for the final step. 
2.4.6.3 Washing 
The PDVF membrane was briefly rinsed with 20 mL of 1 x wash solution (6 mL stock 
washing solution + 90 mL dH2O). The solution was discarded and another 20 mL of 1 x wash 
solution was added and the sample was incubated at RT (5 mins with gentle shaking). This 
step was repeated two more times, discarding the wash solution at each step. The membrane 
was rinsed twice with dH2O. 
2.4.6.4 Chromogenic detection 
The membrane was soaked in 5 mL of the chromogenic substrate solution. This was 
incubated until a purple band for the histidine tagged positive control began to appear (no 




longer than 1 hour). The reaction was stopped by rinsing with dH2O for 2 minutes x 2. The 
membrane was air dried and the image recorded. 
 
2.5 Biophysical techniques 
2.5.1 Analytical SEC 
Analytical SEC was completed on a Superdex 200 10/300GL, 24 mL (GE Healthcare), MW 
range 10 – 600 kDa. The Superdex matrix, dextran beads covalent linked to cross-linked 
agarose, allowed for high resolution analysis and the smaller volumes analysed using this 
column as appose to the 120 mL column reduced the peak broadening effect that can be a 
hindrance when using this method of MW analysis. [8] Blue dextran was eluted through the 
column to assess the void volume (V0), calculated to be 8.34 mL. Before sample analysis and 
purification, the column was calibrated using commercially available standards of a known 
MW (Table 2.17). The partition (Kav) was calculated from the standard elution volumes 
(equation 1, 2.3.2.6, Vc = 24 mL). Log(MW) was plotted against Kav to give a calibration 
curve from which an unknown MW could be calculated (equation 2.3). 
MW = 10 







Ve Kav log MW 
Thyroglobin 669000 9.181 0.055874 5.825426 
Ferritin 440000 10.935 0.167622 5.643453 
Aldolase 158000 13.17 0.310015 5.198657 
Conalbumin 75000 14.525 0.396343 4.875061 
Ovalbumin 44000 15.547 0.461455 4.643453 
Carbonic 
Anhydrase 
29000 16.84 0.543833 4.462398 
Cytochrome C 12400 18.002 0.617864 4.093422 




Table 2.17: Elution volumes of calibration standards of a known molecular weight. Log(MW) is 
plotted against Kav to give the Superdex 200 10/300GL columne calibration curve. 
 
Figure 2.2: Calibration curve for Superdex 200 10/300GL column. 
Protein samples were prepared in the appropriate buffer (Chapter Two at 2.1.7) at varying 
concentrations (0.2 – 10 mg/mL) depending on the experiment.  The column was equilibrated 
in the sample buffer and the protein solution (0.5 mL) was loaded onto the column and run at 
a flow rate of 0.5 mL/min. The absorbance (280nm) was measured to allocate protein elution 
volumes. [8] In some cases the eluted fractions were collected for further analysis e.g. 
equilibrium experiments or SDS-PAGE analysis to check sample purity. The MW was 
calculated from the column calibration curve. This particular method of analysis allowed for 
the calculation of protein oligomer MW [10] and therefore was used as a primary method to 
assess the degree of assembly in the protein native state and under non-native self-associating 
conditions. 
 
2.5.2 Circular Dichroism (CD) 
Circular dichroism was employed to analyse the protein secondary structure. The protein was 
transferred into 10 mM sodium phosphate buffer to remove any salt (NaCl) and reducing 
agents (TCEP) that strongly absorb within the range of the wavelength scan. [16] The buffer 
exchange was completed using a desalting HiTrap 5 mL column (Chapter Two at 2.3.2.7). A 
quartz cuvette (1 mL) with a 1 cm path length was used for all experiments. The 
measurements were made using a ChiraScan CD spectrometer (Applied Photophysics Ltd, 
United Kingdom). The instrument was initialised with dH2O and the buffer was used to 
generate a blank spectra. The CD in response to absorption was measure over a range of 
wavelengths (λ 280 – 190 nm). Correct secondary structure was confirmed by matching the 





















variations in the secondary structure due to changes in the protein sequence or experimental 
conditions were measured in this way. 
2.5.3 Analytical ultra centrifugation (AUC) 
Protein solutions were prepared at concentrations ranging from 0.15 – 0.6 mg/mL to a 
volume of 380 μL. Each sample was analysed with its own blank (400 μL) containing the 
corresponding buffer only. The larger blank volume was needed to accurately place the 
meniscus of the sample cell. [17] The cells used were either quartz or sapphire with a cell 
path length of 1.2 cm. A wavelength scan was run prior to the experiment to determine to 
wavelength (λ = 270 – 280) that provided the optimal optical density (OD270 – 290 between 0.2 
– 1.0 [17]) for all the protein samples that were being analysed at any one point.  During this 
study the centrifugal velocity was initially set at 38 000 rpm as this had shown good data 
around the MW of a peroxiredoxin dimer and dodecamer. Samples of a larger MW were 
studied at 20 000 rpm to allow for sedimentation over a greater number of scans. All runs 
were completed at 20 
o
C. The Svendberg sedimentation coefficient (S) was calculated using 
the c(s) model in SEDFIT. [18] The software was also able to approximate the particle mass 
using the equation below (equation 2.4) 
  
      
       
 
M = mass  
s = sedimentation coefficient 
  = frictional coefficient 
Na = Avogadro’s number 
ρ = solvent density 




2.5.4 Transmission electron microscopy (TEM) 
The structure of the proteins in their native and oligomerised state were analysed using TEM. 
The heterogenous nature of many of the oligomer systems would make other structure 
determining techniques, (X-ray crystallography, SAXS) difficult. The protein samples were 




diluted to 100 or 50 μg/mL in dH2O directly before grid preparation. This was to reduced 
over crowding from excess protein and to remove salts, both of which would diminish the 
clarity of the image collection. Carbon coated formvar 200-mesh copper grids were deposited 
for 1 minute on;  
1) 20 μL protein sample 
2) 20 μL (x 3, 20 seconds each) 
3) 1 % uranyl acetate negative stain 
Excess dye was removed by holding fibre less filter paper to the edge of the grid and 
allowing the liquid to be soaked up, taking care to not touch the centre of the grid.  The grid 
was then air-dried for a least an hour before TEM analysis.   
Image collection was completed by Jackie Healey, University of Canterbury, on a FEI 
Morgagni 268D transmission electron microscope operating at 80 kV, with magnifications up 
to 180k. Images were captured using a SIS/Olympus Megapixel III digital camera mounted 
above the phosphor screen. 
 
2.5.5 Dynamic light scattering (DLS) 
DLS was used a quick method to analyse the particle size of protein assemblies. It was also 
used to map the progression of oligomerisation in real time. DLS was measured on a 
Zetasizer Nano ZS (Malvern UK) which uses a He-Ne laser as the light source (λ = 673) with 
the 173 
o
 back scattering detected  by an avalanche photodiode.  The proteins were prepared 
in the appropriate buffer (Chapter Two at 2.1.7) at varying concentrations (0.1 – 1 mg/mL) 
and the cuvette l (standard disposable cuvette, PMMA, Sigma Aldrige) was placed into the 
thermostated sample chamber, set at 20 
o
C. The sample was equilibrated to the temperature 
and the DH was measure with 3 – 6 scans over 4 minutes. The data was analysed using DTS 
software which plots the correlation function vs time from which the average particle size (Z-











2.6 Manipulations of Lsr2 and its derivatives 
2.6.1 Lsr2 trypsin digest assay 
Trypsin (≥7,500 units/mg solid) was used to cleave at the N-terminal lysine (Lys
4
). 1 µL of 
the enzyme solution (1 mg/mL) was added to 50 µL protein sample (1 mg/mL) resulting in a 
final trypsin to protein solution volume ratio of 1:500. The digest was stopped at varying time 
points (5, 10, 15 and 30 mins) by heat denaturation (5 mins, 96 
o
C). The MW of the protein 
was analysed using SDS-PAGE (Chapter Two at 2.4.3). The samples were prepared by 
adding 5 µL of loading dye and 2 µL of DTT solution (0.5 M) to 10 µL of the protein sample 
and the aliquot was made up to 20 µL with dH2O. Trypsin was also run as a control. The 
DNA agarose gel samples were prepared and run using the methods in 2.2.4.4, with trypsin 
also being analysed as a negative control. 
 
2.6.2 Lsr2 in high salt 
Lsr2 (1 mg/mL) was transferred into high salt buffer (Table 2.3) using a desalting column 
(Chapter Two at 2.3.2.5) and left O/N to allow for DNA dissociation. The protein MW was 
analysed using analytical SEC (Chapter Two at 2.5.2). 
 
2.6.3 Nterm-Lsr2 Trypsin digest 
Trypsin (≥7,500 units/mg solid) was used to cleave at the N-terminal lysine (Lys
4
) which 
facilitated the formation of large oligomeric Nterm-Lsr2 structures. [7] 10 µL of the enzyme 
solution (1 mg/mL) was added to 0.5 mL protein sample of varying concentration resulting in 
a final trypsin to protein solution volume ratio of 1:500. The digest was stopped after 10 
minutes at room temperature by the addition of trypsin inhibitor at 10x the concentration of 
trypsin. The mixture was left to rest for a further 20 minutes to allow for oligomer formation 
and injected onto a 24 mL SEC column equilibrated with storage buffer. A small aliquot was 
retained for TEM analysis. 




2.6.4 Ent-Nterm enteropeptidase proteolysis 
Porcine-enteropeptidase (Applied Biological Materials (ABM) Inc, Canada) was used to 
cleave at the enteropeptidase linker to leave Lys
4
 as the N-terminal amino acid on Ent-Nterm. 
30 units of enzyme (30 µL enteropeptidase solution at 1 U/ µL) were added to a 0.5 mL 
protein sample (1 mg/mL, 50 mM sodium phosphate, 200 mM NaCl, pH 7.4) and stored for 
16 h at room temperature. The mixture was then injected onto a 24 mL SEC column 
equilibrated with storage buffer with a small aliquot kept aside for TEM analysis. 
 
2.6.5 Equilibrium assay 
Equilibrium assays were performed on SEC by selecting a fraction from the centre of each 
oligomer peak and re-injecting onto the column. The concentration for each fraction was 
measured by the Bradford assay [12] prior to re-injection.  
 
2.6.8 pH sensitivity assay 
For variations in pH during oligomerisation, the protein was digested as described above at 
pH 7.4 followed by the addition of 0.5 mL of a buffer with a 4-fold greater buffer capacity 
than that of pH 7.4. The pH values tested were 6, 8 and 9 (Table 2.3).  
After adjusting and checking the pH, the 1 mL sample was injected onto a 24 mL SEC 
column equilibrated with the same buffer used to change the oligomerisation pH. As a control 
a 1 mL sample of Nterm-Lsr2 in pH 7.4 buffer was run under pH 7.4 conditions prior to the 
pH experiment to show that increasing the sample injection volume did not affect the 
positioning of peaks on the spectra. Once the sample had been run on SEC the oligomer 
peaks were collected exchanged into pH 7.4 buffer using a 3 kDa molecular weight cut-off 
concentrator (Centrifugal Concentrators Vivaspin 20 3.000 Cut Off). Around 3 wash cycles 
removed 99% of initial salt concentration. The pH of the resulting sample was measured to 
ensure adequate buffer exchange and the sample was reanalysed on SEC. 
 




2.7 Peroxiredoxin manipulations 
2.7.1 Reduced and non reduced 
The protein was transferred into the appropriate buffer (Table 2.5) using a desalting column.  
The concentration was checked by Bradford assay .[12] and a small aliquot was retained for 
SDS-PAGE analysis. 0.5 mL was loaded onto the SEC analytical column and the MW was 
calculated from the calibration curve (Chapter Two at 2.5.1). The samples for SDS-PAGE 
were denatured using slightly altered conditions to the standard protocol (3.4.3) (95 
o
C, 1 
min) and the oligomerisation was assessed to determine the formation of the active site 
disulfide bond. [20] 
 
2.7.2 Metal ion oligomerisation  
The protein sample (40 μM) was transferred into metal association buffer (Table 2.5) using a 
desalting column. Ni
2+
 was spiked in at a ratio of 1:6, 1:3, 3:1, 6:1 Ni
2+
: Protein. This was left 
O/N at 4 
o
C. The sample concentration was checked prior to any further testing to ensure no 
protein had precipitated. The buffer exchange (removal of imidazole) was achieved via 
stepwise dialfiltration – 1:10 x dilution into coordination buffer, concentrate to a 1/10 of the 
volume (Centrifugal Concentrators Vivaspin 20 10K Cut Off) and repeat five times. The 
concentration was checked again and samples that showed significant precipitation where re-
suspended in 10 mM EDTA but no further testing was done. Samples with a stable 
concentration were analysed on SEC and AUC (Chapter Two at 2.5.1 and 2.5.3). The 
structure of any large oligomers was identified using TEM. 
The 1:1 metal to protein ratio showed the optimal oligomerisation conditions. Different 




) and the extent of assembly was analysed 
using SEC. The oligomers were disassembled by adding 50 mM EDTA.  The dissociation 
was confirmed using SEC (Chapter Two at 2.5.1). Different buffers and pH were trialled in 
accordance to the protocol from Ardini et al.[4] The protein was transferred into pH 7.6 metal 
association buffer (Table 2.1.7.4).  The protein was analysed on AUC prior to metal 
coordinatiton to take note of any differences that occurred because of the change in buffer 
conditions. The coordintation with metal proceeded as above and the oligomers was analysed 
on AUC. The structure was visualised using TEM 




2.7.3 pH switch 
The protein (1 mg/mL) was exchanged into the varying pH buffers (Table 2.6) by O/N 
dialysis using either  2 mL dialysis buttons (Tube-O-DIALYZER, medi, 8K MWCO, 
Bioscience) or 100 μL dialysis buttons (Slide-A-Lyzer, MINI Dialysis Device, 10K MWCO, 
Thermo Fisher Scientific) depending on the amount needed for analysis. The dialysis was 
carried out at 4 
o
C excluding the DLS control assays in which samples were dialysed at room 
temperature. The pH of the sample was checked after dialysis to confirm successful buffer 
exchange. The samples were filtered through a 0.5 mL, 0.2 μm Eppendorf spin filter and the 
concentration was checked using either Bradford assay or Nanodrop to ensure no protein had 
precipitated. The protein oligomeric state was primarily analysed using SEC (Chapter Two at 
2.5.1). Further solution analysis was conducted using AUC and DLS (Chapter Two at 2.5.3 
and2.5.5). The structure of the oligomers was determined by TEM (Chapter Two at 2.5.4).  
 
2.7.4 Protein concentration assay 
1 mL of protein sample was exchanged into the different pH buffers as described above (pH 
7.2, 7.6 and 7.8) at varying concentrations (0.5, 1, 3 and 5 mg/mL). The sample was filtered 
and both the concentration and pH were checked prior to further analysis.  The molecular 
weight was analysed using HPLC with a static light scattering detector. 
2.7.5 High salt 
Non-reduced HsPrx3at pH 8.0 (Table 2.5) was subjected to a range of different salt 
concentrations to disrupt the electrostatic interaction that were aiding the assembly of 










2.7.5.1 NaCl or (NH4)2SO4 
Final salt conc 
(mM) 





Volume of no salt 
buffer (μL) 
0 100 0 100 
100 100 25 75 
200 100 50 50 
400 100 100 0 
Table 2.18 
 
The sample (2 mg/mL) was transferred into a no salt buffer (20 mM HEPES, pH 7.4) by O/N 
dialysis (Tube-O-DIALYZER, medi, 8K MWCO, Bioscience) at 4 
o
C. A (Table 2.6). The salt 
concentration was increased by diluting the sample at different ratios of high salt A or B 
buffers (Table 2.6, NaCl and (NH4)2SO4 respectively) so the final protein concentration was 1 
mg/mL and salt concentration varied (Table 2.18). The protein sample was incubated at 4 
o
C 
and concentration was analysed using Bradford assay at time points 30 mins, 60 mins, 90 
mins, 180 mins and 21 hours. Before concentration analysis the sample was centrifuged to 
remove any precipitated protein. 
2.7.5.2 Disassembly of tubes at pH 7.4 
NaCl was use during this assay due to increased protein precipitation when using (NH4)2SO4. 
The protein was dialysed O/N (Slide-A-Lyzer, MINI Dialysis Device, 10K MWCO, Thermo 
Fisher Scientific, 4 
o
C) into pH 7.4 buffer (Table 2.6) and the sample was analysed using 
SEC to ensure full oligomerisation. The protein solution was split into 3 x 0.5 mL and 
dialysed O/N into the different salt concentration buffers (High salt C, D and E, table 2.6).  
At this point the concentration was checked by Bradford assay and the pH was measured to 
ensure no variation due to buffer exchange.  The sample was analysed using SEC and the 
MW calculated from the calibration curve (Chapter Two at 2.5.1). 
 




2.7.6 Peroxiredoxin activity assay in competition with horse radish peroxidase 
Buffers and solutions 
Activity assay buffer 100 mM KH2PO4, O.1 DPTA, pH 7.5 
1M β-mercaptoethanol 15 μL 14.35 M stock, 85 μL uH2O, pH 7 - 8 
H2O2  6 x 10 
-4
 % w/v serial dilutions from stock (6 % w/v)  - 1:10, 
1:100, 1:1000, 1:10000 (1 mL) 
HRP solution (~ 80 μM) 5 mg HRP-VI, 1 mL assay buffer 
Table 19All solutions were made in uH2O and pH was adjusted using 1 M KOH in uH2O. 
2.7.6.1 Sample preparation 
HsPrx3 was concentrated to 60 μL (between 15 – 20 mg/mL) using a Centrifugal Vivaspin 
500 (μL) 10K cut off concentrator. 2 μL of 1 M β-mercaptoethanol was added to the sample 
and the mix was incubated on ice for 30 mins – 1 hour to ensure complete reduction of the 
peroxidatic cysteine. [21] The protein was loaded onto a Bio-Rad Micro-Spin 
Chromatography column that was primed with the assay buffer. To exchange the assay buffer 
and removed β-mercaptoethanol, the column was spun for 10 mins, 10, 000 x g at 4 
o
C and 
the flow through collected (repeat 4 x for > 99.5% buffer exchange). The protein 
concentration was measured prior to any analysis (Chapter Two at 2.4.1.2).  
H2O2 substrate was prepared to a final concentration of 6 x 10 
-4
 % w/v in ultrapure water 
(uH2O) and the exact concentration was calculated from the absorption at 240 nm of a 6 x 10 
-3
 % w/v dilution. 
[H2O2 6 x 10 
-4
 % w/v] = 
       
          
   




Abs240 = absorbance of 6 x 10 
-3
 % w/v dilution 
Equation 2.5 
To prepare the horse radish peroxidase solution, 5 mg was added to 1 mL of assay buffer.  
The concentration was calculated from the absorption at 403 nm of a 1:10 dilution 






            
    
   






Abs240 = absorbance of 1:10 dilution 
Equation 2.6 
2.7.6.2 Assay 
For the activity assay, all protein concentrations were assessed in triplicate. The 
spectrophotometer (Spectra max M5) was allowed to equilibrate to 25 
o
C before starting the 
assay. Each reaction well contained, HsPrx3 (0 μM – 10 μM), H2O2 (8 μM) and HRP (8 μM), 
with the reaction volume being adjusted to 250 μL per well with the addition of assay buffer. 
HsPrx3 (varying concentration) and HRP (8 μM) were pre-incubated at room temperature for 
at least 10 minutes prior to starting the assay, and then pipetted, in triplicate, into each well of 
a microtitre plate (Greinier 96-well clear bottom plate, Sigma-Aldrige). H2O2 solution was 
added to the wells directly before commencing the assay. The absorbance at 403 nm was 
analysed over 2 minutes with one scan every 8 seconds. 
 
2.7.6.3 Data analysis 
The peroxidatic activity of HsPrx3 was measured by determining the degree to which HsPrx3 
out competed HRP in catalysing the substrate. HRP changes in colour from orange to clear 
and therefore the catalytic inhibition was measure by monitoring the change in solution 




   
                      







(F/(F-1))= ratio of inhibition by HRP 
Equation 2.6 
 




The ratio of inhibition was derived from the change in absorbance at 403 nm (ΔAbs403) when 
compared to the HRP reaction with no HsPrx3. The baseline for the reaction was recorded 
from the assay blank (no peroxidase) (fig 2.3). 
 
 
         A: ΔAbs403                                                   B:  
 
   
           against [Prx] 
 
Figure 2.3: (A) Change in absorbance at 403 nm, black; just HRP, red, blue and green; HRP 
+ increasing amounts of peroxiredoxin. (B)  
 
   
           plotted against [Prx] to give 
kPrx. [22] 
F = x/z     Equation 2.7 




   
           was plotted against [Prx] and the slope gave the second order reaction rate 
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Chapter Three: Controlled oligomerisation of Lsr2 and its 
derivatives 
3.1 Introduction   
Proteins are attractive building blocks (tectons) for the formation of biological nanomaterials 
due to their controllable assembly and the wealth of potential surface functionalisation sites 
that they provide. [1, 2]  The self-association of protein subunits is intrinsically linked to the 
amino acid sequences at the interfaces, which have been arranged, by nature, to drive the 
formation of materials of a specific size, shape and function (Chapter One: at 1.3.3). [3, 4] 
This is inherently difficult to achieve using purely synthetic molecules due to the different 
conformations the self-assembling molecules can take, and the propensity of small 
(nanoscale) units, with a large surface area, to aggregate. [5] When identifying a protein as a 
tecton it is important to consider a number of characteristics: 
(1) Is the protein readily available? 
(2) Can the self-assembly be controlled?  
(3) Is there in-built function or the opportunity to incorporate function into the tectons? 
Lsr2 has been selected in this study as it has the potential to encompass all of the criteria 
stated above.  The N-terminal domain of the protein (Nterm-Lsr2) will also be analysed as it 
has been shown to undergo self-assembly in response to a specific enzymatic cleavage event. 
[6, 7] 
Lsr2 is a small, basic DNA binding protein present in Mycobacteria that regulates gene 
expression and influences the organisation of the bacterial nucleoid (Chapter One at 1.5.1). 
[6, 8-10] It belongs to a group of proteins known as histone-like proteins that have similar 
functions to their eukaryotic counterparts (histone proteins). [11, 12] Although these proteins 
appear to function in a similar manner, non-specific binding to adenine and thymine (AT) 
rich regions of DNA, they have little homology in terms of sequence and structure. [11, 13, 
14] Lsr2 has two domains that are both essential for function; the N-terminal oligomerisation 
domain and the C-terminal DNA binding domain. [6, 13] The DNA binding domain is 
comprised of two α-helices that are joined together by a disordered loop (Chapter One at 




1.5.2). [14]  It is unique to other histone-like proteins in that the α-helices are organised 
almost perpendicular to each other, stabilised in this conformation via a series of hydrophobic 







, within the loop, bind to the minor groove of the DNA helix in a hook motif with the 
binding being stabilised by a hydrogen bonding network. [13, 14] It has been shown that the 




 are substituted for 
an alanine, indicating that these residues are essential for function. [14]   Lsr2 has the ability 
to form highly ordered, stable protein complexes. [10] Furthermore, the protein has been 
shown to organise DNA by bridging two DNA strands through the N-terminal dimerisation 
domain, [15] and even driving the formation of rigid nucleoprotein fibres. [12] 
 
 
Figure 3.1: Pymol image of the oligomerisation via proteolytic cleavage of 
Nterm-Lsr2 [6] Removal of the N-terminal lysine removes electrostatic repulsion 
between the N-terminal extensions.  This allows the formation of an inter-dimer β-
strand between the hydrophobic residues in the random coil. Images generated using 
Pymol with coordinates from PDB:4E1R. 
 
In a study by Summers and co-workers, the truncated form of Lsr2 (Nterm-Lsr2) was shown 
to oligomerise into linear chains via anti-parallel β-sheet formation between the extended N-




termini on neighbouring dimers (fig. 3.1) (Chapter One at 1.5.2). [6] This process has been 
achieved in vitro using trace amounts of trypsin enabling oligomerisation on-demand. [7] The 
protocol provides a useful tool for studying the onset of the oligomerisation of Nterm-Lsr2 
and its uses as a protein tecton.   
It is well established that changes in the physical environment of a protein can alter the 
structure, solubility, activity, and stability of a protein. [16-18] For example, the silk protein 
from Bombyx mori can form different quaternary structures in response to changes in pH. 
[19] To explore the full potential of the Nterm-Lsr2 tecton, impact of factors such as pH and 
protein concentration were also explored as alternate triggers to enzymatic cleavage.  
By studying the full length protein and therefore combing the oligomerisation switch with the 
DNA binding efficiency, [9, 12, 14] it may be possible to design a protein tecton that can 
organise DNA in a controlled manner.  Lsr2 has the potential to be utilised to form hybrid 
nucleoprotein materials which makes it an ideal protein for the discovery and development of 
















3.2 Lsr2 as a protein tecton in bionanotechnology 
Lsr2 has a number of potential functions that make it an attractive target for development into 
a protein tecton. In addition to the DNA binding domain there is also a poly-6-histidine tag, 
located at the C-terminus of the protein.  Metal coordination sites can be used to direct 
assembly though the highly specific ligand-metal association geometry which, in turn, aids 
control over oligomerisation. [20-22]  Metal-binding tags have also been utilised to anchor 
additives to protein nanostructures, for example, Ni
2+
 treated gold nanoparticles (AuNPs), 
bound through the strong Ni
2+
 to imidazole interaction. [23]  This particular functionality is 
not available in the truncated protein (Nterm-Lsr2) due to the positioning of the tag at the N-
terminus of the protein which is removed during proteolysis. [6, 7]  
It is clear that Lsr2 satisfies at least one of the characteristics of a good protein tecton in that 
it has a wealth of in-built functions.  The purpose of this research is to explore the other two 
characteristics; to express and purify Lsr2 in a recombinant protein expression system, and to 
instigate assembly in a controllable manner.  
3.2.1 Protein expression and purification 
The Lsr2 plasmid was kindly provided by Dr Vic Arcus at Waikato University.  The gene had 
been cloned into the expression vector pET30b with a C-terminal histidine tag. 
Electrocompetent E. coli cells (BL21(DE3)*) were transformed with the plasmid using 
electroporation (Chapter Two at 2.2.2.1). The protein was successfully expressed in ZYM-
5052 auto-induction media [24] (Chapter Two at 2.1.6.2) in the presence of kanamycin after 
shaking at 180 rpm, at 37
o
C for 4 hours, and then at 30
o
C for a further 16 hours. 
Cells were lysed using sonication (Chapter One 2.3.2.2) and the soluble and insoluble 
fractions were separated via centrifugation (20 mins, 18,000 x g).  Lsr2 was isolated from the 
soluble crude fraction using immobilised metal-ion affinity chromatography (IMAC) (fig. 3.2 
A) (Chapter Two 2.3.2.5) and the excess imidazole was removed by buffer exchange using a 
desalting column. Matrix-assisted laser desorption/ionisation time of flight mass spectroscopy 
(MALDI-TOF MS) showed the Lsr2 monomer molecular weight to be 13.26 kDa, slightly 
larger than the calculated molecular weight of 13.16 kDa (fig.3.2 B). The presence of Lsr2 in 
the eluted IMAC peak was confirmed by SDS-PAGE (fig. 3.2 C) (Chapter Two at 2.4.3). An 
additional band was also seen on SDS-PAGE.  Initially it was believed that this could be a 
SDS stable oligomer, as had been characterised in previous studies.  However, Western-blot 





















































using the anti-his antibody, confirmed that this band did not relate to Lsr2 but was an 
impurity that did not contain a histidine tag (Appendix 3.1). 
 
         A: IMAC                                                               B: MALDI-TOF MS 
 
                                        C: SDS-PAGE 
 
Figure 3.2: Purification of Lsr2. (A) Elution of Lsr2 from a Ni
2+
 IMAC column 
upon increasing imidazole concentration. Black: absorbance at 280 nm (mAU); grey: 
percentage concentration of 1 M imidazole buffer (%). (B) MALDI-TOF MS of 
purified Lsr2.  The molecular weight (MW) is slightly larger than the calculated 
value of 13.16. (C) SDS-PAGE gel of crude fractions and purified Lsr2 from IMAC.  
1: crude lysate; 2: insoluble crude; 3: soluble crude; 4: IMAC flow through; 5: 
impurity from IMAC; 6: isolated Lsr2 monomer + impurity. 
 
Throughout the purification process there were significant amounts of impurities eluting with 



































was either protein weakly bound to the IMAC column (high native histidine content) or 
trapped within a genomic DNA-Lsr2 complex. If the protein was weakly bound to the IMAC 
column then using a stepwise gradient to increase the imidazole elution buffer concentration 
in increments (0.02 – 1 M in a stepwise fashion) would aid the separation of eluted proteins 
into individual fractions (fig. 3.3 A). Several peaks eluted and the proteins within the peaks 
were identified on SDS-PAGE (fig. 3.3 B). The impurity was observed in the initial eluted 




Figure 3.3: Stepwise purification of Lsr2 using a slow imidazole gradient. (A) 
Elution of Lsr2 and impurities from a Ni
2+
 IMAC column upon increasing imidazole 
concentration in a stepwise gradient. Black: Absorbance at 280 nm (mAU); grey: 
percentage concentration of 1 M imidazole buffer (%). Peaks 1 – 9 were analysed on 
SDS-PAGE. (B) SDS-PAGE gel of the fractions eluted on IMAC. Fractions 1-4: 
impurities; 5: Lsr2 monomer and dimer; 6 – 9: isolated Lsr2 monomer.  Using a 





















































































3.2.2 Trypsin digest of full length Lsr2 
During a study by Summer et al. it was noted that the eluted protein from the IMAC was 
bound to a significant amount of genomic DNA. [6] Instead of removing the DNA 
completely, they utilised the bound DNA to study the effects of DNA compaction and 
protection by Lsr2 in response to trace amounts of trypsin and DNAse. The protein that had 
not been treated with trypsin was unable to protect the genomic DNA from digest, as 
visualised by DNA agarose gel. [6] However, treatment of the protein-DNA sample with 
trypsin for increasing amounts of time not only showed that the DNA was compacted with 
increasing amounts of proteolysis time but, more intriguingly, that it was protected from 
digestion by DNAse. [6] Furthermore, the band corresponding to the monomer completely 
disappeared on SDS-PAGE with increasing amounts of tryspin digest time but the bands 
relating to the dimer and HMW oligomers did not. This further strengthened the argument 
that Lsr2 is used in nature to protect DNA and it does this by oligomerisation at the N-
terminal domain to form HMW protein oligomers that are resistant to denaturation by heat 
and SDS. 
The experiments were repeated in this study to ensure the protein was still able to undergo 
proteolysis with trypsin.  Lsr2 (1 mg/mL) was subjected to a trypsin digest (1:500, 
trypsin:Lsr2 w/v) for increasing amounts of time (5, 10, 15, and 30 mins) at room 
temperature. The digest was stopped via heat denaturation of the protein and enzyme in a 
water bath set at 95
o
C (5 mins). The denatured sample was then split for both SDS-PAGE 
and DNA agarose gel analysis (fig. 3.4 A and B respectively) with trypsin run as a control.  
Unlike the previous study, the monomer band was still prevalent on SDS-PAGE, even after 
30 minutes although it had faded slightly. Interestingly, the protein, which had previously 
appeared as a single monomer band by SDS-PAGE, had assembled into SDS stable 
oligomers while being stored at 4
o
C. It is possible that the degree of DNA binding had 
increased over time, stabilising the complex even under protein denaturing conditions. The 
HMW and dimer bands also showed little variability on SDS-PAGE. The DNA agarose gel 
displayed that the Lsr2 had indeed eluted with significant amounts of DNA with all of the 
lanes containing Lsr2 showing fluorescence with DNA loading dye.  The only lane that had 
no fluorescence contained trypsin only, showing that protein alone was not enough to appear 
under UV light. While there was a small amount of compaction of the DNA band it was not 
to the same extent as noted in the literature. [6]  




               
  
Figure 3.4: Electrophoresis analysis of trypsin proteolysis. (A) SDS-PAGE gel of 
trypsin proteolysis and trypsin. 1: Lsr2 no trypsin; 2, 3, 4 and 5: Trypsin + Lsr2 
(1:500) proteolysis for 5, 10, 15, and 30 minutes respectively; 6: trypsin. (B) DNA 
agarose gel of trypsin proteolysis and trypsin as a negative control. 1: Lsr2 no 
trypsin; 2, 3, 4 and 5: trypsin + Lsr2 (1:500) proteolysis for 5, 10, 15, and 30 minutes 
respectively; 6: trypsin.  All Lsr2 samples contain bound DNA.  This is possibly 
protecting the protein from trypsin digest as very little degradation is seen on SDS-
PAGE. 
 
While this experiment provided a simple means to study potential DNA compaction in 
response to Lsr2 oligomerisation there were too many variables and therefore it was not 
possible to repeat the protocol using exactly the same conditions. The main issue is that there 



























is no control over the concentration of bound DNA. It is possible that the amount of bound 
DNA in the current study exceeded the amounts characterised by Summers et al.  This would 
explain the lack of trypsin digest as cleavage sites may be blocked by the high concentration 
of DNA.  It would also explain the decrease in compaction, as the ratio of protein to DNA is 
less and therefore the DNA compaction is less. To accurately characterise the DNA 
compaction it is necessary to remove the genomic DNA and then replace it with DNA of a 
known concentration. 
3.2.3 Strong DNA binding of Lsr2 
The denatured form of Lsr2 was a monomer at around 13 kDa. This was seen both on SDS-
PAGE and MALDI-TOF MS (fig. 3.2, B and C above). However, when the sample was run 
on size exclusion chromatography (SEC) the major peak eluted at the void which indicated an 
oligomer greater than 660 kDa (fig. 3.4 A). SDS-PAGE molecular weight analysis showed 
that while the other small peaks seen on the SEC trace contained mainly small amounts of 
impurities, Lsr2 eluted almost entirely at the column void (fig. 3.4 B).  
As discussed above, Lsr2 was bound to large amounts of genomic DNA. This has been seen 
in previous studies using techniques such as AFM and TEM which showed that Lsr2 has the 
propensity to form large complexes with DNA. [6, 12, 15] The DNA binding is likely to have 
occurred during cell lysis where large amounts of genomic DNA are released from the cell.  
To accurately assess any oligomerisation that was a direct consequence of trypsin digest and 

















Figure 3.5: Size exclusion chromatography (SEC) analysis of Lsr2. (A) SEC of 
Lsr2 from IMAC (50 mM sodium phosphate, 200 mM NaCl, pH 7.4).  (B) SDS-
PAGE gel of the SEC peaks 1- 5. Almost all of the Lsr2 has eluted at the void 
volume (> 660 kDa), with the peaks at MW containing impurities.  Lsr2 exists as a 
dimer at 26 kDa so the high MW elution volume indicates that the protein has 
aggregated. 
 
DNA binding disruption by environmental conditions 
Numerous methods were employed to try and separate Lsr2 from DNA.  The primary trials 
involved simple environmental conditions such as adding a high concentration of salt and the 
destruction of the DNA via digest with DNAse. These simple variations were not sufficient to 
completely remove the DNA. Agarose gel electrophoresis showed that there was still a 
significant amount of intact DNA in the protein sample and SEC analysis of the high salt 
concentration still displayed a large peak around the column void (Appendix 3.2). A 
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could be reducing the effect of high salt and helping Lsr2 stay bound to DNA.  Furthermore, 
the DNA is likely to be protected from digest by DNAse while still bound to Lsr2 as this 
protein has been identified as protecting DNA from attack from outside sources. [6, 11] 
DNA binding disruption by site specific substitution 
The NMR structure of the C-terminal region of Lsr2 displays two residues that appear to be 




, located in the connecting loop 
region and involved in the DNA binding hook motif (fig. 3.6). The proton signals for these 
residues completely disappear in the presence of DNA. [14] This is indicative of proton 
transfer between the DNA and protein on the NMR time scale, an indication of hydrogen 
bonding. [25] Furthermore, substitutions of these residues for alanine have been shown to 
produce constructs with significantly diminished DNA binding efficiency when compared to 
the wild type. [13] For this reason, the mutants were employed to try and remove the DNA 
from the full length Lsr2 construct. 
 
 
Figure 3.6: NMR structure of the C-terminal DNA binding domain.  [14] The 
DNA-binding residues are highlighted in yellow with hydrogen – white, nitrogen – 
blue, and oxygen – red.  These residues were sequentially mutated to alanine to 
reduce the DNA binding efficiency. Images generated using Pymol with coordinates 
from PDB:2KNG. [14] 
 
The plasmids encoding the mutated proteins (Lsr2-R97A, Lsr2-R99A, and Lsr2-R97AR99A) 









Mutant Site specific substitution 
Single mutant 1 Lsr2-R97A 
Single mutant 2 Lsr2-R99A 
Double mutant Lsr2-R97AR99A 
 
Table 3.1: The site specific mutations of Lsr2. The proposed DNA binding 
residues are removed to try and disrupt the strong Lsr2-genomic DNA interaction. 
                            A: Lsr2-R97A                           B: Lsr2-R97AR99A 
            
Figure 3.7: Agarose gel analysis of DNA binding arginine mutants. (A) Lsr2-
R97A mutant agarose gel, 1 – crude lysate, 2 – insoluble crude, 3 – soluble crude, 4 – 
IMAC flow through, 5 – IMAC peak 1, 6 – IMAC peak 2, 7 – IMAC peak 3 (all 
IMAC peaks contain Lsr2-R97A). (B) Lsr2-R97AR99A mutant agarose gel, 1 – 
crude lysate, 2 – insoluble crude, 3 – soluble crude, 4 – IMAC flow through, 5 – 
IMAC peak 1, 6 – IMAC peak 2 (all IMAC peaks contain Lsr2-R97AR99A).   
 
One single mutant, Lsr2-R97A and the double mutant were selected for analysis.  Both were 
expressed and purified using the methods from section 3.2.1 (above). The eluted fractions 
from the IMAC were analysed on SDS-PAGE and agarose gel electrophoresis. 
For both constructs the denatured protein showed as a single monomer band on SDS-PAGE 
(Appendix 3.3). However, DNA agarose gel showed that the fractions from the IMAC that 
1 2 3 4 5 6BPL 7 1 2 3 4 5 6BPL




were related to the purified protein still contained a significant amount of genomic DNA (fig. 
3.7 A and B).   
Interestingly, the bound DNA is unable to travel through the gel with the fluorescence 
relating to the DNA-protein final eluted IMAC peak being entirely within the well.  This 
indicates large, complex structures that are too big to be transported through the agarose gel. 
3.2.4 Discussion 
While the Lsr2 was successfully produced from a readily available source, all attempts to 
isolate the protein from contaminating genomic DNA were ineffective. In all conditions, 
including site specific substitutions, the DNA was still tightly bound to the protein. This is 
possibly due to the high concentration of DNA released during cell lysis, and a large amount 
of non-specific biding by the full length protein. 
For a protein to be considered as a tecton for nanotechnology there needs to be a degree of 
control over the assembly. Analysis of the controlled oligomerisation via proteolytic cleavage 
would be unreliable while Lsr2 was still bound to DNA, as it would be difficult to separate 
out the different routes towards assembly.  In addition, it would be challenging to employ 
specific DNA binding to direct assembly of nucleoprotein complexes while the protein was 
still bound in a non-specific manner to genomic DNA. Overall, it was deemed that the use of 
Lsr2 as a protein tecton was not possible with the current methodology. For this reason the 
focus was directed towards controlling and improving upon the protocol for assembling the 
truncated form, Nterm-Lsr2, which removed the DNA binding site, thereby eliminating the 











3.3 Nterm-Lsr2 oligomerisation 
The N-terminal dimerisation domain of Lsr2 has been identified as the oligomerisation region 
of the protein and is essential for the continued function of the protein (Chapter 1 at 1.5.2).  
Lsr2 has the ability to bind to DNA, bridging non-specific sequences and even forming 
elongated nucleoprotein fibres with both single-stranded and double helix DNA. [12, 15]  
These attributes, as well as the existence of SDS resistant HMW oligomers seen on SDS-
PAGE, suggest that the protein is able to oligomerise into higher ordered structures, with the 





        B: Dimer 
 
 
       C: Polar  
            contacts 
 
Figure 3.8: Crystal structure of the N-terminal oligomerisation domain. (A) 
Nterm-Lsr2 monomer, one anti-parallel strand, one random coil and one α-helix. (B) 
Nterm-Lsr2 monomer which forms via an anti-parallel β-strand interaction between 
β1 and β1’ to form a four stranded β-sheet which buries ~ 31 % surface area per 
monomer. (C) The polar contacts that further stabilise the dimer interface. Images 

























The N-terminal domain monomer (residues 1 – 61) is a random coil at the N-terminus 
followed by a β-strand and a single α-helix with a significant kink close to the C-terminus 
(fig. 3.8 A). The β-strand and α-helix axis are arranged at approximately a 45
o
 angle with 
respect to each other. Dimerisation occurs between β1 and β1’, forming a four stranded β-
sheet that buries around 31 % of the monomer surface (~1548 Å
2
) (fig. 3.8 B). The kink in 
the α-helix allows for compact packing against the adjacent β-strand and the interface is 




’ from α1’ (fig. 3.8 C).  
The N-terminal residues are remarkably well suited for β-strand formation, comprised almost 
entirely of hydrophobic residues (fig. 3.8 B).   
When the crystal structure was solved it was noted that the dimers did indeed oligomerise via 
a previously uncharacterised inter-dimer β-strand interaction between the N-terminal random 







. The mass of the crystallised protein, determined by electrospray mass 
spectroscopy, was 9198.0 m/z, close to the calculated value of an Nterm-Lsr2 monomer that 




 (6199.8 Da). It was noted that crystals only 
grew after the protein had been left for some time to undergo an unknown maturation 
process. This process was mimicked by the addition of trace amounts of trypsin (1:500, 
trypsin:Nterm-Lsr2) which cleaved between the two N-terminal lysine residues. The structure 
determined from this process also showed linear chains of Nterm-Lsr2, joined together by β-
strands at the inter-dimer interface. [6] 
Trypsin cleavage at Lys
4
 allows for the hydrophobic residues on the N-terminal random coils 
on neighbouring dimers to interact and form a β-strand. Without the removal of the N-
terminal residues, electrostatic repulsion and steric clashes between these residues would 
hinder oligomerisation. In addition to the hydrophobic interactions, there is a complex 
network of polar interactions between the positively charged primary amine of Lys
4
 and the 
carbonyl and acidic groups of the neighbouring dimer which further stabilises the inter-dimer 
interface. This would not be possible without the removal of the histidine tag and three N-
terminal residues. 
Results from the current study concur with Summers’ findings and reinforce the idea that 
controlled proteolysis of the N-terminal residues facilitates the formation of stable HMW 
oligomers from the truncated construct of Lsr2 (Nterm-Lsr2). 




3.3.1 Expression, purification and characterisation of Nterm-Lsr2 
Nterm-Lsr2 was expressed in E .coli BL21(DE3) cells using standard procedures as described 
in section 3.2.1.  It was purified from other soluble proteins in the crude lysate using IMAC 
(fig. 3.9 A) and SEC (fig. 3.9 B). Expression and purification of Nterm-Lsr2 was verified by 
SDS-PAGE analysis (fig. 3.9 C).  
Circular dichroism (CD) spectroscopy showed that the protein was correctly folded with 
troughs at 209 and 219 nm representing the α-helix and β-sheet respectively (fig. 3.10 A).  
MALDI-TOF MS confirmed the molecular weight of the monomer to be 9470 Da (fig. 3.10 
B). Although MALDI-TOF MS is considered to be a soft ionisation method, ideal for the 
analysis of biological molecules, [26] there have been cases where the ionisation is enough to 
fragment the C-terminal residue. [26] The MW of Nterm-Lsr2 is slightly lower that the 
calculated  molecular weight of 9626 Da but this is consistent with the mass if the C-terminal 





















































































          A: IMAC                                                             B: SEC 
                                                                                                      tetramer dimer 
 
              C: SDS-PAGE                                                        D: Western blot 
                                  
Figure 3.9: Purification and isolation of Nterm-Lsr2. (A) Elution of Nterm-Lsr2 
from a Ni
2+
 IMAC column upon increasing imidazole concentration. Black: 
Absorbance at 280 nm (mAU); grey: percentage concentration of 1 M imidazole 
buffer (%). (B) SEC chromatography of eluted IMAC peak showing a prominent 
dimer peak (19 kDa) and a minor peak around the MW of a tetramer (40 kDa).  This 
may be due to the high loading concentration (~10 mg/mL).  (C) SDS-PAGE gel of 
protein extraction and purification. 1: crude lysate; 2: insoluble crude; 3: soluble 
crude; 4: IMAC flow through; 5: IMAC imidazole eluted fractions; 6: isolated 
Nterm-Lsr2 from SEC. (D) Western blot of Nterm-Lsr2. 1: Nterm-Lsr2 and 2: mouse 
anti-polyhistidine tagged ladder. Electrophoresis shows a histidine tagged protein at 




























































      A: CD                                                                     B: MALDI-TOF MS 
 
Figure 3.10: Characterisation of Nterm-lsr2 dimer. (A) CD of full length Nterm-
Lsr2.  The troughs at 209 and 219 nm show the secondary structural elements of α-
helix and β-sheet respectively. (B) MALDI-TOF MS of full length Nterm-Lsr2, 
major peak at 9470 m/z which is consistent with the calculated monomer molecular 
weight if the C-terminal arginine has been lost. 
 
3.3.2 Proteolytic oligomerisation of Nterm-Lsr2 
SEC was used as a simple analytical tool to map the changes from non-oligomerised and 
oligomerised protein by looking at changes in MW. On SEC the non-oligomerised (neat 
sample) eluted at a volume consistent with the dimer MW (19 kDa) (fig. 3.11 B, peak 2), 
around double that of the monomer molecular weight from mass spectroscopy (9473 Da). 
Trypsin cleavage at Lys
4






 but also the poly-6-his tag, 
TEV recognition site and linker which results in a 3444.7 Da (calculated) loss in the 
molecular weight of the monomer after proteolysis. The mass of the digested monomer, 
determined by MALDI-TOF MS, was 6188 Da (fig. 3.11 A).   The dimer was also seen on 
MS with a signal at 12361 m/z.   
By setting the dimer molecular weight at 12.4 kDa, the number of dimeric units in each 
oligomer could be approximated from the mass calculated from the SEC calibration curve. 
Upon partial digestion with trypsin (1:500 w/v) Nterm-Lsr2 oligomerised into three sets of 
HMW structures (fig. 3.11 B). The oligomers were calculated to be a dodecamer, a hexamer 
and a tetramer. The fourth peak on the spectrum was shown, through SDS-PAGE analysis, to 
be protein fragments (Appendix 3.4). Fragmentation of Nterm-Lsr2 is a result of trypsin 
proteolysis at the additional lysine and arginine residues along the polypeptide chain. This 
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  A: MALDI-TOF                                                      B: SEC 
                                                                                                   oligomers  dimer   fragments 
 
Figure 3.11: Molecular weight analysis of Nterm-Lsr2 post proteolysis.  (A) 
MALDI-TOF MS with major peaks at 6188 Da and 12361 Da which represent the 
truncated monomer and dimer respectively.  (B) oligomerised Nterm-Lsr2 at pH 7.4, 
1 mg/mL. Black: full length dimer (19 kDa); grey: Nterm-Lsr2 after trypsin 
proteolysis (72 kDa, 36 kDa and 24 kDa). Treatment with trypsin removes the N-
terminal tag and 3 additional residues, which facilitates the formation of an inter-
dimer β-strand. [6, 7] 
 
Nterm-Lsr2 was successfully oligomerised by reproducing the method described in Summers 
et al. [6] The sizes of oligomers formed were smaller than those seen by Summers, which is 
consistent with the lower protein concentration used in this study. The self-assembly of 
Nterm-Lsr2 in the crystal structure is linear with each dimeric unit having two identical 
oligomerisation interfaces at each end (fig. 3.1). With no known capping mechanism to halt 
assembly, oligomerisation of Nterm-Lsr2 will continue up to the point of protein saturation. 
[27-29] 
 
3.3.3 Effects of concentration on self-assembly of Nterm-Lsr2 
As predicted, increasing the concentration of Nterm-Lsr2 in solution led to an increase in the 
size of the largest oligomer (fig. 3.12). At pH 7.4 there were three oligomer peaks 
representing HMW oligomers ranging from a decamer to a 30-mer, medium molecular 
weight (MMW) oligomers ranging from a hexamer to octamer, and low molecular weight 
(LMW) oligomers which were always a tetramer. Interestingly, the post digest dimer was 
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instrument’s limit of detection. Increasing, the concentration of Nterm-Lsr2 in solution led to 
an increase in the size of the largest oligomer (fig. 3.12). At a protein concentration of 4.3 
mg/mL, the highest molecular weight oligomer was three times larger than the highest 
molecular weight oligomer at 1 mg/mL (30-mer versus decamer) and twice as large as the 
highest molecular weight oligomer at 1.8 mg/mL (30-mer versus tetradecamer). 
 
 
Figure 3.12: Oligomerisation of Nterm-lsr2 at pH 7.4, varying concentrations. 
Black: 4.3 mg/mL; grey: 1.8 mg/mL and dashed: 1.0 mg/mL. Increasing the 
concentration leads to the formation of larger oligomers showing that Nterm-Lsr2 
assembly is concentration dependent. 
 
As the MMW peak was always the most populated at all concentrations it was believed that 
the tetramer and MMW oligomers were in a fast equilibrium and the MMW oligomer needed 
to reach optimal concentration before the HMW oligomers could form. 
 
3.3.4 Equilibrium and distribution of self-assembled supramolecular structures of 
Nterm-Lsr2 
To try and understand the dynamics of protein assembly a number of equilibrium 
experiments were conducted.  It was useful to think of each individual oligomer as a tecton 
that, once an optimal concentration was reached, could associate into the higher molecular 
weight species.  
Partial digestion with trypsin was used to trigger Nterm-Lsr2 assembly on two separate 




























oligomers were separated by size using SEC.  Pooled fractions were concentrated to 0.5 mL 
and re-injected onto the SEC column.  
Upon re-injection, the HMW oligomer (30-mer and tetradecamer at 4.3 mg/mL and 1.8 
mg/mL respectively) re-equilibrated to a MMW oligomer (octamer and heptamer at 4.3 
mg/mL and 1.8 mg/mL respectively) (Appendix 3.5). The apparent uneven number of units 
was believed to be a result of unwanted trypsin cleavage along the peptide chain and the 
inclusion of trypsin digest products in the protein assembly. These results agreed with the 
hypothesis that the HMW and MMW oligomers were in equilibrium whereby the MMW 
weight oligomer, or tecton, must reach an optimal concentration before higher ordered 
structures could form. The oligomer concentration dropped due to dilution on the 24 mL 
column and therefore, upon re-injection, the HMW oligomers dissociated into the MMW 
species. 
The same re-equilibration of oligomers to a LMW species was observed when the MMW 
oligomers (octamer and heptamer at 4.3 mg/mL and 1.8 mg/mL respectively) were re-
injected (Appendix 3.6). The re-injected heptamer (1.8 mg/mL) equilibrated to one species at 
30 kDa, approximately the molecular weight of a pentamer. The re-injected octamer (4.3 
mg/mL) eluted as three distinct oligomers; an octamer, tetramer and a pentamer. 
Unlike the re-injection of the HMW and MMW oligomers described above, the LMW 
oligomers (tetramer) from the 1.8 mg/mL and 4.3 mg/mL oligomerisation stayed at the same 
molecular weight when re-injected (Appendix 3.7). The tetramer was also the smallest 
oligomer seen after proteolysis, suggesting that this was the starting “building block” from 
which the other oligomers were formed. Results suggest that the HMW species associate 
from individual tetramers once an optimal or threshold concentration is reached. 
When observing the protein assembly at varying concentrations it was noted that the ratio of 
MMW oligomers to LMW and HMW oligomers stayed static. The ratio was calculated as a 
percentage of the peak area over the total area of oligomers. For all three concentrations 
tested (1 mg/mL, 1.8 mg/mL, and 4.3 mg/mL, Appendix 3.5 and 3.6 respectively) the 
percentage of MMW oligomers was 44 ± 0.07 % (Table 3.2). In contrast, the percentage peak 
area for the LMW and HMW altered with varying initial protein concentration.  
 


























1 .0 29.25 tetramer 43.89 hexamer 26.86 decamer 
1.8 34.94 tetramer 44.06 heptamer 21.00 tetradecamer 
4.3 16.65 tetramer 43.81 octamer 39.54 30-mer 
  
Table 3.2: Oligomer size and % peak area of the LMW, MMW, and HMW 
assemblies at varying concentrations. The ratio of oligomers is concentration 
dependent with the amount of HMW oligomer increasing with decreasing LMW 
peak area and vice versa. Interestingly, the MMW peak area is approximately the 
same under all concentrations suggesting that MMW to HMW is the rate limiting 
step in Nterm-Lsr2 assembly. The tetramer is always the smallest oligomer. The 
apparent uneven numbers of units are believed to be due to unwanted trypsin 
cleavage along the peptide chain and the resulting inclusion of trypsin digest 
products in the protein assembly.   
 
By combining the information from the equilibrium experiments and the integrated peak 
areas of the different oligomers at varying concentrations, a possible route towards assembly 
was proposed (fig. 3.13). This is consistent with the MMW oligomer acting as a stable 
intermediate that reaches an equilibrium population during assembly of the HMW form. 





Figure 3.13: Schematic of the suggested equilibrium between the LMW, MMW 
and HMW oligomers. The tetramer is the smallest oligomer seen post-proteolysis 
(step 1) and is the starting “building block” from which the other oligomers are 
formed. Under all concentrations the most abundant oligomer observed is the MMW 
suggesting a fast equilibrium between LMW and MMW (step 2). The HMW 
oligomer appears to be formed in a slower equilibrium from the MMW oligomer 











3.3.5 Effects of pH on self-assembly of Nterm-Lsr2 
Variations in pH values have been shown to alter the structure, solubility, activity, and 
stability of proteins.  This is due to the variations in charge of ionisable amino acids above or 
below their pKa values. [30] The charges can either contribute to stability, electrostatic 
interactions or aid in dissociation, electrostatic repulsion. With the additional polar contacts 
that stabilise the Nterm-Lsr2 dimer interface it was of interest to assess the influence of 
varying pH conditions on protein oligomerisation. This not only gave insight into the types of 
interactions taking place in solution, but could also be used as an additional route towards 
manipulating assembly.  
The oligomerisation was conducted at pH 6.0, 8.0, and 9.0 to study how varying this external 
factor affected the protein assembly. Proteolysis was carried out under neutral pH conditions 
to ensure consistent enzyme activity.  After 10 minutes the pH was adjusted to either pH 6.0, 
8.0, or 9.0 by adding 0.5 mL of the appropriate buffer and measuring the pH prior to injecting 
the sample onto a SEC column. There were small changes in the extent of oligomerisation 
when varying the pH to 6 or 8, with the largest oligomer being in the MMW range (Table 3.3, 
Appendix 3.8).  However, when the pH was adjusted to 9.0 there was a marked effect on the 
different types of oligomers seen with only a tetramer forming (fig. 3.14). 
 
pH LWM MMW HMW 
6.0 tetramer hexamer non 
7.4 tetramer hexamer decamer 
8.0 tetramer hexamer non 
9.0 tetramer non non 
  









                                                                          tetramer 
 
Figure 3.14: The influence of pH on the oligomerisation of Nterm-Lsr2. Grey: 
Nterm-Lsr2 post-proteolytic cleavage at pH 7.4, 1 mg/mL. Seen is a mixture of 
HMW assemblies and protein fractions. Black: Nterm-Lsr2 post-proteolytic cleavage 
at pH 9.0, 1 mg/mL. The only visible oligomer is a tetramer.  The assembly is halted 
by an increase in pH. 
 
Characterisation of the oligomerised protein at pH 9.0 confirmed that the secondary structure 
was intact (fig. 3.15). Any variations were attributed to the change in secondary structure 




Figure 3.15: CD spectra of Nterm-Lsr2 at pH 9. Troughs at 219 and 209 nm 
represent α-helix and β-sheet secondary structural elements respectively. Any 
differences between the pH 9 and pH 7.4 CD spectra (Nterm-Lsr2 pre-proteolysis, 
fig. 3.10) are the result of changes in the secondary structure accompanied by the 
higher oligomeric state of the protein at pH 9 (specifically, the loss of random coil 










































This pH switching process was also shown to be reversible.  The tetramer from the 
oligomerisation at pH 9.0 was collected and transferred back into a pH 7.4 sodium phosphate 
buffer using diafiltration. When this was re-injected onto the SEC the tetramer re-equilibrated 
back into larger oligomers in the range of 24 to 130 kDa (fig. 3.16). To ensure that the effect 
was not buffer dependent, the samples were analysed in Tris buffer at pH 7.4 and the same 










Figure 3.16: Switching between pH 7.4 and pH 9.0 is a reversible process. HMW 
oligomers are transferred from pH 7.4 buffer into pH 9.0 leading to disassociation 
into tetramers. This cycle can be a repeated a number of times before the protein 
becomes unstable. 
 
The stabilisation of the Nterm-Lsr2 oligomers is not only due to the hydrophobic interactions 
and H-bonding along the β-strand, but also due to the polar contacts from the N-terminal 
amine (Lys
4
). [6] An increase in pH above the pKa of the residue’s alpha-amine (pKa 8.95) 
would deprotonate the positively charged amine, thereby removing the polar contacts and 
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Figure 3.17: Crystal structure demonstrating the inter-dimer interactions. Yellow 
dotted lines show the electrostatic interactions of the new N-terminal amine and the 




, and the carbonyl group of Val
10
 on the 
neighbouring dimer.  Dimer 1 in grey and dimer 2 in pink (one monomer from each 
dimer is shown for clarity). Deprotonation of the N-terminal amine at pH 9.0 leads to a 
loss of these interactions, reducing the oligomer stability. Images generated using Pymol 
with coordinates from PDB: 4E1R. 
 
The new interactions that are present at the Nterm-Lsr2 oligomerisation interface 
(specifically hydrogen bonding from the backbone of the anti-parallel β sheet, hydrophobic 
interactions between the hydrophobic residues at the dimer-dimer interface, and polar 
interactions between Lys
4






 on the neighbouring dimer) will 
all contribute to stabilisation of the oligomer. [31] At pH 9.0 the protein interface becomes 
less stable due to a loss of the polar contacts. The binding efficiency will decrease with the 
decreasing number of polar contacts available. Furthermore, there will be a loss in enthalpy 
gain as the degree of intermolecular bonding decreases, making the formation HMW and 
MMW oligomers both thermodynamically and kinetically unfavourable.  




It is important to note that the tetramer is still present without these electrostatic interactions.  
In fact, it is the smallest complete protein unit seen, post proteolysis, under all conditions. It 







tetramer, rather than dimer, is the most thermodynamically stable oligomer. The equilibrium 
between dimer, tetramer, MMW and HMW will be sensitive to both protein concentration 
and the stability of the oligomer interface. The oligomer interface has been destabilised by 
increasing the pH to 9.0, and therefore a higher concentration will be needed to drive the 




Nterm-Lsr2 undergoes oligomerisation in response to N-terminal cleavage by trace amounts 
of trypsin.  This makes it an attractive target for use as a protein tecton as it has an “off-on” 
switch at the inter-unit interface and therefore assembly can be initiated on demand. The 
protocols developed by Summers et al. were successfully employed in this study to 
oligomerise Nterm-Lsr2 upon enzymatic cleavage at Lys
4
.   
By studying the new inter-dimer interface it was possible to predict the conditions needed to 
influence the assembly. The crystal structures of both Nterm-Lsr2 digested with 
contaminating proteases (PDB: 4E1P, monoclinic), and Nterm-Lsr2 digested with trypsin 
(PDB: 4E1R, hexagonal), showed dimers that were joined together at identical interfaces 
arrange into a linear chain. [6] This was despite the fact that the two crystals were packed into 
different space groups, which makes it unlikely that the linear arrangement was an artefact of 
crystallisation. Due to the symmetrical nature of the interfaces, the degree of assembly could 
be manipulated by varying the initial protein concentration (a 3-fold increase in size from 1 
mg/mL to 4.3 mg/mL). The response to protein concentration also allowed the analysis of the 
assembly equilibrium, with the tetramer and MMW oligomer forming rapidly and the HMW 
oligomer forming after MMW had reached a critical concentration. The polar contacts at the 
new interface were also utilised to control assembly, with the protein switching from HMW 
oligomers to a tetramer in response to increasing the pH above the pKa of the Lys
4
 amine. 
Throughout the study it was noted that optimal oligomerisation was being hindered through 
unwanted trypsin digest along the polypeptide chain.  This led to fragmentation of Nterm-
Lsr2 which complicated both the analysis and the assembly. 




3.4 Ent-Nterm oligomerisation 
To improve the triggered assembly of Nterm-Lsr2, a new and unique cleavage site was 
designed in which the Lys
4 
would still be the N-terminal amino acid post-proteolysis, but 











--residues 36 – 86 
86 
Met-Nterm M – KVTVTLV---residues 9 – 59 59 
Ent-Nterm MHHHHHHDYKDDDDK – KVTVTLV---residues 23 – 73 73 
 




3.4.1 Designing a specific cleavage site 







, the TEV linker and the his-tag were removed from the sequence, leaving 
methionine as the N-terminal amino acid (Met-Nterm). However, it was previously reported 
that the peptidase activity is vastly reduced when the penultimate amino acid is lysine. [32] 
Another method of cleavage at Lys
4
 was therefore designed to utilise the his-tag linker 







 and the TEV linker were replaced with an enteropeptidase linker. Enteropeptidase 
linkers have been used in previous studies to attach his-tags to recombinant proteins. [33] The 
main benefit of using this linker (instead of a TEV cleavage site) is that the entire linker is 
removed upon proteolysis with enteropeptidase [34] with no extraneous amino acid residues 
left on the protein.   





Figure 3.18: Graphical representation of the engineered new cleavage sites at 
Lys
4
. A new enzyme recognition site has replaced MAK to remove the need for 
trypsin. This means that there will be no unwanted trypsin cleavage along the 
polypeptide chain. 
 
3.4.2 Protein expression of Ent-Nterm 
Ent-Nterm was expressed in E. coli BL21(DE3) cells using standard procedures as described 
in the methodology (Chapter Two at 2.3.2), and was purified using the same methods 
employed for Lsr2 and Nterm-Lsr2 purification (fig. 3.19 A). The isolated protein was 
characterised using SDS-PAGE (fig. 3.19 C).  
MALDI-TOF MS showed that the full length protein monomer was 8148.71 Da (fig. 3.20 B), 
in close alignment to the calculated MW of 8148 Da. Small amounts of dimer could also be 
seen at 16288 Da. CD analysis showed that the protein was correctly folded with a trough at 
209 and 219 nm representing the α-helix and β-sheet respectively (fig. 3.20 A). 
Intriguingly, the undigested Ent-Nterm in solution was a tetramer (fig. 3.19 B). This may be 







which would allow a β-sheet to form. This agrees with the hypothesis that the tetramer is 
the most stable oligomer when these residues are removed (as was seen with the partially 
digested Nterm-Lsr2 at pH 9.0). 
         MAK 
                                                                               M 
 
               
          Histidine tag (MSYYHHHHHH) 
        TEV linker (DYDIPTTENLYFQGA) 
        Enteropeptidase linker (DYKDDDDK) 
        Self-Assembling Nterm       
(KVTVTLVDDFDGSGAADETVEFGLDGVTYEIDLSTKNATKLRGDLKQWVAAGRRVGGR) 





















































         A: IMAC                                                               B: SEC 
                                                                                                               tetramer 
 
 
                                               C: SDS-PAGE 
 
 
Figure 3.19: Purification and isolation of Ent-Nterm. (A) Elution of Ent-Nterm 
from a Ni
2+
 IMAC column upon increasing imidazole concentration. Black: 
absorbance at 280 nm (mAU) and grey: percentage concentration of 1 M imidazole 
buffer (%). (B) SEC of Ent-Nterm with a peak at 32 kDa, the MW of a tetramer. This 
is possibly due to absence of Lys3 in this construct, allowing for a single inter-dimer 
β-strand. (C) SDS-PAGE of protein extraction and purification. 1: crude lysate; 2: 



































































         A: CD                                                                    B: MALDI-TOF MS 
 
Figure 3.20: Characterisation of Ent-Nterm. (A) CD of full length Ent-Nterm. The 
troughs at 209 and 219 nm show the secondary structural elements of α-helix and β-
sheet respectively.  The CD looks similar to that seen for the tetramer at pH 9.0. (B) 
MALDI-TOF MS of full length Ent-Nterm pre-proteolytic cleavage with 
enteropeptidase. The major peak is at 8148.71 Da, equal to the calculated MW of an 
Ent-Nterm monomer (8148 kDa) with a minor peak at the MW of a dimer. 
 
3.4.3 Optimising proteolysis-triggered oligomerisation of Ent-Nterm 
Initial experiments were conducted using the ideal conditions for a typical enteropeptidase 
digest as suggested by the product protocol (1 U/50 µg porcine enteropeptidase /protein, 16h 
at 22 
o
C, Applied Biological Materials (ABM) Inc). Preliminary SEC analysis showed that 
under these conditions there were HMW oligomers within the sample, but there was also a 
large amount of undigested protein present (fig. 3.21 A). The concentration of 
enteropeptidase was increased to 2 or 3 U of enzyme/50 µg of protein. SDS-PAGE and SEC 
analysis showed that at 3 U/50 µg, a negligible amount of undigested Ent-Nterm was present 
(fig 3.21 B) and larger oligomers had formed. 
The most notable difference between Ent-Nterm and Nterm-Lsr2 was that a much lower 
initial protein concentration was needed to reach the top end of the HMW oligomer size (28-
mer from a 1 mg/mL Ent-Nterm sample). Furthermore, a simpler distribution of assemblies 
was observed. One at the HMW range (including a 28-mer) and one within the MMW range 
(octamer). There was also an additional peak that eluted below the lower molecular weight 
range of the column (10 kDa). MALDI-TOF MS showed that this peak was the monomer 
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trypsin digest on Nterm-Lsr2 but was masked by the large protein fraction peak. Removal of 
the N-terminal residues could also cause some disruption along the dimerisation interface.  
                                                            1           2            3 
 
 
Figure 3.21: Enteropeptidase proteolysis; enzyme concentration trials. (A) SEC 
of Ent-Nterm post-proteolytic cleavage with varying concentrations of 
enteropeptidase. Peaks 1, 2, 3 and 4 are HMW, MMW, LMW and monomer 
respectively. Black: 3 U enteropeptidase/ 50 μg/mL Ent-Nterm; grey: 2 U 
enteropeptidase/ 50 μg/mL Ent-Nterm; dashed: 1 U enteropeptidase/ 50 μg/mL Ent-
Nterm.  (B) SDS-PAGE of SEC fractions; 1, 2 and 3: HMW, MMW and LMW 
respectively of 1 U enteropeptidase/ 50 μg/mL Ent-Nterm proteolysis; 4 and 5: 
HMW and MMW respectively of 2 U enteropeptidase/ 50 μg/mL Ent-Nterm 
proteolysis; 6 and 7: HMW and MMW respectively of 3 U enteropeptidase/ 50 
μg/mL Ent-Nterm proteolysis and 8: full length Ent-Nterm.  Proteolysis with 3 U of 
enteropeptidase shows negligible amounts of undigested Ent-Nterm and the highest 
































































     A: MALDI-TOF MS                                                 B: SEC  
                                                                                                 1       2    3        4                                                                            
 
                                                                                                         
Figure 3.22: Molecular weight analysis of Ent-Nterm post proteolysis. (A) 
MALDI-TOF MS with major peaks at 6206 Da and 12391 Da which represent the 
truncated monomer and dimer respectively. (B) Oligomerised Ent-Nterm at 7.4, 1 
mg/mL. Grey: full length tetramer (peak 3 - 32 kDa); black: Ent-Nterm after 
enteropeptidase proteolysis (peak 1 - 174 kDa, peak 2 - 50 kDa and peak 4 – 6 kDa). 
Treatment with enteropeptidase removes the N-terminal tag which facilitates the 
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3.4.4 Equilibrium and distribution of self-assembled supramolecular structures of Ent-
Nterm 
Equilibrium experiments showed that the oligomers behaved in the same way as Nterm-Lsr2 
oligomers. The HMW oligomer (28-mer) re-equilibrated to MMW (octamer) species when 
re-injected onto the column (fig. 3.23 A). Similarly, the MMW oligomer (octamer) re-
equilibrated to a slightly lower molecular weight oligomer, which was probably a dilution 
effect, but the oligomer was still in the MMW range (hexamer) (fig. 3.23 B). 
 
        A: HMW re-equilibration                                   B: MMW re-equilibration 
 
Figure 3.23: Ent-Nterm equilibrium. The eluted peak has been collected, 
concentrated and re-injected onto the column. (A) HMW peak (28-mer) re-
equilibrates to a MMW oligomer (octamer). (B) MMW peak re-equilibrates from an 
octamer to a hexamer. This is similar equilibrium pattern to Nterm-Lsr2 with the 
larger oligomers reducing in size upon re-injection onto the gel filtration column.  










































































































































3.4.5 Effects of pH on self-assembly of Ent-Nterm 
The oligomer peak was collected and concentrated to 0.5 mL. This was then exchanged into 
pH 9.0 buffer using diafiltration. When this was re-injected onto the SEC column the 
oligomers re-equilibrated to a tetramer (fig. 3.24).  
 
                                                                      tetramer 
 
Figure 3.24: The influence of pH on the oligomerisation of Ent-Nterm. Grey: 
Ent-Nterm post-preoteolytic cleavage at pH 7.4, 1 mg/mL. Seen is a mixture of 
HMW and MMW assemblies. Black: Ent-Nterm post-preoteolytic cleavage at pH 
9.0, 1 mg/mL. Only visible oligomer is a tetramer.  Ent-Nterm displays the same 
behaviour as Nterm-Lsr2 post-proteolysis. 
 
3.4.6 Discussion 
The oligomers formed by enteropeptidase cleavage underwent assembly in the same way as 
those formed through the partial trypsin digest method, but with a much cleaner distribution 
of species formed.  Decreasing the concentration led to dissociation of the oligomers into 
smaller species and increasing the pH resulted in a single tetrameric species. It can be 
inferred, therefore, that the route towards assembly is the same in both systems. The main 
difference between the two systems was that the large HMW oligomers formed at much 
lower initial protein concentrations. An explanation for this is that the concentration of 
oligomerisable protein within the system has increased as there is no longer unwanted 
proteolysis along the polypeptide chain. As hypothesised, the change in assembly “trigger” 

























3.5 Transmission electron microscopy  
TEM was used to visualize the arrangement of the protein assemblies. The samples were 
negatively stained and analysed pre and post-proteolysis for both Nterm-Lsr2 and Ent-Nterm.  
The most striking difference between the samples was the formation of long range “spaghetti- 
like” structures of Ent-Nterm after treatment with enteropeptidase (fig. 3.25 B). These 
structures were similar to the networks formed by full length Lsr2 in the presence of DNA. 
[6] Prior to proteolysis (enteropeptidase treatment for Ent-Nterm and partial trypsin digest for 
Nterm-Lsr2) the protein existed as disordered aggregate (fig. 3.25 A, C). Upon partial trypsin 
digest, Nterm-Lsr2 appeared to achieve some long range order. However there was still some 
protein aggregate present (fig. 3.25 D). This was attributed to the additional fractionation that 
occurred during the trypsin digest.  It is likely that the disordered fragments were entwined 
with in the ordered network. 
The removal of the N-terminal residues at Lys
4
 led to the formation of ordered structures 
rather than a disordered aggregate. It was clear from the TEM images that modifying the his-
tag linker cleavage site (and thereby improving the assembly trigger for Nterm-Lsr2) led to 





















  C: Nterm-Lsr2 neat                                             D: Nterm-Lsr2 post proteolysis 
 
 
Figure 3.25: TEM of Ent-Nterm and Lsr2-Nterm pre and post-proteolysis. The 
proteins (50 μg/mL) are negatively stained with uranyl acetate (1%).  Black scale 
bars represent 200 nm. (A) Ent-Nterm pre-proteolysis.  Only random aggregate is 
seen. (B) Ent-Nterm post-proteolysis. An ordered network of strands can be seen. (C) 
Nterm-Lsr2 pre-proteolysis.  Only random aggregate is seen. (D) Nterm-Lsr2 post-
proteolysis. There is a degree of order in the network but a lot of aggregate is still 
visible, likely to be Nterm-Lsr2 fragments.  The addition of a specific recognition 










3.6.1 Lsr2  
The aim of this research was to develop new methods to utilise proteins for novel assembly 
systems. Lsr2 was selected as its N-terminal region had been shown to assemble under mild 
proteolytic conditions. [6] Additional routes towards oligomerisation (namely metal 
coordination and DNA binding) made Lsr2 an attractive candidate for this project. However, 
due to the strong DNA binding of the C-terminal region, it was not possible to easily analyse 
or control assembly. A key feature of an ideal protein tecton is that it should be relatively 
facile to manipulate and it should assemble in a controllable manner. Without the removal of 
DNA, Lsr2 is not an ideal protein for forming novel biological nanomaterials.   
3.6.2 A novel route for triggered assembly of Nterm-Lsr2 
In this study a new route to trigger proteins towards forming higher ordered structures from 
Nterm-Lsr2 was developed. By engineering the protein to include an enteropeptidase 
cleavage site, it was possible to avoid fragmentation as a result of trypsin use. The new 
trigger resulted in an increase in the number of oligomerising units and improved the 
oligomerisation potential in vitro. This was corroborated by TEM, where more ordered, long-
range structures were formed from the new tecton.  
Variation in protein concentration resulted in different sized oligomers being formed in a 
stepwise fashion, with the MMW oligomer acting as a stable intermediate between the low 
and high molecular weight assemblies. pH was used as a switch to toggle between Nterm-
Lsr2 tetramers and higher ordered structures. The oligomers formed through enteropeptidase 
cleavage reacted in the same way to variations in protein concentration and pH as those 
formed from partial trypsin digest.  
With the new enteropeptidase trigger it was possible to form ordered, long-range structures 
with relative ease. [7] The degree of oligomerisation was regulated through external factors 
which gave additional control of the system.  Downstream, this new tecton trigger could be 
used as the basis of new responsive materials, biosensors, electronics, or drug delivery 
vehicles.   
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Chapter Four: High molecular weight assembly of HsPrx3-6his 
 
4.1 Introduction 
Prxs can adopt a wide range of highly ordered quaternary structures, from dimers and toroids 
[1, 2], to stacks and tubes [3, 4], catenanes [5], and, under certain conditions, cages (Chapter 
1 at 1.6.8). [6] Many members of the Prx family have the capacity to function not only as a 
peroxidase [7, 8] but also a chaperone, [9] a H2O2 regulator, [10] and other physiological 
roles (Chapter 1 at 1.6.7). [11] This ability to function in multiple cellular roles is intrinsically 
linked to the oligomeric state of the protein. [12] With the wealth of understanding available 
in the literature on how these different oligomers form, it is possible to predict conditions that 
can initiate controlled assembly of biological nanoscale materials. [4, 13] For this reason, Prx 
has been identified as an ideal candidate for forming novel structures in the field of protein 
nanotechnology. [4] 
The first step towards generating nanoscale materials from proteins is designing a stable 
tecton from which more complex structures can assemble.  In the case of human Prx 3 
(HsPrx3), this is the LMW dodecameric ring, which is formed from six oblique homodimers. 
[4] There are a number of ways of stabilising the ring that have been seen in the literature 
(Chapter 1 at 1.6.6). One such method involves adding a reducing agent which prevents the 
active site disulfide bond from forming, a key event in the disassociation of the ring. [1, 4, 7] 
Other methods incorporate site specific mutations, which lock the ring in place. [14]  The pH 
conditions can also influence the toroid stability. A histidine residue at the inter-dimer (A-
type interface), conserved in many typical 2-cys Prx, forms an salt bridge (with arginine on 
the adjacent dimer) that locks the Cp loop in the closed conformation in pH conditions below 
the histidine side group pKa (pH 7.37). [15] This is believed to stabilise the LMW structure at 
pH 7.3 and below. [15] It has been hypothesised that histidine is involved in stabilising the A-
type interface of other peroxidredoxins that exist as oxidised toroids above pH 7.3. For 
example, the crystal structure of Ancylostoma ceylanicum Prx 1 (AcePrx-1) showed that 
His
107
 can form electrostatic interactions with backbone oxygen on the adjacent dimer as well 
as π-π stacking with His
107
’. [16] This residue is conserved in human Prx 4 (HsPrx4), which 
is also a stable oxidised toroid above pH 7.3. [17] 
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Intriguingly, the addition of an N-terminal affinity tag, often cleaved after protein 
purification, can have a profound effect on the oligomeric state of Prx (Chapter One at 1.6.6). 
In the case of histidine-tagged bovine Prx 3 (BtPrx3), which shares a 93% sequence 
homology with HsPrx3, the dodecamer is stabilised in both the reduced and oxidised form. 
[18] Additional non-native residues at the N-terminus of the protein have also been shown to 
have a direct influence on the geometry of the ring. [19] Furthermore, histidine tags have 
been used to aid the assembly of the LMW tecton into the HMW stacks and rings via divalent 
metal coordination. [13] 
It is clear that histidine in the native protein sequence is involved in the quaternary structure 
assembly of many Prxs. [15-17] Furthermore, the presence of a histidine tag can aid the 
controlled assembly of LMW Prx into its HMW form. The evidence that the tags can not only 
be utilised directly via metal coordination, but also have the capacity to change the ring 
geometry and quaternary structure of Prx indicates that there is an abundance of potential 
influences yet to be explored. The following chapter will document how the presence of an 
N-terminal poly-6-histidine tag on HsPrx3 (HsPrx3-6his) affects the structure and behaviour 
of the protein, and the novel methods that have been employed to harness these changes to 
drive assembly into complex biological nanomaterials. 
 
4.2 Expression and purification of HsPrx3-6his 
 
The gene encoding HsPrx3-6his, cloned into pET151-D-TOPO, was synthesised by Epoch 
Life Science Inc.  Chemically competent E. coli cells (BL21 (DE3) ROSETTA, Novagen, 
2013; genotype – F- ompT hsdSB[B- mB-] gal dcm [DE3] pRARE [CamR]) were 
transformed with the plasmid using heat shock (Chapter 2 at 2.2.2.2). These cells were 
chosen due to the pRARE codon, which supplied tRNA for the rare codons of HsPrx3 and the 
presence of T7 RNA polymerase, which allowed expression from the pET vector. The protein 
was successfully expressed in standard lysogeny broth (LB) media (Chapter 2 at 2.3.1.1) after 
shaking (180 rpm) at 37
o
C for 4 hours, in the presence of ampicillin and chloramphenicol, 
and then at 26
o
C (with the addition of IPTG) for a further 20 hours. 
 
 


























               A: IMAC                                                                        B: SEC 
  
C: SDS-PAGE 






Figure 4.1: Purification of HsPrx3-6his: (A) Elution of HsPrx3-6his from a Ni
2+
 
IMAC column upon increasing imidazole concentration. Black: absorbance at 280 
nm (mAU); grey: percentage concentration of 0.5 M imidazole buffer (%).  (B) SEC 
chromatography of eluted IMAC peak. The major peak elutes as a dodecamer (peak 
2) with a small shoulder (peak 1) and a peak at lower MW containing impurities and 
small amount of HsPrx3-6his (peak 3). (C) SDS-PAGE gel of HsPrx3-6his 
purification. 1: crude lysate; 2: insoluble crude 1; 3: insoluble crude 2; 4: soluble 
crude; 5: IMAC flow-through; 6: IMAC imidazole eluted fraction; 7: SEC peak 2; 8: 
SEC peak 2; 9: SEC peak 3. 
 
Cells were lysed using sonication (Chapter 2 at 2.3.2.2) and the insoluble fraction was 
removed by centrifugation (18 000 x g, 30 minutes, 4 
o
C). HsPrx3-6his was isolated from the 
soluble crude broth using IMAC and the sample was separated from any remaining impurities 
using SEC (fig. 4.1 A and B). SEC data showed a major peak around 305 kDa, close to the 
calculated molecular weight of the HsPrx3-6his dodecamer (304 kDa), flanked by a HMW 
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(HsPrx3-6his monomer) on SDS-PAGE (fig. 4.1 C).  It is possible that trace amounts of Ni
2+
 
had been leached from the IMAC column and coordination to the histidine tag was driving 
the formation of the HMW species. This phenomenon has been noted in previous studies. [4, 
13, 18]  
During the final purification step of SEC, the protein was transferred into storage buffer 
(Chapter 2 at 2.3.2.6) which contained a chelating agent, 10 mM EDTA, and reducing agent, 
2 mM TCEP. After incubation at 4
o
C in the presence of EDTA for at least an hour, and the 
subsequent removal of the chelating agent, no shoulder peak was observed (fig. 4.2).   
 
                                                 dodecamer 
 
Figure 4.2: SEC of HsPrx3-6his after removal of EDTA and Ni
2+
 in reducing 
conditions (150 mM NaCl, 20 mM HEPES, 2 mM TCEP, pH 8.0, 1 mg/mL).  The 
shoulder peak is no longer present and the oligomer is in the LMW form (305 kDa, 
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4.3 N-terminal 6-histidine tag stabilises the toroid in non-reducing 
conditions 
Like many other typical 2-cys Prxs (Chapter 1, at 1.6.6), [2, 5, 20]  wild type human Prx 3 
(HsPrx3-WT) switches between a dimer and a dodecamer under non-reducing and reducing 
conditions respectively. [4] Without a reducing agent present, a disulfide bond can form 
between the peroxidatic cysteine (Cysp) and the resolving cysteine (Cysr) on the neighbouring 
subunits. [2, 7, 21] For this to occur, the Cp loop must undergo local unfolding [22] which, in 
turn, displaces key residues at the A-type interface causing the toroid to disassemble (Chapter 
1 at 1.6.6, fig. 1.15). [2]  
While the N-terminus of the protein is not located at the A-type interface, the presence of 
additional amino acids at this point has been shown to influence the toroid stability (Chapter 
1 at 1.6.6). [17-19, 23] With the evidence from the literature, it is apparent that there are 
routes towards toroid stabilisation that do not involve direct mutations of the A-type 
interface.  Through the size and structure characterisation techniques employed in this work, 
it has been established that the presence of an N-terminal histidine tag on HsPrx3 generates a 
stable dodecamer in both reducing and non-reducing conditions. This provides an ideal tecton 
from which larger structures can be formed.  
 
4.3.1 Analysis of HsPrx3-6his under non-reducing conditions  
Size Exclusion Chromatography 
HsPrx3-6his was transferred into non-reducing buffer at pH 8.0 (Chapter 2 at 2.3.2.5) which 
removed the reducing agent, the EDTA, and any trace metals from the protein sample. This 
was to allow for the formation of the intra-dimer disulfide bond and to eliminate the 
possibility of oligomerisation via histidine tag to metal ion chelation. The sample was left 
O/N to allow the protein rings to dissociate in accordance with protocols from the literature. 
[4] After this time, the protein sample was analysed using a gel filtration column pre-
equilibrated with the non-reducing pH 8.0 buffer (Chapter Two at 2.5.1). Unlike the wild type 
untagged construct, [4] non-reduced HsPrx3-6his eluted at 305 kDa. This shows that, even 
without the addition of a reducing agent, the dodecamer does not dissociate into its dimeric 
form (fig. 4.3). 
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                                           dodecamer 
 
Figure 4.3: SEC of HsPrx3-6his after removal of EDTA and Ni
2+
 in non-
reducing conditions (150 mM NaCl, 20 mM HEPES, pH 8.0, 1 mg/mL). Unlike 
HsPrx3-WT, [4] the protein exists predominantly as a dodecamer.  
 
This is consistent with the findings of Cao et al. who found that the BtPrx3-tagged dodecamer 
is stable under non-reducing conditions at 1 mg/mL, whereas the untagged construct only 
exists as a mixture of dimer and dodecamer at concentrations in excess of 10 mg/mL. [18] 
Additional conditions were also trialled (with varied imidazole and EDTA concentration, 
incubation time, and low protein concentration) but none were successful at destabilising the 
dodecamer (Appendix. 4.1). The untagged construct (HsPrx3-WT) dissociates under non-
reducing conditions, without the addition of chelating agents, at 4 
o
C and at 1 mg/mL. [4] The 
only major difference between the two constructs is the presence of the tag and linker. 
Therefore, the stability of HsPrx3-6his dodecamer under non-reducing conditions is likely to 
be a consequence of the additional sequence at the N-terminus of the protein. 
Analytical Ultracentrifugation and Transmission Electron Microscopy 
While gel filtration was a good starting point, used to confirm toroid stability, additional 
analysis was needed to confirm the accurate size and structure of HsPrx3-6his. During gel 
filtration there is always a degree of dilution due to the diffusion of the sample as it passes 
through the column. [24] It is possible that there is a low concentration of dimer present that 
may not be visible on SEC. 
Samples were prepared for the AUC in the same way as for the gel filtration column. The 
concentration was reduced to take gel filtration dilution into account while maintaining an 
OD greater than 0.1 at 280 nm, necessary for detection in the AUC. [25] As a comparison 







































reducing agent (2 mM TCEP) which showed a single species at the molecular weight of a 
dodecamer (appendix 4.2).  
 
                   A: AUC 












Figure 4.4: Further size and structural analysis of HsPrx3-6his under non-
reducing conditions (150 mM NaCl, 20 mM HEPES, pH 8.0). (A) AUC of HsPrx3-
6his shows a single species corresponding to the molecular weight of 300 kDa, close 
to the calculated weight of the dodecamer. (B) TEM of the HsPrx3-6his, diluted to 
50 μg/mL in dH2O prior to grid preparation and stained with 1% uranyl acetate, (140 
k x magnification) shows that the protein is in the LMW (dodecameric) form. This 
further demonstrates that the presence of the histidine tag is stabilising the toroid 
under non-reducing conditions. 
 
For the non-reduced sample there was a predominant species around 310 kDa (fig. 4.4 A), 
with a sedimentation coefficient of 11.19 and a frictional ratio of 1.41 (Equation 1). [26] 
There was also a small peak around the molecular weight of a dimer and a number of peaks 
100 nm
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relating to HMW oligomers but all of these were < 2% of the peak volume of the dodecamer 
peak.   
  
      
       
 
M = mass  
s = sedimentation coefficient 
  = frictional coefficient 
Na = Avogadro’s number 
ρ = solvent density 




The trace amounts of dimer seen by AUC that were not visible using gel filtration indicate a 
small concentration dependence for dodecamer stability. However, the predominant species 
was still a dodecamer with the ratio (~98:2) between the two oligomers. This is far greater 
than that seen in other studies at the same protein concentration. [2] Therefore the tag 
significantly improves the stability of the dodecamer under non-reducing conditions. 
The structure of the dodecamer was confirmed using TEM (fig. 4.4 B). The sample was 
diluted to 50 μg/mL in dH2O directly before grid preparation and stained with uranyl acetate 
(1 %). It is not possible to observe dimers on TEM due to the resolution being too low to 
image such a small structure. Unlike previous studies, there were no double stacks seen using 
TEM, [4] likely due to the additional step in this study of metal chelation after IMAC 
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4.3.2 The formation and disruption of the active site disulfide bond 
Non-reducing SDS-PAGE 
A disulfide bond between the active site thiols forms as a reaction intermediate during the 
catalytic cycle (Chapter 1 at 1.6.1). [1, 21, 27] This is later reduced by a thiol reductant to 
regenerate the peroxidatic cysteine. [2, 7, 12] Due to the covalent nature of this intra-dimer 
bond, the oligomer is SDS-resistant and the denatured protein appears as a dimer band (50 
kDa) on non-reduced SDS-PAGE electrophoresis. Reducing agents can break the disulfide 
bond, or site specific mutations of peroxidatic cysteines can prevent the formation of 
disulfide bonds, resulting in the a 25 kDa protein band as expected for a monomer. [28]. The 
formation of the disulfide bond is preceded by local unfolding of the active site which, in 
turn, displaces key residues at the A-type interface resulting in dissociation of the toroid into 
dimeric units (Chapter 1 at 1.6.6). HsPrx3-6his is a stable toroid under non-reducing 
conditions, so it is important to ensure that the disulfide bond is still able to form. The 
protein, which had not been pre-treated with EDTA, was analysed with or without reducing 
agent (± 2 mM TCEP) and under varying chelating conditions (± 10 mM EDTA, ± 20 mM 
imidazole). The different chelating conditions were analysed as it was hypothesised that trace 
amounts of metal could coordinate to the histidine tags. This would further stabilise the 
dimer, giving a false positive result.  Bovine serum albumin (BSA) was used as a positive 
control to show that protein oligomers can be seen on non-reduced SDS-PAGE (fig. 4.5, lane 
1). 
A mixture of dimer (~ 50 kDa) and monomer (~ 25 kDa) was seen for HsPrx3-6his in the 
presence of a reducing agent.  The dimer band was weakened with the addition of imidazole 
and completely disappeared with EDTA and EDTA + imidazole (fig. 4.5 lanes 2 - 5). It is 
possible that trace amounts of Ni
2+
 in the sample were helping to stabilise the dimer through 
coordination to the histidine tag. Once the metal ions were removed, and with no disulfide 
bond at the B-type interface, the oligomer disassembled upon denaturing with heat. 
For all the non-reduced samples, only a dimer (~ 50 kDa) was seen on SDS-PAGE, even after 
heating the protein at 95 
o
C for 60 seconds (fig. 4.5, lanes 6 – 9). Unlike the reduced samples, 
the addition of chelating agents did not disrupt the strong intra-dimer interactions. This 
showed that the dimer interface was stable, indicating the formation of a disulfide bond as 
seen in previous work on HsPrx3. [28] 












Figure 4.5: SDS-PAGE of HsPrx3-6his under varying conditions. Wells 2 – 5 
contain 2 mM TCEP (red) and wells 6 - 9 are non reduced (NR). 1: BSA oligomer 
positive control; 2: Hsprx3-6his red; 3: Hsprx3-6his red + 20mM imidazole; 4: 
Hsprx3-6his red  + 10 mM EDTA;  5: Hsprx3-6his red  + 20 mM imidazole and 10 
mM EDTA; 6: Hsprx3-6his NR; 7: Hsprx3-6his NR  + 20mM imidazole; 8: Hsprx3-
6his NR  + 10 mM EDTA; 9: Hsprx3-6his NR  + 20 mM imidazole and 10 mM 
EDTA.  The reduced dimer becomes unstable with the addition of chelating agents 
indicating the stability of the dimer in this form is due to the presence of Ni
2+
. The 
NR dimer remains stable throughout indicating the presence of an intra-dimer 
disulfide bond. 
 
These results show that the protein active site is still redox sensitive. However, unlike the 
non-tagged construct, local unfolding of the active site that occurs upon disulfide bond 
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4.3.3 The quaternary structure of HsPrx3-WT is sensitive to the active site redox state 
 
Within the translated protein sequence of HsPrx3-6his there is a tobacco etch virus protease 
(TEV) recognition site.  This allows for the N-terminal histidine tag and linker to be cleaved 
via proteolysis with rTEV protease. [29] To ensure the toroid stabilising effect was a result of 
the tag and not the protein handling or purification, a sample of HsPrx3-6his was processed in 






The protein sequence of HsPrx3-WT post-proteolytic cleavage with rTEV. The five 
additional non-native N-terminal residues are in bold. 
 
It has been shown in previous studies that the oligomeric state of HsPrx3, with the tag 
removed, is sensitive to changes in the redox state of Cysp with the dodecamer dissociating 
into dimers in non-reducing conditions. [4] Analysing the cleaved construct in this study will 
therefore provide a control to ensure that the stabilisation is a direct consequence of the 
presence of the histidine tag. 
A series of different concentrations of protease to Prx were trialled at small scale to identify 
the optimal conditions for tag cleavage (Chapter 2 at 2.3.3). The concentration, 1:20 
TEV:HsPrx3, was used to cleave the tag, and the mixture was left O/N at 4
o
C in the presence 
of a reducing agent (2 mM TCEP). At this point the cleaved and non-cleaved proteins were 
separated using an IMAC column that had been charged with Co
2+ 
(fig. 4.6 A). The protein 
that was successfully digested with rTEV was not able to bind to the column. Furthermore, 
any uncleaved protein and the rTEV enzyme (both of which have a histidine tag) [29] would 
coordinate to the column and only elute upon increasing imidazole concentration. Because of 
this, it was the pass-through that was collected. Any additional peaks eluting upon increasing 
imidazole concentration were also analysed on SDS-PAGE. SDS-PAGE analysis confirmed 
that the flow through contained the cleaved construct (HsPrx3-WT) (fig. 4.6 B). 
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Figure 4.6: Purification of HsPrx3-WT. (A) Elution of HsPrx3-WT from a Co
2+
 
IMAC column upon increasing imidazole concentration. Black: absorbance at 280 
nm (mAU); grey: percentage concentration of 0.5 M imidazole buffer (%).  (B) SDS-
PAGE gel of HsPrx3-WT purification.  1: HsPrx3-6his + TEV protease digest crude; 
2: TEV protease (~30 kDa); 4 to 6: IMAC flow through containing the isolated 
cleaved construct (~20 kDa); 7: weakly bound cleaved product with a small amount 
of uncleaved dimer present. The protein post-proteolysis has the MW of the wild 
type monomer. 
 
Initial SEC analysis showed the HsPrx3-WT peak eluting later than the tagged dodecamer, 
indicating a smaller molecular weight due to the removal of 33 residues at the N-terminus 
(fig. 4.7). The elution volume showed a molecular weight of 250 kDa, close to the calculated 
molecular weight of HsPrx3-WT dodecamer species. After one hour in the absence of a 
reducing agent (2 mM TCEP) the dodecameric form still persisted (fig. 4.8 A). However, 
dodecameric rings had completely dissociated into dimers after 2 days at 4 
o




































































Chapter Four: High molecular weight assembly of HsPrx3-6his 
147 
 
                                             dodecamer 
 
Figure 4.7: SEC of tagged and untagged constructs under reducing conditions 
(150 mM NaCl, 20 mM HEPES, 2 mM TCEP, pH 8.0,1 mg/mL). Black: Hsprx3-WT 
dodecamer; dotted: HsPrx3-6his dodecamer. The untagged construct has a smaller 
molecular weight due to the loss of the tag and linker residues. 
 
 dodecamer     dimer  
                 









Figure 4.8: SEC of HsPrx3-WT under non-reducing conditions. (A) After 1 hour 
and (B) after 48 hours. With time, in the absence of reducing agent, the active site 
disulfide bond can form leading to destabilisation at the A-type interface [2] and the 
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The method of leaving the protein over time instead of directly adding H2O2 was employed to 
avoid overoxidation. The active site sulfenic acid can undergo further oxidation by an 
additional H2O2 [1, 4, 14] to form sulfinic acid which the resolving cysteine is unable to 
reduce to form the intra-dimer disulfide bond. [10, 30]  This not only leads to inactivation of 
the enzyme [10] but also restricts the local unfolding, which is believed to be needed to 
destabilise the A-type interface, [2, 22] and the subsequent dissociation of the toroid. [2, 31] 
A stable toroid in this instance would give a false positive result.  
These results made it clear that the stabilisation of the toroid form of HsPrx3-6his was a 
direct consequence of the tag, and was not due to any additional changes that may have 
occurred during protein expression and purification.   
 
4.3.4 Discussion 
There are a number of explanations for toroid stabilisation with the addition of a histidine tag.  
Histidine tags are generally accepted to have minimal effect on the structure and function of 
recombinant protein. [32] However, there are exceptions where the histidine tag can interact 
directly with the native structure, [33] reduce enzyme efficiency, [34] have a long range 
influence on the protein dynamics, [35] and even disrupt the protein quaternary structure. 
[36] 
Additional amino acids on the N-terminus of other typical 2-cys Prxs have been shown to 
have a long range effect on the positioning of key residues at the B-type interface (Chapter 1 
at 1.6.6). [19] The β-slip of 6 Å and rotation of 17.2 
o
 around the axis parallel the β7 strand in 
the tagged form of Plasmodium yoelii Prx 1a (PyPrx1a
N*
) result in changes in the ring 
geometry, and subsequently the tagged protein exists as an octamer rather than the native 
decameric form (PyPrx1a). [19] There is a less pronounced disparity between the dimensions 
of the wild type and histidine tagged toroids of HsPrx3, with the tagged toroid being more 
compact. [4] It is possible that changes at the B-type interface are repositioning key 
interacting residues at the A-type interface, which in turn would stabilise the ring.  A crystal 
structure of HsPrx3-6his would be useful to confirm this hypothesis. 
Prxs have a variety of different functions, one of these being their ability to behave as a 
putative chaperone (Chapter 1 at 1.6.7). [3, 7, 9, 14, 30, 37] The histidine tag and linker 
peptide used in the production of HsPrx3-6his are unusually long at 33 residues; the average 
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length is around 14. [32] A BLAST search of protein structures that contained the same tag 
and linker sequence at the N-terminus was conducted and gave a number of different resolved 
structures.  The majority of tags and linkers were disordered. It is possible that the presence 
of a disordered peptide in the dodecamer lumen of peroxiredoxin is initiating a chaperone 
response which would lead to the locked ring structure. This hypothesis will be explored in 
more detail in chapter 5. 
 
Finally, histidine tags have the potential to interact with each other, with other parts of the 
protein, [39] and to influence the quaternary structure of recombinant proteins. [36] It is 
possible that the histidine tag in this construct is interacting directly with the protein, enabling 
the stabilisation of the toroid. However, a crystal structure would be needed to confirm this 
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4.4 Assembly of HsPrx3-6his via divalent metal coordination 
 
Histidine tags have been used in the field of protein science for many years as an ideal ligand 
to coordinate to divalent metals for the purification of recombinant proteins (Chapter 1 at 
1.4.3). [40, 41] In many instances the tag is removed after purification using an enzymatic 
cleavage site. [32, 42] In the case of Prxs the histidine tag can not only have an effect on the 
structure and function of the enzyme, but can also be utilised to drive HMW oligomer 
formation (Chapter 1 at 1.6.8). [18, 19] There are many examples in the literature of metal 
coordination being utilised to drive supramolecular assembly. [43-46] Furthermore, there are 
numerous instances in nature where the symmetry and function of a complex system is 
governed by metal ion coordination. [43, 47]  
The binding of metal ions is selective, with the geometry being directly affected by the pH of 
the solution and the selectivity of the metal. [48, 49] At pH 8, one Ni
2+
 ion binds to six 
imidazole side groups with octahedral symmetry. These imidazoles may come from one or a 
number of different histidine tags within the protein system. If imidazoles from tags on 
neighbouring subunits were to interact with the same metal ion this could help to stabilise and 
therefore drive the assembly of HMW oligomers. Due to the fact that many Prx toroids are 
predisposed to assemble into complex HMW oligomers, [3, 4, 6] it was predicted that the 
addition of metal ions would aid this process. In fact, it has been shown in the literature that 
chelation of Ni
2+
 to the histidine tags on SmPrx1 decamers is enough to stabilise the 
interactions at the ring interface (R-type interface) so that the toroids assemble into tubes. 
[13] Furthermore, chelation to metals adds an additional route towards functionalisation of 
any protein nanomaterials formed from HsPrx3-6his.  
 
4.4.1 Nickel concentration influences the degree of oligomerisation 
 
In order to investigate the optimal conditions needed for oligomerisation via metal chelation a 
range of metal ion concentrations were trialled, from 1:6 to 6:1 ratio of metal ion:protein. 
This information was used to determine the ratio of HsPrx3-6his to metal ion needed to drive 
the formation of HMW assemblies without forming random aggregates. As an additional 
precaution, 20 mM imidazole was added to the buffer and removed in a step wise fashion. 
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This was to control the rate of metal ion to histidine coordination and therefore reduce the 
formation of random aggregates. A number of different methods were employed to measure 
the assembly of the toroids in response to metal chelation, SEC, AUC and TEM. SEC and 
AUC showed the increase in molecular weight and TEM was used to determine the types of 
structures formed.  
Size Exclusion Chromatography 
The protein was transferred into non reducing metal ion coordination buffer which contained 
20 mM imidazole (Chapter Two at 2.7.3) and Ni
2+
was spiked in at a ratio of 6:1, 3:1, 1:1, 1:3 
or 1:6 metal ion to HsPrx3 monomer (HsPrx3-6his concentration = 1 mg/mL, ~ 40 μM). A 
small amount of the sample at the 1:1 ratio was analysed on SEC to ensure the protein was 
not aggregating in the presence of imidazole (fig. 4.9 A). The solution was left O/N at 4
o
C. 
After this time the imidazole in the buffer was removed in a stepwise fashion via diafiltration 
to allow for metal ion coordination. 
 
      HMW   dodecamer 
        
            A:  + 20 mM  




            B: no  





Figure 4.9: SEC trace of HsPrx3-6his with 1:1Ni
2+
:monomer (~40 μM). Both 
samples are at 1 mg/mL, pH 8.0 non-reduced buffer. (A) + 20 mM imidazole, (B) no 
imidazole.  Upon removal of imidazole the protein assembles into HMW oligomers 
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The samples containing 6:1 and 3:1 metal ion to HsPrx3 precipitated out during diafiltration.  
It was possible to resolubilise the protein with the addition 10 mM EDTA and therefore it 
was believed that excess Ni
2+
 led to the disordered aggregation of the protein. Because of 
this, no further testing was conducted on samples containing these ratios. 
There was a drop in protein concentration for the 1:1 metal ion to HsPrx3-6his sample, as 
measured by Bradford assay (1 mg/mL – 0.6 mg/mL). [50] This was attributed to the 
diafiltration method used to exchange the buffer and the concentration of Ni
2+
 was adjusted 
accordingly to ensure the ratio remained the same. It was clear from the SEC trace (fig. 4.9 
B) that the metal had a considerable effect on the oligomeric state of the protein. The peak 
shifted towards the column void with a large shoulder eluting at 600 kDa. This indicated the 
MW of stacks of two or more dodecamers. 
 
                                                  dodecamer 
A:  1:3 
 
 






Figure 4.10:  SEC trace of HsPrx3-6his with (A) 1:3 and (B)1:6 Ni
2+
:monomer 
ratio. In both cases there is not a sufficient concentration of Ni
2+
 to fully initiate 
assembly. The peak at 1:3 is slightly broader indicating a possible mix of species. 
 
The degree of oligomerisation decreased with decreasing metal ion to HsPrx3-6his ratio. The 
sample at 1:3 had a single peak just above the molecular weight of a single toroid. The peak 
was broader than was usually seen for a single dodecamer, indicating that there may be a 
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single ring (fig. 4.10 B). These results showed that the ideal concentration for the metal 
association was at 1:1 ratio metal ion to Hsprx3-6his monomer.   
Analytical Ultracentrifugation and Transmission Electron Microscopy 
Due to the size limits of gel filtration, the mass of the protein oligomers was measured using 
AUC. The protein was exchanged into a buffer containing 20 mM imidazole, and Ni
2+
 was 
spiked in at a 1:1 ratio with the protein monomer. Imidazole removal was carried out via 
diafiltration as before, and the sample was prepared for AUC analysis with a small aliquot 
retained for TEM. 
AUC showed that the predominant species was a double stack with additional peaks at the 
molecular weights of stacks of three or four rings (fig. 4.11 A). Interestingly there was still a 
small amount of the single ring present. This peak was not seen exclusively on SEC but the 
broad shoulder around the double stack range did extend into elution volumes corresponding 
to the dodecamer molecular weight. There was also a peak relating to the dimer. This was due 
to the lower concentration of sample measured on AUC (0.3 mg/mL). 
TEM grids were prepared following procedures as described in Chapter 2 at 2.4.4. The 
images corroborated with the AUC data with a mixture of single rings, double, triple and 
quadruple stacks (fig. 4.11 B, I - IV). It was noted that there were a number of species that 
resembled cages (fig. 4.11 B, V) similar to structures seen in the literature. [6] However, 
upon closer inspection, the parameters of these species did not match well with the diameter 
of a cage. It was hypothesised that the electron density visible within the lumen was in fact 








                                                  
  

























              








Figure 4.11: Further size and structural analysis of HsPrx3-6his in the presence 
of equimolar amounts of Ni
2+
. (A) AUC shows a mixture of single rings and stacks 
of 2 – 4 dodecamers with the most prevalent species being a double stack. (B) TEM, 
diluted to 50 μg/mL in dH2O prior to grid preparation and stained with 1% uranyl 
acetate (140 k x magnification) I: full EM image, black bar represents 100 nm; II: 
stack of 5 rings; III: stack of 3 rings; IV: stack of 2 rings; V: toroid with central 
electron density. The addition of Ni
2+
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4.4.2 Disassembly with EDTA 
 
Previous methods to remove Ni
2+
 ions that had been leached from the IMAC column showed 
that EDTA had sufficient chelating efficiency to disassemble the HMW species (4.2). An 
excess of EDTA was spiked into the sample to a final concentration of 50 mM. The solution 
was incubated for at least one hour at 4
o





                                              dodecamer  
 
Figure 4.12: SEC trace of HsPrx3-6his after the removal of metal via EDTA 
chelation. The chromatogram shows a single species eluting at the molecular weight 
of the dodecamer. Stripping the metal from the HMW species removes the means by 
which they can assemble. This provides a switch between the LMW and HMW 
oligomers. 
 
To ensure full dissociation had occurred, the sample was analysed using SEC where a single 
peak eluted around the molecular weight of a dodecamer (305 kDa) (fig. 4.12). This was 
further proof that the formation of HMW species was a direct consequence of metal ion 
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4.4.3 Different divalent metals 
 
The affinity of the imidazole side groups on the histidine tag for different divalent metals can 
influence the binding. [49] Recombinant proteins can be purified using metals other than Ni
2+
 
on the IMAC due to over or under-protein coordination to the column. [41] This is related to 













To ensure that the oligomerisation of HsPrx3-6his was a direct consequence of Ni
2+
 
coordination a range of different divalent metals were trialled.  
 
                                       HMW dodecamer dimer 
 
 




                  






Figure 4.13: SEC of HsPrx3-6his with equimolar amounts of divalent metal (~40 
μM). (A) Co
2+
 and (B) Mg
2+
. The extent of oligomerisation reduces with decreasing 
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.  Of all the divalent 
metals Ni
2+
 had the most notable influence, with a peak eluting at the void volume flanked by 
a shoulder peak (fig. 4.9 B, above). Co
2+
 instigated some stacking but a significant amount 
less than Ni
2+
 (fig. 4.13 A). Unsurprisingly, Mg
2+
, which has little to no affinity with 
imidazole, had no effect on the oligomeric state of the protein with a single peak eluting 
around the molecular weight of a single dodecamer (fig. 4.13 B). This demonstrated that the 
oligomerisation of Prx was a direct consequence of divalent metal to histidine tag 
coordination as the efficiency of the system decreased with decreasing metal affinity. 
Furthermore, it provided a potential degree of control around the sizes of oligomers formed. 
This could be utilised in future work when employing this method to form protein 
nanomaterials for varying applications. 
 
4.4.4 Different buffer conditions 
 
Throughout the trials with divalent metal the degree of stacking was not to the same extent as 
had been seen in the literature. [13] Because of this, the conditions in which assembly 
occurred were varied so as to exactly match those used in the previous study. MOPS buffer 
was used at pH 7.6. [13] It was important to lower the pH from pH 8.0 due to the efficiency 
of MOPS to act as a suitable buffer above this point, and to keep the conditions equal to those 
reported in the literature. [13] It has been shown that histidine tags still associate with Ni
2+
 in 
the same geometry at this pH. [48] 
Before any metal was added to the system the sample with MOPS and imidazole was 
analysed on AUC as a control to identify major changes to the oligomeric state that might be 
due to changes in buffer conditions. AUC showed that the sample was almost entirely a 
single ring with a small amount of HMW oligomers visible on the trace (fig. 4.14 A). This 




To induce assembly, Ni
2+
 was added in the presence of imidazole (20 mM) and the sample 
was left O/N at 20
o
C. [13] After the stepwise removal of imidazole, the protein was analysed 
using AUC. While there was an increase in the amount of HMW oligomers, the single ring 
was still the most prevalent (fig. 4.14 B).   
























                                                          1x    2x  >2x dodecamer 
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Figure 4.14: AUC of HsPrx3-6his in MOPS pH 7.6 buffer with or without 
equimolar amounts of Ni
2+
 (40 μM). (A) Sample without Ni
2+
, there is a small 
amount of oligomerisation and (B) With no imidazole the degree of assembly 
increases but the major oligomer is still a dodecamer. 
 
4.4.5 Different pH conditions 
 
In addition to the conditions described above, the influence of pH variations on the 
oligomerisation with metal was also investigated. The geometry of Ni
2+
 to histidine 
coordination can vary at pH 7.0 and below. [4, 48] This could lead to changes in the 
orientation of the toroids with respect to each other and add another approach towards 
controlling the size and shape of the protein nanomaterials. 
Due to the fact that the HsPrx3 can already assemble at pH conditions below 7.0, [4] pH 7.0 
was chosen as the starting point. While a small amount of HMW oligomers were visible at 
pH 7.6 (MOPS), the assembly into larger structures increased significantly at pH 7.0 
(HEPES) without the addition of Ni
2+
. The fact that the protein oligomerised at pH 7.0 would 
make it difficult to discern any changes in molecular weight that were due exclusively to 
metal chelation.  Furthermore, the degree of assembly at pH 7.0 was far greater than that 
achieved via Ni
2+
 binding. For this reason, no further experiments were completed on this 
sample and the focus was changed towards the pH sensitivity of HsPrx3-6his. In future work 
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it may be possible to utilise the histidine tags as a form of functionalising these protein 




The use of divalent metal coordination was successful in driving the association of single 
HsPrx3-6his toroids. This was unsurprising due to the indication of HMW structures forming 
as a consequence of leached Ni
2+
 from the IMAC column. However there was a significant 
amount of variability between the structures formed. In previous studies using a decameric 
typical 2-cys Prx, Ni
2+
 had been successfully utilised to aid SmPrx1-6his assembly into 
elongated 1D nanotubes. [13] These structures were not seen in the current study despite a 
range of different conditions being trialled. It is important to note that there are a number of 
significant differences between the two Prxs which may explain why the extent of divalent 
metal assembly is less for HsPrx3-6his: 
1. The geometry of the ring: 
SmPrx1-6his is a decamer [13] whereas HsPrx3-6his is a dodecamer. This means that 
is it likely that there are different points of contacts at the R-type interface upon 
oligomerisation with a divalent metal ion.   
2. The number of tags per ring: 
It is probable that the number of tags within the ring will have an effect on assembly.  
The increased number of potential Ni
2+
 binding regions may explain why the protein 
was more susceptible to random aggregation rather than controlled association into 
discrete tubes. Furthermore, having multiple 6 histidine tags within one toroid made 
intra-toroid rather than inter-toroid coordination more likely due the D6 symmetry 
with which imidazole coordinates with divalent metals. 
3. The linker between the tag and the protein: 
While the length itself is different, which may influence the extent of inter-toroid 
coordination, there is also an additional region of metal binding residues as part of the 
linker in SmPrxI-6His. This is in the form of the enteropeptidase cleavage site which 
contains 4 aspartic acid residues in succession. [13] Ni
2+
 can coordinate to the 
carboxylic acid side chain [51] which adds another mode of protein association.  
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Overall, divalent metal ions do influence the oligomeric state of HsPrx3-6his, but more work 
will need to be done to optimise this manner of assembly. 
 
4.5 HsPrx3-6his is highly sensitive to variations in pH 
 
It has been well established in previous studies that adjusting the pH can have a profound 
effect on the oligomeric state of Prx (Chapter 1, at 1.6.6-1.6.8). [4, 15] Wild type HsPrx3 
assembles into 1D tubes at pH 4.0 [52] and the toroid is stable under non-reduced conditions 
at pH 7.0. [4] The pH sensitivity of typical 2-cys Prxs was explored in more detail by Morais 
et al. [15] They found that in many typical 2-cys Prxs there are two conserved residues at the 
A-type interface, a histidine and arginine. These residues stabilise the A-type interface via 
electrostatic interactions when the protein is in conditions below the pKa of the histidine side 
group (pH 7.37). With all this in mind, the variability of the oligomeric state of Prx due to 
changes in pH is a good starting point from which to predict possible assembly routes. 
Furthermore, as was described above, HsPrx3-6his does assemble into a large oligomer at pH 
7, indicating that the tag has more than just a dodecamer stabilising effect.  
To be able to compare the influence of pH on HsPrx3-6his to those seen for HsPrx3-WT, the 
tagged construct was initially subjected to the same pH range, pH 9.0, 7.0, and 4.0. This was 
to highlight any variations that could be attributed to the presence of a histidine tag.  It was 
also hypothesised that the reduced wild type dodecamer becomes unstable at pH 9.0 due to 
disruption along the A-type interface, and it was interesting to note whether the tag reduces 
this affect.  The conditions that resulted in HMW oligomerisation were explored further to 
understand how the assembly occurred and therefore gain more control over oligomerisation.   
 
4.5.1 Influence of pH on the oligomeric state of HsPrx3-6his 
 
HsPrx3-6his was dialysed into three different buffers at pH 9.0, pH 7.0, or pH 4.0 (Chapter 
Two at 2.1.7.6) O/N at 4
o
C.  The pH was checked after this time and the sample was analysed 
using TEM, SEC, or both. As an additional control to ensure any large oligomers seen on 
TEM were formed from Prx, the cleaved construct was also dialysed into pH 4.0 buffer. It 
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has been well documented that the protein forms tubes under these conditions [4, 52] and this 
provided a baseline image that any other potential Prx tubes could be compared to. 
pH 9.0 
HsPrx3-6his at pH 9.0 dissociated into dimers, with an additional shoulder peak eluting 
around the molecular weight of a tetramer (fig. 4.15). The alkaline pH, well above the pI of 
the protein (~6), may be enough to start denaturing the protein.  If this were to occur, then the 
key interactions at the A-type interface would be disrupted. Additional experiments to 
determine the folding and stability of the protein under these conditions, such as DSF or CD, 
could be employed to explore the phenomenon in more detail. However, as the aim of this 
project was to form large structures from stable tectons, the behaviour of the protein under 
this particular condition was not analysed further. 
 




Figure 4.15: SEC of HsPrx3-6his at pH 9.0.  The protein has dissociated into the 
dimeric species with only trace amounts of the dodecamer and a shoulder peak 
corresponding to the tetramer. 
 
pH 4.0 
As in the cleaved construct at pH 4.0 (fig. 4.16 A) the tagged protein oligomerised into HMW 
assemblies.  TEM analysis showed these assemblies to be 1D nanotubes (fig.4.16 B). The 
imidazole group on a free histidine has a pKa of around 6. It was initially thought that the 
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rings.  However, it is clear from the TEM that this is not the case and that tube formation is 
not hindered by the presence of the tag. The samples at pH 4.0 were not analysed on SEC as 
the TEM showed tubes of multiple rings that would be larger than the size range of the 
















Figure 4.16: TEM of HsPrx3 at pH 4.0. (A) HsPrx3-6his and (B) HsPrx3-WT. 
Both show extended tubes, with the tagged construct appearing to have slightly 
shorter tube lengths.  The black bar represents 100 nm. The presence of the histidine 











Perhaps the most remarkable result was the assembly of HsPrx3-6his at pH 7.0. The tagged 
construct, when exchanged into pH 7.0 buffer, eluted entirely in the void on SEC (fig. 4.17 
A). TEM analysis showed that these HMW structures were one dimensional nanotubes (fig. 
















Figure 4.17: Size and structural analysis of HsPrx3-6his at pH 7.0. (A) SEC trace 
of HsPrx3-6his at pH 7.0 (1 mg/mL). All of the protein eluted at the void indicating a 
species greater than 660 kDa. (B) TEM of HsPrx3-6his 1D tubes at pH 7.0, diluted to 
50 μg/mL in dH2O prior to grid preparation and stained with 1% uranyl acetate. The 
black bar represents 100 nm. Lowering the pH from 8.0 to 7.0 triggers the assembly 
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4.5.2 pH switch  
To assign a point at which the HMW oligomerisation occurred, a range of pH buffers were 
tested, 8.0, 7.8, 7.6, 7.4, and 7.2.  (Sample preparation, SEC and HPLC analysis were carried 
out by Jack Sissons, a summer student working at Callaghan Innovation between November 
2014 and February 2015.) The influence of varying pH was trialled under reducing and non-
reducing conditions. This was to determine whether the structural changes that occur in the 
wild type enzyme during the formation of the active site disulfide bond [22] influence the 
formation of HMW structures. 
Size Exclusion Chromatography 
Non-reduced 
The protein was transferred into the respective buffer by O/N dialysis. To ensure complete 
buffer exchange, the pH of the protein sample was measured prior to any further analysis. All 
SEC was carried out at 1 mg/mL to eliminate any potential differences that may be caused by 
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                                        HMW  dodecamer 
 
A: pH 7.8   
 
 
B: pH 7.6 
 
 









Figure 4.18:  SEC chromatograms of the oligomerisation of HsPrx3-6his with 
decreasing pH in non-reducing conditions (1mg/mL). (A) pH 7.8, (B) pH 7.6, (C) 
pH 7.4 and (D) pH 7.2. As the pH is lowered the protein assembles into structures 
with MW greater than the column limits (>660 kDa) causing the peak to shift 
towards the void.  The switch between single rings and HMW oligomers occurs 
between pH 7.6 and 7.4 with a shoulder volume at HMW elution volume starting to 
appear at pH 7.6. 
 
While only single rings where seen at pH 7.8 (fig. 4.18 A), the protein began to associate at 
pH 7.6 with a small shoulder corresponding to HMW oligomers appearing on the 
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column void (fig. 4.18 C) indicating structures above the molecular weight range of the 
column (> 660 kDa). The same profile was seen at pH 7.2 (fig. 4.18 D) which accounts for a 
switch between single rings and HMW structures occurring between pH 7.4 and 7.6. 
Reduced 
In previous studies it had been hypothesised that rearrangement of the active site that 
occurred upon disulfide bond formation between peroxidatic Cysp and Cysr, is needed to 
facilitate the interactions at the R-type interface that instigate oligomerisation of SmPrx1 
decamers into HMW assemblies. [3] If the addition of a reducing agent hindered the 
assembly within the current system, this would give an indication of the types of interactions 
at the R-type interface that were driving the assembly of the tagged construct at physiological 
pH. 
The reduced samples were subjected to the same conditions as the non-reduced samples with 
the addition of 2 mM TCEP. For all of the samples there was little difference between the 
reduced and non-reduced forms (Appendix 4.3).  The sample at pH 7.4 did display a more 
pronounced shoulder at the lower molecular weight range but reduction of the active site 
disulfide bond was not sufficient to completely disrupt the stacking (fig. 4.19). 
 
 
Figure 4.19: SEC trace of Hsprx3-6his at pH 7.4. Black: the reduced form and 
dotted: non-reduced.  HsPrx3 at pH 7.4 oligomerises to a lesser extent in the 
presence of reducing agent. The shoulder peak extends towards the dodecamer range 
when the protein is reduced. 
 
It is important to note that there are differences in the stacking of decamers and dodecamers. 
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cog-wheel like interaction. [3] This is seen to a lesser extent for tubes of HsPrx3-WT at pH 
4.0 as the geometry of the ring is different. [4, 52] As a result, while there will be similarities 
in the points of contact at the R-type interface between the two proteins, the interactions are 
not identical. This means that the local unfolding of the active site that appeared to be 
necessary for the formation of stacks of SmPrx1 decamers [3] may not be needed for the 
stacking of HsPrx3-6his. Furthermore, it is evident that the presence of a histidine tag is 
promoting assembly into tubes at a much higher pH than was seen with the cleaved construct. 
It is likely that there are additional points of interaction in this construct that have not been 
observed before.  
 
4.5.3 Further size and structure analysis of non-reduced HsPrx3-6his; pH 8.0 – 7.2 
Analytical Ultracentrifugation 
The samples were prepared as described previously and were run at 38,000 rpm. This 
velocity was chosen as it had previously given good data around the dodecamer and double 
stack range.  
As seen on SEC, HsPrx3-6his at pH 7.8 only existed as a single ring (fig. 4.20 A).  The first 
significant change came at pH 7.6 where a small shoulder peak began to appear, reminiscent 
of the shoulder peak seen on SEC (fig. 4.20 B). Again, the size increased considerably 
between pH 7.6 and 7.4, with masses around five times the dodecamer molecular weight 
indicating stacks and tubes (fig. 4.20 C).  Interestingly there was a further increase in size 
between 7.4 and 7.2 that was not visible by SEC (fig 4.20 D). 
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Figure 4.20: AUC traces of HsPrx3-6his at varying pH. (A) pH 7.8, (B) pH 7.6, 
(C) pH 7.4 and (D) pH 7.2. The initial switch between LMW and HMW species 
occurs between pH 7.6 and 7.4.  Decreasing the pH to 7.2 leads to the formation of a 
heterogeneous mix of large oligomers. The AUC centrifuge velocity is 38,000 rpm, 
which is too fast to gain enough data around the MW of the larger oligomers at pH 
7.2.   
 
Due to the large mass, the oligomers at pH 7.2 sedimented within the first few scans of the 
AUC run at 38,000 rpm. This meant that there was insufficient data to be able to confidently 
attribute masses to the peaks. Because of this, the run was repeated at a slower velocity; 
20,000 rpm. At this velocity the larger oligomers sedimented over a broader range of scans 
which provided sufficient data around the upper end of the size ranges (fig. 4.21).   
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When fitting data to a heterogeneous mix of species using Sedfit, it is wise to measure the 
regularization by both the Maximum entropy (Equation 4.1, at 4.3.1, above) and the 
Tikhonov-Phillips regularization using the second derivative. [53] The latter smooths out any 
noise and/or artefacts from the Sedfit calculation. When this regularization was applied to the 
data at pH 7.2 a smooth curve was seen with a maximum around S = 55, relating to the mass 
of 5 x dodecamers (fig. 4.21). This shows that there was a heterogeneous mix of HMW 
species within the system rather than individual discrete species. However, it was still 
possible to discern from the data that minute changes in pH had a large effect on the 
oligomeric state of HsPrx3-6his. This level of control has not been seen previously for Prx 
 
                                                     5 x dodecamer                                                    
 
Figure 4.21: AUC trace of HsPrx-6his in pH 7.2 at 20,000 rpm. When completing the 
regularisation using maximum entropy (black), the larger oligomers give defined peaks, 
consistent with discrete species, with the most abundant species being around the 
molecular weight of 5 x dodecamer. However, the regularisation by the 2
nd
 derivative 
(dotted, with fewer artefacts) shows a heterogeneous mix of species, with the maximum 
at 5 x dodecamer. This is closer to a true representation of the range of molecular 
weights in the sample. 
 
Transmission Electron Microscopy  
Protein samples were transferred into the different pH buffers by O/N dialysis at 4
o
C. The 
samples were diluted in dH2O to a final concentration of 50 μg/mL immediately before TEM 
grid preparation. HsPrx3-6his at pH 7.8 presented as single rings, similar to those seen at pH 
8.0 (fig. 4.22 A). There was some evidence of the rings grouping together into clusters, 
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seen on AUC and SEC.  At pH 7.6 stacks of two or three rings began to form (fig. 4.22 B), 
although there was still a significant amount of single rings present which aligns well with 
the profile displayed in the solution data. As expected, lowering the pH to 7.4 led to the 
formation of tubes ranging between 16 – 160 nm in length with the average length at 70 nm 
(fig. 4.22 C).  Aside from a small number of outliers, the tubes were remarkably uniform in 
length, more so than has been seen previously.  Again, this aligns with the AUC solution 
data. Following the trend with the solution data, there was a shift towards much longer tubes 
at pH 7.2 (fig. 4.22 D).  The sizes ranged from 12 nm – 471 nm in length.  Surprisingly, the 
average length was lower than that of the tubes at pH 7.4 at 56 nm.  However, the standard 
deviation was 59 nm, meaning that the distribution of tube lengths was too great to discern an 
accurate average. 
The TEM results agree well with the solution data with long tubes beginning to form at pH 
7.4, at which point the length is particularly uniform. It is important, when designing self-
assembling nanomaterials for specific function, to have control over the dimensions of the 
structures that are formed. At pH 7.2 the tubes extended even further, however there was less 
regularity between the tube sizes. It is intriguing that the pH sensitivity is over a 
physiological range. The same range has been noted as significant within the 
mitochondria,[54] the native location of HsPrx3. [28] While the tagged construct is a non-
native form, the interactions within the wild type sequence may be similar, with the histidine 
tag acting as a stabiliser to the HMW oligomers. While it was not within the scope of this 
project to explore, the possible physiological relevance of the pH sensitivity definitely 
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A: pH 7.8                                                           B: pH 7.6 
 
C: pH 7.4                                                            D: pH 7.2 
 
Figure 4.22: TEM of HsPrx3-6his at varying pH.  (A) pH 7.8, 100 μg/mL (180 k x 
magnification), (B) pH 7.6, 50 μg/mL (180 k x magnification), (C) pH 7.4, 50 μg/mL 
(140 k x magnification) and (D) pH 7.2, 50 mg/mL (110 k x magnification).  The 
degree of oligomerisation increases with decreasing pH, with the switch been rings 
and stacks to tubes occurring between pH 7.6 and 7.4. This aligns with the solution 
data, showing that the trend towards tube formation upon lowering pH can be 
confirmed using TEM. The tubes at pH 7.4 are remarkably uniform, while at pH 7.2 
there is a much more heterogeneous mix of lengths. 
 
 
100 nm 100 nm
100 nm
100 nm
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4.5.4 Impact of varying protein concentration on the degree of toroid stacking 
 
The tecton from which the HsPrx3-WT 1D nanotubes form has D6 symmetry with two 
orthogonal axes, a 6-fold symmetry axis perpendicular to the plane of the ring and a 2-fold 
symmetry axis within the plane of the ring. [52] For HsPrx3-WT tubes at pH 4.0, the rings 
interact with a 7
o
 rotation with respect to each other which leads to the formation of structures 
with high order helical open symmetry. This means the rings can continue to associate with 
additional tectons. [55] Because of this ability to continually associate, the length of the tubes 
is directly influenced by the initial protein concentration. [4] Due to the similarity in the TEM 
images of the extended tubes of HsPrx3-6his at pH 7.2 and 7.4 to those of HsPrx3-WT at pH 
4.0, it was hypothesised that the assembly of HsPrx3-6his dodecamers would have a very 
similar symmetry and mode of association. If correct, this hypothesis would mean variations 
in the initial protein concentration of HsPrx3-6his at physiological pH would lead to changes 
in tube length. 
High pressure liquid chromatography (HPLC) was utilised to study the effect of 
concentration on the HMW oligomers at pH 7.8, 7.6, and 7.2 (Chapter 2 at 2.7.4). 
Concentrations between 0.5 and 5 mg/mL were analysed to see the influence, if any, the 
amount of protein within the system had on the size of the oligomers. 
The sample at pH 7.8 did have a molecular weight slightly below that of a dodecamer which 
gradually increased as the concentration increased (Table 4.1, Appendix 4.4 A). This could 
be attributed to the slight concentration dependence of the toroid formation under non-
reducing conditions, which results in a mixture of species within the peak. However, at no 
point was a resolved dimer seen. The molecular weight at pH 7.6 was higher than a single 
dodecamer (Table 4.1, Appendix 4.4 B).  SEC, AUC, and TEM indicated a mixture of mainly 
single rings, and some HMW oligomers at this pH.  The high molecular weight seen on 
HPLC could also be a mixture of species. There did not appear to be any trend between the 
protein concentration and the molecular weight of the peak, with the size at 0.5 mg/mL being 
the same as that at 5 mg/mL. However, at pH 7.2, there was a marked increase in molecular 
weight in response to a rise in the protein concentration (table 4.1, appendix 4.5 A).  
 
 







mg/mL 7.8 7.6 7.2 




268              581          970,    
                                    1800 
1 271              571         535 
 
0.5 269              562         380 
 
Table 4.1: Table showing the concentration dependence of the HMW formation 
at varying pH. At pH 7.8, the size varies between ~ 300 and 270 kDa.  It is possible 
that at lower concentrations, at this pH, there is an equilibrium between the dimer 
and dodecamer, tending towards the dodecamer, and there is a mixture of species 
within this peak. At pH 7.6 there appears to be a mix of HMW and dodecamer 
species with little difference between the concentrations. At pH 7.2 there is a clear 
trend towards HMW species upon increasing protein concentration, demonstrating 
that the tube formation is concentration sensitive. 
 
The effect of concentration on the formation of large oligomers is intuitive. The interactions 
needed for the dodecamer to assemble into HMW structures are facilitated by a drop in pH. 
Without this pH change the interactions do not readily occur, and the higher concentration 
has no affect. Once the HMW oligomers can form, the concentration has a significant 
influence on the size of the structures. With more dodecamers within the system there is a 
higher probability that they will associate to form large structures.  
 
4.5.5 R-type interface electrostatic interactions 
To try and understand the mechanism of assembly and how the toroids interact, one of the 
low pH oligomers (pH 7.4) was subjected to a range of different salt concentrations. Along 
with the addition of an increased amount of sodium chloride, ammonium sulfate was also 
studied as it has been seen to have a detrimental effect on the formation of HsPrx3-WT 1D 
tubes at pH 4.0. [4] To ensure that reduction in the tube length was not due to protein 
precipitation and therefore a reduction in concentration, controls were run on the sample at 
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salt concentrations 0 – 400 mM. Sodium chloride and ammonium sulfate buffers were 
prepared at 800 mM (50 mM HEPES, pH 8.0).  This was mixed at a 1:1, 1:2 and 1:4 ratio 
with a sample of 2 mg/mL HsPrx-6his that had been dialysed into a pH 8.0 buffer with no 
sodium chloride (Chapter 2 at 2.7.5.1). The final protein concentration was 1 mg/mL with salt 
concentrations of 0, 100, 200, or 400 mM. It was found that, while sodium chloride had little 
effect on the protein concentration (Appendix 4.6 A), increasing the concentration of 
ammonium sulfate caused the protein to precipitate over time (Appendix 4.6 B). This could 
be an explanation for the reduction of the tube length of HsPrx3-WT at pH 4.0, and it also 
showed that ammonium sulfate could not be used in this experiment. 
HsPrx3-6his (pH 7.4, 150 mM NaCl, 1 mg/mL) was dialysed into buffer containing 300, 600, 
or 1200 mM NaCl. This was then analysed on SEC to measure if the salt concentration 
altered the size of the HMW oligomers. The protein concentration and pH of the sample were 
measured prior to SEC analysis to ensure that only the salt conditions had varied. For all 
samples, both the protein concentration and pH was stable. 
The SEC trace showed that the salt began to disassemble the stacks at 300 mM sodium 
chloride (Table 4.2). At this concentration the peak shifted from the void towards the 
molecular weight of a single ring with a large shoulder. At 1200 mM NaCl, the stacks had 
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NaCl concentration (mM) Molecular weight (kDa) Oligomer 
   









   
 
Table 4.2: Increasing the salt concentration disrupts tube formation. This 
suggests that assembly at the R-type interface is primarily driven by electrostatic 
interactions, in keeping with what has been noted in the literature.[3, 52] All samples 
were analysed at 1mg/mL and the concentration was checked before and after 
dialysis to ensure no protein had precipitated. Images generated using Pymol with 
coordinates from PDB:4MH2 
 
Electrostatic interactions are non-covalent interactions that stabilise protein quaternary 
structure, and can be disrupted by a high concentration of ions within the system. [56] 
Sources in the literature have suggested that the association at the R-type interface is driven 
via electrostatic interactions. [3, 4, 52] The fact that salt does not favour the HMW oligomers 
suggests that, at physiological pH, the interactions that are driving the assembly of HsPrx3-
6his are also electrostatic. 
The salt affect not only gives insight into the types of interactions that are initiating HMW 
assembly, but also provides a facile route towards nanostructure dissociation, thereby 
creating a switch between the different forms.  
 




4.5.6 R-type interface mutations 
A study conducted by Radjiana et al. [52] on the high resolution cryo-EM structure of 
HsPrx3-WT tubes at pH 4.0 identified two key residues as possible points of electrostatic 




 which are 
located on the β-2 of the HsPrx3-WT monomer (fig. 4.23). The interactions were identified 
by docking the crystal structure of SmPrx1 chaperone species [3] into the reconstructed Cryo-
EM electron density map. To explore the importance of these residues at the R-type interface, 









      pET151 D-TOPO-hsPrx3 K23A 
pET151 D-TOPO-hsPrx3 K23H 
pET151 D-TOPO-hsPrx3 K23R 
 
Table 4.3: List of R-type interface mutations including the plasmid into which 
they were cloned. The design is based on the hypothesis that lysine is a key charged 



















 at the R-type interface. [3] The image on the right shows the 




 between adjacent decamers. 
Numbering is from SmPrx1. Lys
23
 on HsPrx3-6his will be mutated to try and disrupt 
this interaction. Images generated using Pymol with coordinates from PDB:3ZVJ. 
 
The plasmids where provided by Mazdak Radjiana, transformed into chemically competent 
BL21 Rosetta cells and expressed and purified using the same methods as HsPrx3-6his.  All 
constructs eluted as a single ring in the final SEC purification step and showed as a single 
band on SDS-PAGE (Appendix 4.8). 
Lys
23
 at the R-type interface was substituted for either histidine, arginine, or alanine.  The 
three constructs were transferred into pH 7.2 buffer using methods described previously.  
SEC analysis showed that while substitution for histidine or arginine had little effect on tube 
assembly, substituting a charged residue for a neutral one (alanine) reduced the degree of 
oligomerisation (fig 4.24 A-C). However, there was still some stacking present with a broad 
peak tending towards the HMW range.  While the results show that the substitution K23A did 
lead to the formation of smaller species there was still a degree of stacking. Therefore, there 
must be additional interactions that are influencing the HMW stabilisation. 
Interestingly, it was noted that the TEM of HsPrx3-K23H at pH 8.0 showed some stacks of 
two or three dodecamers (fig. 4.25 A), whereas only single rings were seen for the arginine 
substitution (fig. 4.25 B). The pKa of a histidine side chain (6.0) is much lower than that of 
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arginine (12.48) or lysine (10.53). It is possible that there is a degree of charge repulsion 
between rings around the Lys
23
 side groups at pH 8.0, and changing this for a residue with a 
more neutral side group is allowing stacking to occur. This was not seen in the solution 
studies and is likely to be attributed to the sudden increase in protein concentration upon 
sample drying.  Nevertheless, the result shows that HsPrx3-6his is predisposed to form HMW 
structures and that single amino acid substitutions can influence this. Furthermore, it gives 
more insight into the important role histidine plays in the HMW assembly. 
 
                                         HMW  dodecamer 
  
 A: K23A 
 
 
                   
         B: K23H 
 
 





Figure 4.24: SEC of HMW oligomerisation of R-type interface K23 mutants at 
pH 7.2. (A) K23A, (B) K23H and (C) K23R. The oligomerisation is only partially 
disrupted when K23 is substituted for a neutral residue, indicating that while the 
lysine is involved in assembly, there are also other factors that are producing 
interactions at the R-type interface at pH 7.2. Substitution for a charged residue has 
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A: K23H                                                                B: K23R 
 
 
Figure 4.25: TEM of the R-interface mutantations to a charged residue (pH 8.0). 
(A) K23H and (B) K23R.  The substitution for a histidine allows some stacking at 
pH 8.0.  
 
4.5.7 Discussion 
The alteration between the behaviour of Hsprx3-6his and HsPrx3-WT has been made evident 
in this study. The histidine tag has an effect on the oligomeric state of the protein which, in 
turn, influences its response to environmental variations. The results show that the tagged 
protein is highly sensitive to small changes in pH, and this can be used to control the 
oligomerisation of the stable toroid into stacks and tubes.  
There are a number of different possible explanations for the formation of tubes of HsPrx3-
6his at physiological pH. Firstly, histidine has been shown to be a key residue that interacts 
directly with an arginine at the A-type interface, which in turn stabilises the toroid under non-
reducing conditions. The interaction holds the Cp loop in the locked position which stabilises 
the A-type interface pH values below the pKa of this histidine (His
113
in LbPrx1m and His
79
 in 
HsPrx3, pKa 7.37). [15] While this particular study focused on LbPrx1m, the residues 
involved are conserved in HsPrx3. Without knowing the exact pKa of the imidazole side 
chains in the histidine tag it would not be possible to say with conviction that a similar inter-
toroid interaction is occurring within the current system. However, the pH switch is within 
the same range and definitely warrants further study. Furthermore, the sensitivity to high 
concentrations of salt indicated the presence of electrostatic interactions at the R-type 
100 nm 100 nm
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interface. The main additional area of charge on the protein is the histidine residues within 
the tag and linker sequences. 
Due to the stabilisation of the A-type interface and slight variations in the geometry of the 
ring, [4] it is possible that there are structural changes that provide additional points of 
contact for the tagged construct. It has been noted that small structural changes that are not at 
the R-type interface can have a long range influence on the stabilisation of stacks. [57] 
Furthermore, additional residues on the N-terminus of Prxs have been shown to have a 
significant effect on the quaternary structure. [13, 17-19] Correctly placed interactions 
combined with the potential open helical symmetry of HsPrx3-6his, make the ideal circular 
tecton from which stacks and tubes can form. [55] With this in mind, further structural 
research into the exact points of contact between the HsPrx3-6his toroids would be beneficial 
to truly understand the mode of stacking. 
Finally, it has been suggested that Prx decamers and dodecamers are predisposed to form 
stacks. The interactions readily form, but require changes in the structure that occur in 
response to external conditions in order to be stabilised. [58] If the tag and linker were to 
interact with the protein in a way that stabilised the stacks at pH 7.4 and below, this could 
allow continued assembly into long tubes. The influence of the different residues within the 
tag and linker sequence will be explored in more detail in Chapter 5. 
Overall, the presence of the linker and tag have enabled assembly of HsPrx3-6his at 
physiological pH.  While the exact mode of oligomerisation is, as yet, unclear, the exquisite 
control over the assembly though small changes in pH places this protein as an ideal tecton 
for the formation of biological nanomaterials.  With the addition of the metal binding ability 
of the tag, these tubes have a wealth of potential functionalities. Furthermore, with a switch 
that occurs within a physiological pH range, this method of assembly and disassembly could 











Histidine tagged human Prx 3 (HsPrx3-6his) proved to be an ideal candidate for the 
formation of switchable nanoscale biomaterials. The comprehensive knowledge afforded by 
the literature allowed for the prediction of model conditions needed to achieve this, and 
throughout this study new and tailorable methods have been developed. 
The presence of the histidine tag at the N-terminus provides a simple means to stabilise the 
LMW dodecameric ring. This has been seen in previous research conducted on N-terminal 
tagged typical 2-Cys Prxs [18], but the extent to which these structural changes can be 
manipulated to drive assembly had not been fully explored. It is clear that while the protein 
differs significantly from its native form, the changes were conducive for this study. 
With the addition of a histidine tag, there is the option to utilise metal coordination to form 
protein nanostructures. The conditions needed to bind divalent metals to histidine have been 
well documented since the advent of immobilised metal chromatography as a means to purify 
recombinant proteins. It was shown in this study that Ni
2+
 can be used to assemble Prx 
dodecamers into stacks. By studying different divalent metals that have a lesser affinity 
towards the imidazole side group, it was demonstrated that the stacking is indeed a result of 
metal coordination with the degree of assembly decreasing with decreasing metal affinity. 
Furthermore, the stacks can be dissociated with the addition of a chelating agent, providing a 
switch between the LMW and HMW forms.   
HsPrx3-WT has been shown to be sensitive to changes in pH. For this reason, a range of pH 
conditions were analysed to discover if this method can be used to oligomerise HsPrx3-6his 
into tubes, and if there are any significant differences between the two homologues.  Indeed, 
the addition of non-native residues at the N-terminus has an effect on the behaviour of 
HsPrx3. The protein assembles into tubes at a higher pH than has been seen in the literature, 
with the association occurring between pH 7.6 and 7.4. In addition to this, the tubes formed at 
pH 7.4 are more uniform than had been seen previously. Dissociation of the tubes is achieved 
with the addition of relatively high concentrations of salt. This not only gives insight into the 
types of interactions occurring at the R-type interface that are driving assembly, but also 
provides a means to switch between the HMW and LMW forms. Further analysis of specific 
residues at the inter-dodecamer interface (that may be aiding assembly) shows that the 
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charged residue, lysine 23, plays a role but is not the only important residue at the R-type 
interface. 
The capability to form switchable structures of distinct dimensions using Prx as a tecton 
within the physiological pH range is new.  Furthermore, the degree of control in the 
dimensions of the materials formed is beyond what has been previously reported.  It is 
essential, when designing nanoscale materials for a specific function, to be able to have this 
level of control.  Therefore, the work accomplished in this study has real world significance, 
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Chapter Five: Tag and linker peptides influence the pH sensitivity 
and oligomerisation of HsPrx3 
 
5.1 Introduction 
Proteins have evolved to organise themselves into a staggering array of intricate assemblies 
that are directly related to their function and behaviour in vivo. [1, 2] The route towards this 
structure and function relationship has been well studied, with the oligomerisation being 
controlled by both the amino acid content of the protein and the environment in which it 
exists. [1, 3, 4] For this reason, proteins are an attractive target in the field of materials 
science. [5, 6]  By understanding the influence of the environmental factors on a native 
protein, and using this to design specific differences in the amino acid content, it is possible 
to manipulate this innate self-assembling ability to drive the bottom-up formation of 
nanoscale materials with a wealth of potential functionalisation opportunities. [5, 7] 
In the previous chapter, the influence of the recombinant histidine tag and linker peptide on 
human peroxiredoxin 3 (HsPrx3) was explored.  It was found that the presence of these 
additional amino acids on the N-terminus of the protein not only helped to stabilise an ideal 
tecton, dodecamer toroid, but also had a marked effect on the behaviour of the protein in 
response to external factors that differed from the native form.  It was hypothesised that 
changes to the quaternary structure were related to the stabilisation of the A-type interface as 
this phenomenon had been noted in previous studies. [8, 9] The additional pH influence, a 
new route towards assembly, was attributed to electrostatic interactions at the R-type 
interface that helped to drive assembly into one dimensional (1D) tubes. 
Histidine tags have been shown to have an influence on the quaternary structure and function 
of recombinant proteins, whether this be due to direct contact with the protein at key subunit 
interfaces, [10] interactions with the substrate binding site, [11] or changing the protein 
dynamics. [12] Furthermore, the presence of the charged side group on histidine has been 
utilised to develop a non-native pH response in the assembly of proteins. [13] It has also been 
identified as a residue that is involved in controlling the pH sensitivity of peroxiredoxin 
oligomeric state. [14] The histidine residues in the tag and linker peptide are the prime 




candidates for the origin of the electrostatic interactions. With the assembly being driven by 
electrostatic interactions, having a large area of surface charge is likely to have an effect.  
Substitutions for residues that were implied in the stacking of the wild types construct at pH 
4.0, did not completely disrupt the interactions at the R-type interface, further suggesting that 
additional residues were involved. 
HsPrx3 has been reported to be a putative chaperone. [15] This type of chaperone function, 
holdase, prevents the aggregation or misfolding of proteins but it is not involved in the ATP-
dependent refolding step. [16] Peroxiredoxins can adopt this function under stress conditions 
such as heat or high H2O2 concentration.  [17, 18] The toroid (single or stacked) holds 
unfolded or partially unfolded protein within the lumen via series of hydrophobic 
interactions. [19]  With the unusually long linker sequence of disordered peptide at the N-
terminus of HsPrx3-6his, it is possible that the R-type interface stabilisation is, in part, related 
to a chaperone response, increasing the surface area of the toroid lumen (and thereby 
increasing the points of contact for hydrophobic interactions).  A series of constructs with 
varying linker length and amino acid content were developed to probe this hypothesis. 
Exploring the origins of the pH sensitivity of HsPrx3-6his and its propensity to oligomerise 
into large structures was also important for the design of protein nanomaterials that self-
assemble from peroxiredoxin in a controllable manner. In addition to the variations in the tag 
and linker amino acid content, the kinetics of assembly will also be probed. Producing protein 
nanomaterials with in-built function is also an attractive prospect in the field of 
bionanotechnology. Therefore the primary function of the enzyme, its peroxidatic activity, 
will also be examined. With the understanding that this research affords, there will be 
systems put in place for the further development of HsPrx3 as a protein tecton. 
 
5.1 Design of tag and linker variations 
There are distinct differences between histidine tagged and cleaved HsPrx3-WT, the most 
notable being the stability of the toroid under non-reducing conditions at pH 8. This has also 
been seen for bovine peroxiredoxin 3, [9] which shares a 93% sequence homology to HsPrx3.  
HsPrx3-6his is also responsive to small variations in pH, with a conversion from single rings 
to stacks and then to tubes at pH 8.0, 7.6, and 7.4 respectively. Unlike the dodecamer 
stability, this was not seen in the bovine construct. [9] The main point of difference between 




the two proteins is the linker between the tag and the protein and therefore a series of 
constructs were designed whereby the amino acid content in the tag and linker sequence was 
varied to try and allocate where the pH effect was originating.  The influence of varying the 
number of metal binding residues was also explored. 
It was established in the previous chapter that the interactions at the R-type interface were 
electrostatic in nature, with the tubes dissociating at high salt concentration.  A key residue 
(Lys
23
), was identified at this interface, as it was hypothesised that it was capable of forming 
a salt-bridge with an aspartic acid (Asp
24
) on the neighbouring toroid (Chapter 1 at 1.6.6). 
[15] While mutating this residue to alanine, and thereby removing the salt-bridge, led to a 
small variation in the size of the tubes and stacks (and partially disrupting the interface) there 
were alternative contacts involved. The poly-6-his tag represents an area of potentially 
charged residues within the pH range. It is possible that theses residues form electrostatic 
interactions with the protein/with each other to stabilise the R-type interface and facilitate the 
assembly into long tubes. It was identified as the first point for sequence variations, the 
hypothesis being that reducing the amount of charge-charge interactions from this point 
would reduce the pH sensitivity of the oligomerisation. The pKa value of the histidine side 
chain can vary along the tag.  The charge can migrate from one chain to another, ranging 
from acidic to basic from the N-terminal to the C-terminal end respectively. [20] Therefore 
changing the length of the tag also provides the possibility of varying the pKa values of the 
histidine side chains within the tag. 
With the differing number of histidines within the tag there is also the potential for variations 
in metal ion coordination.  In the previous chapter it was noted that having multiples of six 
histidine residues within the D6 symmetry of the ring may have been detrimental to inter-
toroid coordination.  Changing the tag length may help to drive metal ion mediated inter-
toroid stabilisation without the formation of random aggregate.  The use of metal ions to 
assemble proteins not only overcomes the problems associated with the large surface area 
needed for non-covalent interactions between protein units, [21] but can also be used to direct 
the shape of the oligomers via the geometry of the metal to ligand coordination.[21-23]  
The length of the linker is a major point of difference between BtPrx3 and HsPrx-6his.  Non-
native amino acids have been implemented in structural changes of other peroxiredoxins, [8] 
so it is possible this explains the difference in behaviour between the two constructs. 
Furthermore, many peroxiredoxins have the capacity to function as a chaperone in response 




to cell stress conditions such as heat and high H2O2 concentration that can cause proteins to 
unfold. [17] With the unusually long length of the tag and linker sequence used in this study 
(33 aa) it is possible that HsPrx3 is identifying the sequence as an unfolded protein which, in 
turn, may instigate a chaperone response.  With the long flexible linker there is also the 
potential for the tag to interact directly with the protein and therefore changing the length 
may trigger variations in the mechanism of assembly.  The linker length was therefore varied 
systematically by removing different parts of the sequence that were related to its function, 
for example the V5 epitope tag or the TEV recognition site.  One construct had all of the 
linker residues removed, leaving the histidine tag directly at the N-terminus of the native 
protein sequence. A further construct was designed whereby an enteropeptidase recognition 
site, as described in chapter 3 (at 3.4) was placed in between the tag and the protein.  It was 
predicted that this would have a dual function of investigating the impact of adding sequential 
acidic residues within the tag (DDDDKD), and also provide the means to cleave the tag 
completely by enteropeptidase proteolysis (leaving the “true” wild type sequence). 
The sequences for all the variations are listed below with their predicted properties, 










HsPrx3NoTEV 6.2 23897 89.3 -0.133 24.9 
HsPrx3NoV5 6.0 23919 86.5 -0.144 26.1 
HsPrx3NoLink 6.2 22494 87.8 -0.132 26.5 
HsPrx3Ent 5.9 23489 84.4 -0.254 25.5 
HsPrx3His2 5.7 24774 89.6 -0.090 25.7 
HsPrx3His4 5.8 25048 88.8 -0.177 25.5 
 
Table 5.1: Protein parameters for the original histidine tag and linker variation 
constructs. The proteins were designed to probe the origin of both the dodecamer 
stability and pH sensitivity of HsPrx3-6his.  All constructs were deemed to be stable 
under base line conditions, pH 8.0 aqueous buffer.  The main differences between the 
proteins are the molecular weight (MW), isoelectric point (pI) and hydropathicity. 











































New construct sequences.  The tag and linker residues are in bold.  
 
During the write up of this thesis it became apparent that the plasmids that were provided by 
Epoch (Epoch Life Science, Inc, US) did not actual contain the requested sequence. The 
plasmid map that was provided by the company showed the protein sequence, but no DNA 
sequencing data was provided.  When this was sent upon request, it showed that there was an 
additional 6-histidine tag and thrombin cleavage site, translated at the N-terminus of the 
protein due to the restriction sites (between the NdeI and XhoI) into which the open reading 




frame had been cloned.  This was further confirmed by liquid chromatography mass 
spectrometry (LCMS) (Appendix 5.1). While it was no longer feasible, due to time 
constraints, to complete analysis of the original protein sequences, the results gained from the 
provided plasmids were analysed.  The following chapter documents the work done of these 
















PRX3A 6.6 26073 83.4 -0.241 25.7 
HsPrx3NoV5 
(1) 
PRX3B 6.5 26065 82.0 -0.218 25.0 
HsPrx3NoLink 
(1) 
PRX3C 6.5 24623 82.9 -0.194 27.2 
HsPrx3Ent (1) PRX3D 6.2 25644 80.0 -0.317 26.3 
HsPrx3-8his PRX3E 6.1 26904 85.0 -0.150 26.3 
HsPrx3-10his PRX3F 6.1 27174 83.2 -0.176 26.2 
 
Table 5.2: Protein parameters for the constructs expressed by the supplied 
plasmids.  Due to an error in the plasmid manufacturing, these are the proteins that 
have been expressed.  The major difference between the two plasmids is the addition 
of an N-terminal 6-histdine tag and a thrombin cleavage site.  The isoelectric point 
has increased across all constructs, as has the molecular weight and hydropathicity, 

























































New construct sequences with an extra N-terminal 6-histdine tag and a thrombin cleavage 
site 
 




5.3 Histidine content variations 
5.3.1 Expression and purification of PRX3E and PRX3F 
The genes, cloned into pET 28a(+) between the NdeI and XhoI restriction sites, were 
synthesised by Epoch Life Science. The open reading frame was cloned into a different 
expression vector to HsPrx3-6his due to the original vector being discontinued by the 
company supplying the plasmids.  
Host E. coli chemically competent cells (BL21 (DE3) ROSETTA, Novagen, 2013; genotype 
– F- ompT hsdSB[B- mB-] gal dcm [DE3] pRARE [CamR]) were transformed with the 
plasmids using heat shock (Chapter 2, at 2.2.2.2). These cells were chosen due to the pRARE 
codon, which supplied tRNA for the rare codons of HsPrx3 and the presence of T7 RNA 
polymerase, which allowed expression from the pET vector. The protein was successfully 
expressed in standard LB media (Chapter 2 at 2.3.1.1) after shaking at 37
o
C for 4 hours, in 
the presence of kanamycin and chloramphenicol, and then at 26
o
C, with the addition of IPTG, 
for a further 20 hours. 
Cells were lysed using sonication (Chapter 2 at 2.3.2.2) and the insoluble fraction was 
removed by centrifugation (18 000 x g, 30 minutes).  The target proteins were isolated from 
the soluble crude broth using IMAC (fig. 5.1 A and B). SDS-PAGE analysis of the flow 
through showed that both constructs bound successfully to the IMAC column and were eluted 






































































































































        A: PRX3E                                                             B: PRX3F  
 
Figure 5.1: Elution of 8-histidine tagged (PRX3E) and 10-histidine (PRX3F) 
tagged HsPrx3 from IMAC. (A) PRX3E and (B) PRX3F elution from a Ni
2+
 IMAC 
column upon increasing imidazole concentration. Black: absorbance at 280 nm 
(mAU); grey: percentage concentration of 0.5 M imidazole buffer (%).  Both 
constructs have been expressed and purified successfully.  The presence of target 


















































           
 








Figure 5.2: SDS-PAGE analysis of 8-histdine tagged (PRX3E) and 10-histidine 
(PRX3F) tagged HsPrx3 purification.  (A) PRX3E purification; 1: crude lysate; 2: 
insoluble crude; 3: soluble crude; 4: IMAC flow through; 5-8: weakly bound protein; 
9: target protein. (B) PRX3F purification; 1: crude lysate; 2: insoluble crude; 3: 
soluble crude; 4: IMAC flow through; 5-7: weakly bound protein; 8: target protein.  
Both constructs elute as pure protein upon increasing imidazole concentration.  The 
SDS-PAGE shows the presence of a strong dimer, even under reducing conditions.  
This could be due to trace amounts of leached nickel from the IMAC column. 
 
For the final purification step, the protein was further isolated by SEC (fig. 5.3 A and B). 
This was also the desalting step by which the protein was transferred into the storage buffer 




















































displayed a major peak eluting at a volume corresponding to the MW of a single dodecameric 
species with a shoulder peak, representing a HMW oligomer (fig. 5.3 A and B). There was 
also a small dimer peak. The elution profile was similar to HsPrx3-6his with the exception of 
the slightly broader and less well resolved peaks in PRX3F. This indicated a mixture of 
assemblies in an equilibrium that was faster than the SEC separation time scale. With an 
increasing number of histidine residues (6his to 10his) within the linker sequence, it is 
possible that the degree of oligomerisation via metal ion coordination (Ni
2+
 leached from the 
IMAC) was more pronounced for PRX3F.  
 
 
        A: PRX3E                                                           B: PRX3F 
       HMW dodecamer dimer                                 HMW dodecamer dimer 
Figure 5.3: SEC trace of 8-histidine (PRX3E) and 10-histdine (PRX3F) tagged 
Hsprx3 eluted IMAC peak. (A) PRX3E and (B) PRX3F.  Both peaks are broader 
than was seen for the 6- histidine construct indicating a mixture of HWM and LWM 
species.  There is a large shoulder peak in the HMW range and a small peak around 
the molecular weight of a dimer.   Removal of trace nickel through EDTA chelation 
removes the shoulder peak (fig. 5.4 A and B). 
 
5.3.2 Non reduced PRX3E and PRX3F are comparable to HsPrx3-6his at pH 8.0 
To ensure that the behaviour of the histidine tag variation constructs was comparable to the 6-
histidine tagged form, the characteristics of non-reduced PRX3E and PRX3F at pH 8.0 were 
evaluated. This was to develop a baseline from which any variations in response to changes 
in environmental conditions could be measured. 
 






















































Dodecamer stability and metal chelation conditions 
It was important to ensure that changing the tag did not influence the toroid stability under 
non-reducing conditions, as this was the tecton from which more complex structures formed. 
In addition to the toroid stability it was important to also assess if the HMW oligomers (seen 
in the final purification step) were still able to dissociate with the same concentration of 
chelating agent. The protein was dialysed in pH 8.0 non-reducing buffer to remove the EDTA 
and any Ni
2+
 leached from IMAC purification.  The samples were incubated at 4
o
C overnight 
to allow for ring disassociation as per the methods in the literature. [24] The change in the 
histidine tag length did not diminish the stability of dodecamer at pH 8.0 under non-reducing 
conditions. Furthermore, both the 8-histidine and 10-histidine tagged proteins eluted as a 
single low molecular weight (LMW) species on SEC. This not only confirmed that the HMW 
oligomers noted in the final purification step were the result of metal ion coordination, but 
also showed that the chelating conditions (10 mM ETDA) were sufficient enough to disrupt 
stacking (fig. 5.4 A and B).  
 
 
A: PRX3E                                                                   B: PRX3F 
               dodecamer                                                            dodecamer 
 
Figure 5.4:  SEC trace of 8-histidine (PRX3E) and 10-histidine (PRX3F) tagged 
Hsprx3 at varying concentrations.  (A) PRX3E and (B) PRX3F are both in pH 8.0, 
non-reducing conditions with the EDTA and nickel dialysed out.  Black: 10 mg/mL 
and dotted: 0.5 mg/mL.  The constructs elute around the molecular weight of a single 
LMW ring at both concentrations.  Removal of Ni
2+
 using EDTA as the chelating 
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Protein concentration 
The tubes formed from HsPrx3-6his at pH 7.4 and below were sensitive to changes in the 
protein concentration.  With the additional histidine residues in the new sequences it was 
interesting to investigate if high concentration aided assembly.  The protein sample was 
concentrated to 10 mg/mL, an excess of protein in comparison to HsPrx3-6his analysis, and 
analysed using SEC.  Both proteins eluted as a single peak on SEC with a similar elution 
profile as seen at 0.5 mg/mL (fig. 5.4 A and B). The size at 10 mg/mL for PRX3F was higher 
than expected for a single dodecamer and the peak was broad. It is possible that there was a 
small amount of HMW oligomer present under these conditions. There was a slight shift to a 
lower MW between 10 mg/mL and 0.5 mg/mL for PRX3F.  At low concentrations (0.5 
mg/mL), both proteins were behaving in much the same way as HsPrx3-6his at baseline 




Transmission electron microscopy  
TEM was used to analyse the quaternary structure of the protein.  For both constructs only 
single rings were seen (fig. 5.5 A and B). 
 
A: PRX3E                                                       B: PRX3F 
 Figure 5.5: TEM of 8-histidine (PRX3E) and 10-histidine tagged (PRX3F) 
HsPrx3 at pH 8.0 non-reducing conditions. (A) PRX3E and (B) PRX3F 
were diluted to 100 μg/mL in dH2O prior to TEM grid preparation and stained 
with uranyl acetate (1 %).  Only single rings are seen.  Black line represents 
100 nm. 





Finally, all three constructs were analysed using DSF to measure any potential variations in 
temperature stability.  The melting temperature was determined to be 63
o
C for all three 
constructs, showing that the change in histidine tag length, plus the additional tag and 
thrombin cleavage site, did not influence the protein’s temperature stability (Appendix 5.2 A, 
B and C). 
All the results confirmed that at baseline conditions the different histidine tag length 
constructs were comparable in characteristics and behaviour to HsPrx3-6his.  The change in 
plasmid vector did not hinder the recombinant protein stability, and the length of the tag led 
to no significant changes at pH 8.0 non-reducing conditions.   
 
5.3.3 Increasing the histidine content leads to random aggregation with divalent metal 
ions 
Due to the change in the number of imidazole groups available for coordination it was 
hypothesised that the degree of oligomerisation would increase.  With the different geometry 
afforded by the change in the tag length there was also the possibility of more inter-toroid tag 
coordination. 
The samples were transferred into pH 8.0 buffer containing 20 mM imidazole and Ni
2+
 was 
spiked in at a ratio of 1:1 Ni
2+
: PRX3E or PRX3F (~40 μM). To allow for Ni
2+
 to histidine 
tag association the mixtures were incubated over night at 4
o
C before the imidazole was 
removed via diafiltration.  To assess the level of oligomerisation the size of the protein was 
analysed using AUC (38, 000 rpm).  For both constructs, the metal ion coordination appeared 
to have a lesser influence on protein assembly, with the degree of oligomerisation decreasing 
when compared to HsPrx3-6his (fig. 5.6 A and B). However, it is important to note that there 
was a significant amount protein precipitation during this procedure.  During the analysis it 
was attributed to the mechanics of diafiltration. It is now apparent that coordination of Ni
2+ 
to 
the additional imidazoles at the N-terminus was causing the protein to aggregate. It is likely 
that the protein that was analysed on AUC was the protein that had not coordinated to Ni
2+ 
and therefore had not precipitated. To optimise assembly of these constructs via metal 
coordination a range of different conditions would need to be trialled.  These include the Ni
2+
 
concentration, initial concentration of imidazole in the assembly buffer, variations in the 































buffer exchange, temperature of assembly, and the assembly time. Unfortunately, it was not 
possible to complete the experiments within the time constraints of the current study.  
Interestingly, TEM showed a similar distribution of rings and stacks as HsPrx3-6his (fig. 5.7 
A and B).  It is possible that the increase in concentration that occurs during grid preparation 
improved the degree of oligomerisation. 
 
 
                                             dimer  1x   2x dodecamer 
              A: PRX3E 
 
 





Figure 5.6: AUC trace of 8-histidine (PRX3E) and 10-histidine tagged (PRX3F) 
HsPrx3 with 1:1 Ni
2+
: protein monomer (~40 μM).  (A) PRX3E and (B) PRX3F. 
The major species sediments around the molecular weight of a single ring with a 
small amount of HMW oligomers present.  During the removal of imidazole some of 
the protein crashed out.  It is possible that this contained the metal coordinated 










                     A: PRX3E                                                               
 
                       B: PRX3F 
 
Figure 5.7: TEM of 8-histidine (PRX3E) and 10-histidine tagged (PRX3F) 
HsPrx3 with 1:1 Ni
2+
: protein monomer. (A) PRX3E and (B) PRX3F were diluted 
to 50 μg/mL in dH2O prior to TEM grid preparation and stained with uranyl acetate 
(1%).  There is a mixture of single rings, some with electron density in the lumen, 
and double and triple stacks visible. Black line represents 100 nm. 
 
5.3.4 Increasing the histidine content increases the pH sensititivity 
The main area of charge residues that differs to the wild type (HsPrx3-WT) construct is the 
histidine tag. For this reason, it was likely to be involved in some way in the increased pH 
sensitivity of HsPrx3-6his. To determine if this was the case both constructs were analysed, 
100 nm
100 nm




initially using SEC at pH 7.4 (Appendix 5.3 A and B) to see if any HMW oligomers were 
forming, and then at pH 7.4 and 7.2, on AUC and TEM. 
Transmission electron microscopy 
PRX3E and PRX3F were transferred into the appropriate buffer with pH values ranging from 
7.8 – 7.2. The sample concentration and pH was checked before and after dialysis to ensure 
complete buffer exchange, and to show that there was no protein precipitation. The samples 
were diluted to 50 μg/mL in dH2O directly before TEM grid preparation.  The grids were 
prepared as per the methodology (Chapter 2 at 2.5.4) using 1 % uranyl acetate as the heavy 
metal stain. TEM images showed a similar spread of different oligomers to HsPrx3-6his at 
pH 7.8 and 7.6, with single rings present at pH 7.8 and a mixture of rings and stacks of two or 
three dodecamers at pH 7.6 (fig. 5.8 and 5.9 A and B for PRX3E and PRX3F, respectively).  
Upon lowering the pH to 7.4 the stacks began to increase in length, and at pH 7.2 elongated 
1D tubes had formed (fig. 5.8 and 5.9 C and D for PRX3E and PRX3F, respectively). 
The first major difference between the proteins with varying tag lengths was noted at pH 7.4, 
with the tube lengths appearing to elongate when the number of histidine residues in the N-
terminal tag was increased.   
To confirm this was a genuine observation, a range of EM images were selected for size 
analysis. The width of a single ring along the D6 axis was measured and used to quantify the 
number of rings per tube.  Inputting this information onto a histogram showed a clear trend 
towards increasing tube length at pH 7.4, with increasing histidine content (fig. 5.10 A). 














 A: pH 7.8                                                               B: pH 7.6 
 
 C: pH 7.4                                                              D: pH 7.2 
 
Figure 5.8: TEM of 8-histidine tagged HsPrx3 (PRX3E) at varying pH. (A) pH 
7.8, (B) pH 7.6, (C) pH 7.4 and (D) pH 7.2 were diluted to 50 μg/mL in dH2O prior 
to TEM grid preparation and stained with uranyl acetate (1%).  The tube length 
increases with increasing pH with the switch between stacks and tubes occurring 















A: pH 7.8                                                                     B: pH 7.6 
 
 C: pH 7.4                                                                D: pH 7.2 
 
Figure 5.9: TEM of 10-histidine tagged HsPrx3 (PRX3F) at varying pH. (A) pH 
7.8, (B) pH 7.6, (C) pH 7.4 and (D) pH 7.2 were diluted to 50 μg/mL in dH2O prior 
to TEM grid preparation and stained with uranyl acetate (1%).  The tube length 
elongates with increasing pH, with the switch between stacks and tubes occurring 











Figure: 5.10:  Histograms showing the variation of in extent of tube assembly, as 
seen on TEM, relative to the histidine tag length; red: 6-histidine; blue: 10-
histidine and green: 8-histidine. (A) Tube length at pH 7.4.  The tubes are less 
heterogeneous and shorter in length than those formed at pH 7.2.  PRX3E and 
PRX3F have the longest tubes, validating the trend between tube length and histidine 
tag length. (B) Tube length at pH 7.2; all tubes are heterogeneous in length with the 
most prevalent length being between 10 – 20 x dodecamers. The constructs with 
longer tags are similar in size with PRX3E forming slightly longer tubes. The tubes 





































































To ensure the HMW oligomers were stable in solution, the proteins at pH 7.4 and 7.2 were 
analysed using AUC.  Due to the large nature of these assemblies, the centrifuge was set at a 
lower velocity than the standard measurements (20,000 rpm instead of 38,000 rpm). The 
samples were prepared as described above, and the MW of the oligomers was approximated 
from the sedimentation coefficient. The samples were also filtered before AUC analysis to 
ensure that there was no precipitation. As the traces showed a heterogeneous mixture of 
species, the regularisation by the maximum entropy and regularisation by the 2
nd
 derivative 
were utilised to gain a line of best fit. 
At pH 7.4 the oligomers for both PRX3E and PRX3F were significantly larger than HsPrx3-
6his. The most populated states were within the 5 – 7 dodecamer MW range, with the 
distribution of the oligomers being similar for both constructs (fig. 5.11 A and B).  
 









Figure 5.11: AUC of 8-histidine (PRX3E) and 10-histidine tagged (PRX3F) 
HsPrx3 at pH 7.4.  (A) PRX3Eand (B) PRX3F; black: regularisation by the 
maximum entropy; dotted: regularisation by the 2
nd
 derivative. For both constructs 
there is only a small amount of LMW oligomer present with the tubes at 
approximately 5, 6 and 7 x the dodecamer molecular weight being the most 
prevalent.  Regularisation by the 2
nd
 derivative shows that both samples are 
heterogeneous.  The data shows that the large oligomers are stable in solution. 




























 Again, there was a further shift towards HMW oligomers upon decreasing the pH from 7.4 to 
7.2 with the most populated states ranging from 8 – 10 dodecamers (fig. 5.12 A and B). The 
difference between the upper-end of the size ranges was more pronounced for PRX3F, with 
peaks extending to MWs upwards of 40 x dodecameric stacks, far larger than anything seen 
for HsPrx3-6his.  For both constructs there was a small speak, relating to the MW of a single 
ring ,but the majority of the dodecamers had stacked into higher ordered structures.   
 
                                           8x 9x 10x dodecamer 
  A: PRX3E 
 
 
   B: PRX3F 
 
Figure 5.12: AUC of 8-histidine (PRX3E) and 10-histidine tagged (PRX3F) 
HsPrx3 at pH 7.2. (A) PRX3Eand (B) PRX3F; black: regularisation by the 
maximum entropy; dotted: regularisation by the 2
nd
 derivative. For both constructs 
there is only a small amount of LMW oligomer present with the tubes at 
approximately 8, 9, and 10 x the dodecamer molecular weight being the most 
prevalent. Regularisation by the 2
nd
 derivative shows that both samples are 
heterogeneous. The tubes formed at pH 7.2 are longer than those formed at 7.4. 
 
 
While there is some variability between the different experiments due to the heterogeneous 
mixture of structures seen, the differences between the protein HMW oligomers were deemed 
greater than would be expected for mere batch-to-batch variability. Overall it would appear 
that by increasing the number of histidine residues, and therefore the number of charged 




residues in the N-terminal tag, this led to an increase in the size of the structures formed. This 
agrees well with the hypothesis that the pH sensitivity is originating from the non-native 
histidine residues within the tag. 
 
5.3.5 Increasing the number of histidine residues increases the rate of assembly 
To try and understand the reasoning behind this trend a series of experiments were run 
whereby the tube growth was measure over time on DLS. 
Because the starting point had to be at t0, the usual method of exchanging buffer through 
dialysis could not be used. This meant that controls needed to be run to assess the differences 
between the methods.  Buffer at pH 7.2 was spiked into a pH 8.0 blank buffer to determine 
the ratio that was needed for a complete pH switch. The pH of the protein samples was 
adjusted according to this ratio, and the pH of the sample was checked before further 
analysis.  So as to study one variable at a time, the samples were incubated at 4
o
C overnight 
while another batch of protein was simultaneously dialysed into the appropriate buffer. At 
this time the hydrodynamic radius (DH) of the protein was measured to check for 
comparability between these two methods. 
 
 pH 7.2 O/N (20
o
C) pH 7.2 O/N (4
o


















32.49  ± 
2.62 
0.690 







53.02  ± 
0.51 
0.250 
74.95  ± 
39.53 
0.717 




Table 5.3: DLS measurements showing the difference between methods of 
inducing a pH switch. The samples with a PdI < than 0.3, the hydrodynamic radius 
for peak 1 was measured instead of the Z-average.  




For HsPrx3-6his, both the methods of pH change, overnight dialysis or dilution, gave 
comparable values on DLS (Z-ave ~30) (Table 5.3). Interestingly, PRX3E and PRX3F 
displayed variability in sizes between the different methods, with the sizes of tubes from the 
dilution method being lower than those seen for buffer exchange via overnight dialysis. It is 
possible that the slow exchange in buffer facilitated a more controlled assembly, which 
increased the stability of the structures formed.  Due to the measurements on DLS being 
made at 20
o
C, the samples were exchanged into a different pH by dilution and left over night 
at this temperature as an additional control. For the 6-histidine construct this lead to a slight 
increase in the hydrodynamic radius. For the other proteins it appeared to have a detrimental 
effect, with the size decreasing (Table 5.3). There is a degree of variability in the assembly of 
these heterogeneous tubes, and therefore the differences in DH could also be attributed to 
batch-to-batch deviation. 
Due to the variations in the assembly in response to changes in the buffer exchange protocol 
it was not possible to directly compare the kinetics of assembly to the standard overnight 
dialysis method of assembly. However, it was still possible to measure changes in the 
assembly rate by testing the histidine residue content as the only variable.  
The increase in hydrodynamic radius at pH 7.2 was measured over the course of 4 hours to 
note the differences in behaviour of the proteins.  The first major variation was an initial 
jump in size upon dilution into the pH 7.2 buffer, which was significantly greater for the 
longer histidine tagged constructs.  The sizes continued to increase over the period of 4 hours, 
with the PRX3F reaching the highest MW (fig. 5.13). 
The concentration that was used for the DLS experiments (0.1 mg/mL) was lower than that 
used in other solution experiments.  Samples with a higher concentration gave results that did 
not meet the equipment quality criteria, possibly as a consequence of the large particle size 
which resulted in over-scattering, and therefore a lower concentration was used.  Due to the 
nature of assembly, using a lower protein concentration leads to smaller sized oligomers. As a 
result the size of assemblies on the DLS are likely to be inherently lower than seen in other 
experiments.  That said, the results showed a clear trend in the sizes that correlated well with 
all the other analysis, and gave good insight into where these changes were originating. 
 





Figure 5.13: Rate of increase in Z-average over time. Green: HsPrx3-6his, blue: 
PRX3E and red: PRX3F. All samples were diluted into pH 7.2 conditions and the 
increase in the Z-average was measured over the course of two hours.  There appears 
to be a trend between length of the tag and the size of the oligomers with PRX3F 
continuing to assemble up to 150 d.nm. 
 
From these results it is possible to design methods towards assembly depending on the types 
of structures that are needed.  If heterogeneity is not an issue, then pH exchange to 7.2 via 
dilution of the longer tagged constructs would be the best route.  The tubes form almost 
instantaneously but there is a large degree of variability between the sizes.  If more 
homogenous structures are required, then slow pH exchange via overnight dialysis to 7.4 of 
HsPrx3-6his appears to give the most regular sizes according to TEM and AUC. 
 
5.3.6 Discussion 
When designing systems in which proteins assemble in a controllable manner it is imperative 
to have a good understanding of the correct conditions needed to instigate oligomerisation. 
The results described here show that the longer histidine tag length constructs form larger 
structures with a more heterogeneous range of sizes.  This correlated well with the hypothesis 
that the electrostatic interactions at the R-type interface were originating from the histidine 
residues.  As the points of interactions increased, the stability of the interface increased and 
the structures formed more rapidly. 
Without knowing the exact pKa of these residues, or their exact positioning within the protein 




















placement of the tag in respect to the native sequence and the charges that the residues carry).  
However, this study is not the first instance of histidine tags affecting the folding and 
oligomerisation of native protein structure. [10, 25] In fact tags, have been implemented in 
the reduction of enzyme efficiency, [26] the change of the physico-chemical properties of 
recombinant proteins [10] and the protein dynamics [12], and even reducing the substrate 
binding efficiency. [11]  In a study by Hlima et al. it was found that placing a histidine tag at 
the hydrophobic dimerisation interface of Streptomyces sp SK glucose isomerise destabilised 
the native interaction, meaning that the dimer did not form. [10] One hypothesis is that 2-Cys 
peroxiredoxins are predisposed to stack via the R-type interface and that variations, for 
example structural changes due to overoxidation, are actually stabilising this interaction 
rather than solely driving assembly. [27] An inverse of the affect seen by Hlima might be at 
play here. Placing charged residues at an electrostatic interface (R-type interface) [15, 28] 
may in fact stabilise the interactions that are utilised in the formation of stacks and tubes. 
With this in mind, it is possible to predict a mechanism of assembly (fig. 5.14): 
1. At pH 8.0 the histidine residues carry a net neutral charge.  While the toroids 
intermittently interact, the quaternary structure is not stable and the rate of 
dissociation is too rapid for the formation of stacks and tubes. 
2. Lowering the pH to 7.6 protonates some, but not all of the histidines within the tag.  It 
has been shown that the pKa of the histidine side chains in a standard poly-6-histidine 
tag have varying pKa depending on their proximity to the carbonyl or amine. [20]  The 
charged residues lend some stability to the R-type interface and stacks begin to appear 
in solution and on EM. 
3. At pH 7.4 a high percentage of the histidine residues are protonated, and the high area 
of positive charge can interact with either negatively charged residues or back-bone 
carbonyl groups on the adjacent toroid.  This interaction is stable in solution, and 
large structures are seen. 
4. At pH 7.2, the majority of the histidine residues within the tags carry a positive 










Figure 5.14: Schematic for the possible route of assembly through varying pH. 1 
– The protein at pH 8.0 and 7.8.  Stacks rapidly assemble and disassemble with 
interactions at the interface too weak to form stable oligomers.  Histidine tags are 
coloured in red to show the non-charged “off” state. 2 – Reducing the pH causes the 
histidine within the tags to become charge (green – “on”).  3 - The charge steadily 
increases from 7.6 – 7.2 leading to increased stabilisation of the R-type interface. 4 – 
The stacks begin to assemble into large structures at pH 7.4 and 7.2.  5 – Long 1D 
tubes form at pH 7.2 and high concentration seen on TEM. 6 – The electrostatic 











5.4 Linker variations 
Changes in the linker length and amino acid content were studied to assess how this affected 
the oligomeric state of the protein. While the tag has been shown to the influence the 
oligomeric state of HsPrx3’s close bovine counterpart (BtPrx3), there are significant 
differences between the two proteins. The protein quaternary structure in this study is highly 
sensitive to variations in pH.  This was not seen for the bovine construct. The length of the 
linker is a major point of difference between BtPrx3 and HsPrx-6his, and this was therefore 
an ideal region to study. With the knowledge that the plasmids were incorrect it is important 
to note that in addition to variations in linker length, the histidine content was also doubled.  
The following results will discuss how this affected the quaternary structure and stability of 
these constructs in pH 8.0 non-reducing conditions. 
 
5.4.1 Expression and purification 
The genes, cloned into pET 28a(+) between the NdeI and XhoI restriction sites, were 
synthesised by Epoch Life Science. Host E. coli chemically competent cells (BL21 (DE3) 
ROSETTA) were transformed with the plasmids using heat shock (Chapter 2 at 2.2.2.2). The 
proteins were successfully expressed in standard LB media (Chapter 2 at 2.3.1.1) after 
shaking at 37
o
C for 4 hours in the presence of kanamycin and chloramphenicol, and then at 
26
o
C with the addition of IPTG, for a further 20 hours. 
The proteins were purified using the methods in section 5.3 (Appendix 5.4 A - D) and 
impurities brought through from the IMAC column were removed by SEC (fig. 5.15 A - C). 
This was also the desalting step by which the protein was transferred into the storage buffer 
and the excess imidazole was removed (Chapter 2 at 2.3.2.6). All constructs eluted as a 
mixture of HMW and LMW oligomers as well as a small amount of dimer. The elution 
volume of the LMW peak for both PRX3A and PRX3B calculated as a MW that was higher 
than a single dodecamer indicating a mixture of species.  PRX3A and PRX3B also had the 
highest ratio of HMW to LMW oligomers, with the other two constructs having a higher 
proportion of dodecamers.  The presence of purified target protein in both the HMW and 
LMW peak was confirmed by SDS-PAGE, with the predominant band being a monomer with 
a small amount of dimer present (fig. 5.16 A – D).  The peak corresponding to the dimer MW 



















































































also contained the purified protein. However, for all four constructs there were additional 
impurities within these fractions and no further work was completed on them. 
 
 
A: PRX3A SEC                                                 B: PRX3B SEC 
      HMW dodecamer dimer                                  HMW dodecamer dimer 
   C: PRX3C SEC                                             D: PRX3D SEC  
 
Figure 5.15: SEC chromatography of eluted IMAC peak. (A) PRX3A, (B) 
PRX3B, (C) PRX3C and (D) PRX3D.  All constructs elute as a mixture of HMW 
and LMW oligomers as well as a small amount of dimer. The apex of the LMW peak 
for PRX3A and PRX3B is slightly higher in MW than a dodecamer, indicating a 
mixture of species.  PRX3A and PRX3B appear to have the highest ratio of HMW to 
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B: PRE3C 






Figure 5.16: SDS-PAGE gel analysis of linker variant purification. (A) PRX3A 
and PRX3B purification; 1-4: PRX3A crude fractions; 5: isolated PRX3A from 
IMAC; 6-8: PRX3B crude fractions; 9: isolated PRX3B from IMAC. (B) PRX3C 
and PRX3D purification; 1-4: PRX3C crude fractions; 5: isolated PRX3C from 
IMAC; 6-8: PRX3D crude fractions; 9: isolated PRX3D from IMAC. All 4 
constructs have been isolated successfully from the IMAC column and run primarily 










5.4.2 Linker composition influences oligomeric state 
The SEC that was completed during the purification process showed that variations in the 
linker composition and/or the amount of histidine in the tag had a significant effect on the 
oligomeric state of the protein at pH 8.0.   
Protein concentration 
HMW species of HsPrx3-6his are sensitive to changes in protein concentration, with larger 
oligomers forming with increasing concentration. To see if the HMW species seen for the 
linker variations were also sensitive to variations in protein concentration the new constructs 
were concentrated to 5 mg/mL, or diluted to 0.5 mg/mL, and their size was measured.  The 
samples were not analysed at 10 mg/mL as at this point some of the protein began to 
precipitate.  This indicates the formation of disordered aggregates and suggests that the 
change in linker length and histidine residue content had a detrimental influence on the 
protein stability in aqueous solution at this concentration. 
PRX3A, PRX3B, PRX3C and PRX3D had all eluted as a mixture of LMW and HMW 
oligomers analytical SEC (fig. 5.17 A – D), with PRX3B and PRX3C having the highest and 
lowest ratio of HMW oligomers at 5 mg/mL respectively (Table 5.4).  It is important to note 
that the mass for the “LMW” peak for both PRX3A and PRX3B was slightly higher than the 
predicted mass of a dodecamer.  It is likely that there was a mixture of single and double 
rings within this peak which resulted in the peak eluting at a higher MW. Decreasing the 
protein concentration to 0.5 mg/mL led to a slight decrease in the amount of HMW oligomers 
seen (fig. 5.17 A – D, Table 5.5).  Furthermore, there was a shift towards lower elution 
volumes in the LMW peak for PRX3A and PRX3B, indicating a possible reduction in 
concentration of double stacks.  However, for all constructs there were still oligomers eluting 

























































































































































































































 A: PRX3A                                                         B: PRX3B    
   HMW dodecamer                                              HMW dodecamer 
         C: PRX3C                                                          D: PRX3D 
Figure 5.17: SEC traces of linker variation constructs at varying concentrations. 
(A)PRX3A, (B) PRX3B, (C) PRX3C and (D) PRX3D are all at pH 8.0, non-reducing 
conditions with the EDTA and nickel dialysed out.  Black: 5 mg/mL and dotted: 0.5 
mg/mL.  For all constructs there is a shift towards the LMW oligomer upon 
decreasing concentration.  However, there is still a large amount of HMW oligomer 
present, even after the addition of EDTA, indicating that these are formed in a 
















 Area/Peak area (volume) % 
 


















HMW 33.02 14.65 35.29 10.53 22.24 14.13 29.56 18.97 
LMW 66.98 76.54 64.71 89.47 77.76 85.87 70.44 81.03 
Dimer - 8.81 - - - - - - 
Table 5.4:  Integrated peak values for SEC concentration variations. The volume 
of the LMW peak (%) increases with decreasing protein concentration. 
 
High salt concentration 
It had been shown in the previous chapter (at 4.5.5) that the HMW oligomers of HsPrx3-6his 
were responsive to changes in salt concentration, likely to be due to the disruption of 
electrostatic interactions at the R-type interface. To try and assess the origin of the HMW 
oligomers in response to linker variations, the samples were tested under a range of salt 
concentrations to determine whether electrostatics were involved in their assembly. 
 
SEC was run on all samples in high salt (600 mM NaCl), non-reduced buffer at pH 8.0.  For 
all the samples there was no significant change in the ratio of HMW and MMW oligomers 
(Table 5.5, Appendix 5.5) showing that, unlike the stacks and tubes formed from HsPrx3-6his 
at pH 7.4 and below, electrostatic interactions were not the primary origin of oligomerisation 










Area/Peak area (volume) % 
 PRX3A PRX3B PRX3C PRX3D 
HMW 29.12 31.63 9.02 21.52 
LMW 70.88 68.37 90.98 78.48 
Table 5.5: Integrated peak values for SEC 600 mM NaCl. All show a mixture of 
HMW and LMW oligomers. Increasing the salt concentration from 150 mM to 600 
mM does not disrupt the interactions that are driving HMW assembly. 
 
AUC 
All proteins were further analysed on AUC.  This allowed size determination for the 
oligomers > 660 kDa.  The samples were spun at 38,000 rpm and the frictional ratio was set 
at 1.45, which is the approximate frictional ratio calculated from the crystal structure of 
BtPrx3 [29] to allow an accurate mass calculation.  The size distribution was regularised 
using both the maximum entropy and 2
nd
 derivative, as described in Chapter 4.  Both 
calculations give a heterogenous mix of discrete species showing that the peaks seen on the 
trace were real and not artefacts of the Sedfit program (fig. 5.18 A – D). 
For all constructs apart from PRX3C, the peak relating to the double stack was the most 
populated (fig. 5.18 A – D). Surprisingly, there was also a small amount of tetramer seen on 
all traces that was not seen on SEC.  This is possibly due to the dilution of the sample as it is 
loaded onto a SEC column. [30] 
The ratio of each of the different quaternary structures was calculated from the peak integrals 
(Table 5.6). Stacks of 4 or more dodecamers were calculated as one peak.  This is because: 
1. There were no discrete peaks. 
2. The large oligomers settled within 10 scans at 38,000 x g meaning that there was not 
enough data within this region to accurately determine MW. 
 
 


















































                                    1x 2x 3x >3x dodecamer 
 
  A: PRX3A 
 
 
  B: PRX3B 
 
 
  C: PRX3C 
 
 
  D: PRX3D 
 
Figure 5.18: AUC of linker variation constructs at 600mM NaCl. High 
concentration of salt was added to the protein sample (1 mg/mL) in non-reduced 
buffer pH 8.0. (A) PRX3A, (B) PRX3B, (C) PRX3C and (D) PRX3D all show a 
mixture of dimer, dodecamer and HMW oligomers. Regularisation by the maximum 
entropy (black) and by the 2
nd
 derivative (dotted) both show discrete species.  
PRX3A and PRX3B have the highest proportion of HMW oligomers. A dimer peak 














> dodecamer x 
3 
PRX3A 7 14 26 18 35 
PRX3B 7 12 29 12 40 
PRX3C 7 47 42 4 0 
PRX3D 4 26 36 15 19 
 Table 5.6: Integrate peak areas of PRX3A, PRX3B, PRX3C and PRX3D on 
AUC. The peak with the largest area is highlighted in yellow 
 
TEM 
TEM was used to analyse the structure of the HMW and LMW oligomers. The samples were 
prepared as described in the methodology on Formvar coated copper mesh grids, using 1% 
uranyl acetate as the negative stain. 
For all constructs, a mixture of single rings and stacks were seen.  This agreed well with the 
solution data, with proteins with the most stacks being PRX3A and PRX3B. It was noted that 
on several of the images there was additional electron density in the centre of the ring 
(fig.5.19 A-D). This was most prevalent for PRX3B, which had also shown the highest 
percentage of HMW oligomers on both SEC and AUC (fig. 5.20). 
To try and determine whether there was a small amount of impurities in the protein, and 
therefore an impurity that might be binding the centre of the toroid, a Western blot was run 
on the proteins.  Overloaded SDS-PAGE gel was run in tandem to assess the amount of stable 
HMW oligomers. An anti-mouse histidine tag antibody was used to identify bands on the 
SDS-PAGE gel that corresponded to the target protein (Appendix 5.6 A).   
The overloaded linker variants all ran as a mixture of monomers, dimers and HMW 
oligomers.  All of these bands were identified as target protein when analysed on Western 
blot.  Additionally, there were small amounts of impurities or protein degradation products 
seen on SDS-PAGE (Appendix 5.6 B), but the HMW oligomers were stable.  This shows that 
even under harsh denaturing conditions, the proteins still retained some of the quaternary 
structure.  This pertains to a highly stable interface which may explain why the HMW 
oligomers appear to be so stable and readily formed from the linker variant constructs. 







A: PRX3A                                                             B: PRX3B 
 
C: PRX3C                                                              D: PRX3D 
 
Figure 5.19: TEM of linker variation constructs at pH 8.0 non-reducing conditions.  All 
samples were diluted to 50 μg/mL prior to grid preparation and stained with uranyl actetate 
(1%). (A) PRX3A, (B) PRX3B, (C) PRX3C and (D) PRX3D all show a mix of LMW and 
HMW oligomers.  This agrees well with the solution data. Across all images there is evidence 
of single toroids with electron density in the centre.  These are most prominent for PRX3B. 









Figure 5.20: TEM of PRX3B.  There are a number of different oligomeric states for 
this construct with a larger number of rings with electron density in the centre 
(within red squares) as well as stacks and short tubes.  This construct had the largest 
oligomers on AUC as well as TEM. The images represent the different oligomers 
formed from PRX3B and are not to scale. 
 
5.4.3 Discussion 
Varying the length of the linker has a marked effect on the protein quaternary structure.  This 
is unlikely to be due solely to the additional histidine tag and thrombin cleavage site, as this 
was not seen for PRX3E and PRX3F.  Furthermore, the addition of high salt did not disrupt 
the interactions at the R-type interface, and so assembly based exclusively on charge-charge 
interactions and salt-bridges appeared unlikely. However, it is possible that the increased 
amount of histidine within the tag led to π-π stacking between the imidazole side groups of 
adjacent toroids, stabilising the interface. This interaction has been noted at the A-type 
interface of other peroxiredoxins between neutral histidine residues. [31] 
It is also interesting to note that there was some dimer present which was not seen for the full 
length tag and linker construct. The ring stability gained from the presence of a full length tag 
and linker may be disrupted when the linker length is varied, further demonstrating that the 
N-terminal tag can have a long range effect on the overall structure of the protein. [8] 
Due to the high degree of electron density within the toroid lumen as visualised of TEM, 
especially for PRX3B which also had the largest oligomers, it was hypothesised that the 
presence of a disordered polypeptide chain within the dodecamer lumen may have been 
instigating a chaperone response. HMW oligomers of HsPrx3 at pH 4.0 have been identified 
as displaying the characteristics necessary for a putative chaperone. [15]   While there is 




evidence that LMW peroxiredoxin can act as a holdase chaperone, [18]  the majority of 
reported chaperone species exist as stacks. [17, 19, 28, 32-34] This is believed to be due to 
the increase in the hydrophobic surface area within stack lumen when compared to a single 
ring, the binding site for the unfolded or partially unfolded protein substrate. [15, 17, 28, 35] 
Varying the linker sequence may influence this putative chaperone response and stabilise the 
peroxiredoxin assembly. 
 
5.5 Structure and function relationship 
Over the course of many years of interest in peroxiredoxins, it has been noted that there are a 
range of different functions that the protein can adopt. [17, 36-39]  The structure and 
oligomeric state is intrinsically linked to the function which is taking place (Chapter 1 at 
1.6.6). [40] Of these functions the first to be confirmed, and still considered to be the primary 
function, is the peroxidase activity. [32, 39, 40] 
It has been shown that the switch between dimer and toroid is important for optimal 
peroxidatic function due to the increased binding efficiency of the thiol reductant to the dimer 
during the recycling step. [41] This has been further confirmed by the development of 
mutants with a locked ring structure which show a lower peroxidase activity. [41] The 
stacking has also been shown to have a detrimental effect on the peroxidatic activity, 
although the reasoning behind this is not well understood. [33] 
One of the benefits of using an enzyme as a proton tecton is that it has in-built function.  It is 
therefore important to discern whether this particular function could be utilised when 
developing biological nanomaterials. 
 
5.5.1 Peroxidase activity assay 
The peroxidase activity of all of the constructs was analysed.  This was to determine whether 
the variations in quaternary structure, linked to the changes in linker and tag length, had a 
detrimental effect on the enzyme activity. The assay, measured as a competitive kinetics 
assay with horse radish peroxides (HRP), was developed by Amy Yewdall at the 
Biomolecular Interaction Centre (BIC) lab at the University of Canterbury, and was based on 
the Ogusucu method. [42]  The colour of HRP changes from orange to clear during the 




reduction of H2O2 to H2O and the rate of this reaction is measured by determining the change 
in absorbance at λ = 403 nm.  The samples were prepared as described in the methodology 

















HsPrx3-6his 3.4 x 10 
7
 1.6 x 10 
5
 0.95 
PRX3A 2.4 x 10 
7
 9.4 x 10 
5
 0.97 
PRX3B 1.6 x 10 
7
 9.3 x 10 
5
 0.94 
PRX3C 2.0 x 10 
7
 7.0 x 10 
5
 0.98 
PRX3D 2.7 x 10 
7
 1.4 x 10 
5
 0.96 
PRX3E 2.8 x 10 
7
 1.7 x 10 
5
 0.95 
PRX3F 3.1 x 10 
7
 1.5 x 10 
5
 0.96 




) of the peroxidatic 
activity of all 7 constructs.  The competitive activity assay, using HRP as the 
competitive reactant, was run in accordance to the protocol described in the 
methodology (Chapter 2 at 2.4.1). kPrx was calculated by plotting  
 
   
           
against [Prx]. 
  
All constructs showed fast turn over, with the rate constants ranging from 1.6 x 10
7







 (Table 5.7).  HsPrx3-6his, PRX3E and PRX3F had the fasted reaction rates, with 
the rate constants being comparable due to the standard errors.  The activity appeared to 
decrease for the linker length variation constructs. There was also a significantly larger 
standard error for these constructs.  Overall, all enzymes were able to complete their 
peroxidase activity despite the changes in their quaternary structure that, according to the 
literature, have the potential to disabled this function. [9, 17, 34] 




5.5.2 Oligomerisation in assay buffer conditions 
The assay was completed at pH 7.5.  With the knowledge that the proteins are sensitive to 
changes within this pH range, it was important to determine an approximate MW for these 
samples. 
All samples were dialysed overnight into the assay buffer and the MW was analysed by 
measuring DH on DLS.  As expected, there was a shift towards HMW oligomers at pH 7.5.  
The Z-ave for a decameric ring at pH 8.0 is ~ 13 d.nm and the smallest oligomer under assay 
buffer conditions was HsPrx3-6his at 16.47 d.nm.  The largest species were PRX3F and 
PRX3D at 30 and 39 d.nm respectively (Table 5.8).  There did not appear to be any 
correlation between the oligomer size and the activity of the enzyme.  PRX3F had one of the 
highest second order rate constants, and yet was once of the largest oligomers under assay 
buffer conditions as visualised on DLS.  It is important to note that the concentration used on 
DLS (0.1 mg/mL), is different to the range of concentrations used for activity assay (0.1 
mg/mL ~ 4μM).  To accurately assess the MW of all of the oligomers in exactly the same 
conditions used for the assay it would be helpful to analyse the samples using AUC.  
However, due to the equipment availability it was not possible to complete this within the 
time frame of this study. 
Protein Z-ave (d.nm) PdI 
HsPrx3-6his 16.47 0.21 
PRX3A 25.27 0.17 
PRX3B 26.57 0.23 
PRX3C 22.31 0.23 
PRX3D 39.91 0.29 
PRX3E 23.98 0.17 
PRX3F 30.38 0.18 
 
Table 5.8: Size of the protein oligomers in assay buffer conditions. DH was 
measure using DLS.  All constructs show an increase in size when in assay buffer 
conditions (pH 7.5, reduced).  PRX3D has the highest MW. 
 





All seven constructs showed a high peroxidatic activity despite the locked ring and stack 
conformation.  There did not appear to be any correlation between the oligomer size and the 
activity of the enzyme. 
Interestingly, PRX3B showed the lowest activity.  This was the construct that also contained 
a large amount of electron density within the toroid lumen according to TEM.  It is possible 
that this construct, in particular, had more chaperone characteristics.  The conditions that are 
normally used to drive toroid assembly; acidic pH, [24, 28] high concentration of H2O2, [17] 
and significant changes in temperature, [18] may induce structural changes that are 
detrimental to the peroxidase activity. It is hypothesised that peroxiredoxin stacks are still 
highly active as long as the active site (and other regions that contribute to enzymatic 
activity) are in the conformation that allows optimum catalytic activity. [43] With this in 
mind PRX3B, which appeared to be acting as a chaperone on TEM, [18] would have the 
lowest enzymatic activity due to a switch in function, and not solely because of an increase in 
complex quaternary structure.  While not within the scope of this project, a crystal structure 
would be useful to comprehensively analysis this hypothesis.  A chaperone activity assay 
would also be necessary.  
The redox activity of the active site could lead to the development of functional materials. 
For example, the protein could be bound to a surface in a direct or indirect manner utilising 
the metal chelation tag, or the electrostatic contacts, respectively.  This could be used in the 
development of a high surface area catalyst such as a “green science” catalytic converter, 
converting H2O2 to H2O.  The proton transfer involved in this redox reaction could also be 
utilised to develop a battery, with the protons carrying the charge. 
Overall, the fact that all proteins show high peroxidatic activity provides a wealth of 










While the hypothesis behind the original design of the tag and linker variation constructs 
could not be tested due to the error in plasmid production, the data gained still gave insight 
into the mechanism of assembly and the ways in which it could be controlled 
With an increase in the amount of histidine available for electrostatic interactions there was 
an increase in the degree of oligomerisation in response to changes in pH.  This further 
strengthened the idea that stack and tube stabilisation is a consequence of electrostatic 
interactions between the protonated histidine residues and areas of negative charge on the 
neighbouring dodecamer. It also provided a means of designing tubes of a certain length 
within a specified time frame.  All of the linker variants stacked at pH 8.0, meaning that 
studying the assembly at pH lower than this would be difficult.  However, it was interesting 
to note that these changes did have a large impact on the quaternary structure of the protein.  
For all four constructs there was evidence of SDS stable HMW oligomers that formed stacks 
and tubes, as visualised by AUC and TEM. Perhaps most intriguingly, there was a significant 
amount of electron density within the lumen of many of the dodecamers, as visualised by 
TEM.  The tag and linker are likely to exist as disordered peptides.  It was postulated that this 
could be initiating a chaperone response, causing the dodecamers to stack, however further 
investigation would be needed to confirm this.  
There was no discernible correlation between oligomeric state and peroxidase activity.  
However, the construct that showed the lowest activity, PRX3B, also had the highest amount 
of toroids with electron density within the lumen.  This would suggest that the reduction in 
peroxidase activity is not directly linked to the quaternary structure, but instead the switch in 
function of the peroxiredoxin (specifically from a peroxidase to a chaperone). 
Overall, it is clear from this study that the presence of a non-native peptide sequence on the 
N-terminus of HsPrx3 has a large effect on its the oligomeric state.  This change in 









1. Anfinsen CB: Formation and stabilisation of protein structure. Biochemical Journal 
1972, 128(4):737-&. 
2. Marianayagam NJ, Sunde M, Matthews JM: The power of two: protein dimerization 
in biology. Trends in Biochemical Sciences 2004, 29(11):618-625. 
3. Arakawa T, Prestrelski SJ, Kenney WC, Carpenter JF: Factors affecting short-term 
and long-term stabilities of proteins. Advanced Drug Delivery Reviews 1993, 10(1):1-
28. 
4. Rose GD, Fleming PJ, Banavar JR, Maritan A: A backbone-based theory of protein 
folding. Proceedings of the National Academy of Sciences of the United States of 
America 2006, 103(45):16623-16633. 
5. Cingolani R, Rinaldi R, Maruccio G, Biasco A: Nanotechnology approaches to self-
organized bio-molecular devices. Physica E-Low-Dimensional Systems & 
Nanostructures 2002, 13(2-4):1229-1235. 
6. Yeates T: Nanobiotechnology: protein arrays made to order. Nature Nanotechnology 
2011, 6:541 - 542. 
7. Gradisar H, Jerala R: Self-assembled bionanostructures: proteins following the lead of 
DNA nanostructures. Journal of Nanobiotechnology 2014, 12(1):4. 
8. Gretes MC, Karplus PA: Observed octameric assembly of a Plasmodium yoelii 
peroxiredoxin can be explained by the replacement of native "ball-and-socket" 
interacting residues by an affinity tag. Protein Science 2013, 22(10):1445-1452. 
9. Cao Z, Bhella D, Lindsay JG: Reconstitution of the mitochondrial PrxIII antioxidant 
defence pathway: General properties and factors affecting PrxII activity and 
oligomeric state. Journal of Molecular Biology 2007, 372(4):1022-1033. 
10. Ben Hlima H, Ayadi D, Aghajari N, Bejar S: Differential properties of native and 
tagged or untagged recombinant glucose isomerases of Streptomyces sp SK and 
possible implication of the glycosylation. Journal of Molecular Catalysis B: 
Enzymatic 2013, 94:82-87. 
11. Majorek KA, Kuhn ML, Chruszcz M, Anderson WF, Minor W: Double trouble-
Buffer selection and His-tag presence may be responsible for nonreproducibility of 
biomedical experiments. Protein Science 2014, 23(10):1359-1368. 
12. Thielges MC, Chung JK, Axup JY, Fayer MD: Influence of histidine tag attachment 
on picosecond protein dynamics. Biochemistry 2011, 50(25):5799-5805. 
13. Watanabe H, Matsumaru H, Ooishi A, Feng YW, Odahara T, Suto K, Honda S: 
Optimizing pH Response of Affinity between Protein G and IgG Fc. How 
electrostatic moddulation affect protein-protein interactions. Journal of Biological 
Chemistry 2009, 284(18):12373-12383. 
14. Morais MAB, Giuseppe PO, Souza T, Alegria TGP, Oliveira MA, Netto LES, 
Murakami MT: How pH modulates the dimer-decamer interconversion of 2-Cys 
Peroxiredoxins from the Prx1 subfamily. Journal of Biological Chemistry 2015, 
290(13):8582-8590. 
15. Radjainia M, Venugopal H, Desfosses A, Phillips AJ, Yewdall NA, Hampton MB, 
Gerrard JA, Mitra AK: Cryo-electron microscopy structure of human Peroxiredoxin-3 
filament reveals the assembly of a putative chaperone. Structure 2015, 23(5):912-920. 
16. Kumsta C, Jakob U: Redox-regulated chaperones. Biochemistry 2009, 48(22):4666-
4676. 
17. Jang HH, Lee KO, Chi YH, Jung BG, Park SK, Park JH, Lee JR, Lee SS, Moon JC, 
Yun JW et al: Two enzymes in one: Two yeast peroxiredoxins display oxidative 




stress-dependent switching from a peroxidase to a molecular chaperone function. Cell 
2004, 117(5):625-635. 
18. Teixeira F, Castro H, Cruz T, Tse E, Koldewey P, Southworth DR, Tomas AM, Jakob 
U: Mitochondrial peroxiredoxin functions as crucial chaperone reservoir in 
Leishmania infantum. Proceedings of the National Academy of Sciences of the United 
States of America 2015, 112(7):E616-E624. 
19. Konig J, Galliardt H, Jutte P, Schaper S, Dittmann L, Dietz KJ: The conformational 
bases for the two functionalities of 2-cysteine peroxiredoxins as peroxidase and 
chaperone. Journal of Experimental Botany 2013, 64(11):3483-3497. 
20. Svanedal I, Boija S, Almesaker A, Persson G, Andersson F, Hedenstrom E, Bylund D, 
Norgren M, Edlund H: Metal ion coordination, conditional stability constants, and 
solution behavior of chelating surfactant metal complexes. Langmuir 2014, 
30(16):4605-4612. 
21. Brodin JD, Ambroggio XI, Tang C, Parent KN, Baker TS, Tezcan FA: Metal-
directed, chemically tunable assembly of one-, two- and three-dimensional crystalline 
protein arrays. Nature Chemistry 2012, 4(5):375-382. 
22. Brodin JD, Smith SJ, Carr JR, Tezcan FA: Designed, helical protein nanotubes with 
variable diameters from a single building block. Journal of the American Chemical 
Society 2015, 137(33):10468-10471. 
23. Huard DJE, Kane KM, Tezcan FA: Re-engineering protein interfaces yields copper-
inducible ferritin cage assembly. Nature Chemical Biology 2013, 9(3):169-176. 
24. Phillips AJ, Littlejohn J, Yewdall NA, Zhu T, Valery C, Pearce FG, Mitra AK, 
Radjainia M, Gerrard JA: Peroxiredoxin is a versatile self-assembling tecton for 
protein nanotechnology. Biomacromolecules 2014, 15(5):1871-1881. 
25. Chant A, Kraemer-Pecore CM, Watkin R, Kneale GG: Attachment of a histidine tag 
to the minimal zinc finger protein of the Aspergillus nidulans gene regulatory protein 
AreA causes a conformational change at the DNA-binding site. Protein Expression 
and Purification 2005, 39(2):152-159. 
26. Chen Z, Li Y, Yuan Q: Study the effect of His-tag on chondroitinase ABC I based on 
characterization of enzyme. International Journal of Biological Macromolecules 
2015, 78:96-101. 
27. Noichri Y, Palais G, Ruby V, D'Autreaux B, Delaunay-Moisan A, Nystrom T, Molin 
M, Toledano MB: In vivo parameters influencing 2-Cys Prx oligomerization: The role 
of enzyme sulfinylation. Redox Biology 2015, 6:326-333. 
28. Saccoccia F, Di Micco P, Boumis G, Brunori M, Koutris I, Miele AE, Morea V, 
Sriratana P, Williams DL, Bellelli A et al: Moonlighting by different stressors: 
Crystal structure of the chaperone species of a 2-Cys Peroxiredoxin. Structure 2012, 
20(3):429-439. 
29. Cao Z, McGow DP, Shepherd C, Lindsay JG: Improved catenated structures of 
Bovine Peroxiredoxin III F190L reveal details of ring-ring interactions and a novel 
conformational state. PLOS One 2015, 10(4). 
30. Duong-Ly KC, Gabelli SB: Gel filtration chromatography (size exclusion 
chromatography) of proteins. In: Laboratory Methods in Enzymology: Protein, Pt C. 
Edited by Lorsch J, vol. 541. San Diego: Elsevier Academic Press Inc; 2014: 105-
114. 
31. Nguyen JB, Pool CD, Wong CYB, Treger RS, Williams DL, Cappello M, Lea WA, 
Simeonov A, Vermeire JJ, Modis Y: Peroxiredoxin-1 from the human hookworm 
Ancylostoma ceylanicum forms a stable oxidized decamer and is covalently inhibited 
by conoidin A. Chemistry & Biology 2013, 20(8):991-1001. 




32. Hall A, Karplus PA, Poole LB: Typical 2-Cys peroxiredoxins - structures, 
mechanisms and functions. Federation of European Biochemical Societies Journal 
2009, 276(9):2469-2477. 
33. Banerjee M, Chakravarty D, Ballal A: Redox-dependent chaperone/peroxidase 
function of 2-Cys-Prx from the cyanobacterium Anabaena PCC7120: role in oxidative 
stress tolerance. BioMed Central plant biology 2015, 15(1):444-444. 
34. Angelucci F, Saccoccia F, Ardini M, Boumis G, Brunori M, Di Leandro L, Ippolitl R, 
Miele AE, Natoli G, Scotti S et al: Switching between the alternative structures and 
functions of a 2-Cys Peroxiredoxin, by site-directed mutagenesis. Journal of 
Molecular Biology 2013, 425(22):4556-4568. 
35. Tavender TJ, Sheppard AM, Bulleid NJ: Peroxiredoxin IV is an endoplasmic 
reticulum-localized enzyme forming oligomeric complexes in human cells. 
Biochemical Journal 2008, 411:191-199. 
36. Wood ZA, Schroder E, Harris JR, Poole LB: Structure, mechanism and regulation of 
peroxiredoxins. Trends in Biochemical Sciences 2003, 28(1):32-40. 
37. Karplus PA, Hall A: Structural survey of the peroxiredoxins. Sub-Cellular 
Biochemistry 2007, 44:41-60. 
38. Poynton RA, Hampton MB: Peroxiredoxins as biomarkers of oxidative stress. 
Biochimica Et Biophysica Acta-General Subjects 2014, 1840(2):906-912. 
39. Karplus PA: A primer on peroxiredoxin biochemistry. Free Radical Biology and 
Medicine 2015, 80:183-190. 
40. Perkins A, Poole LB, Karplus PA: Tuning of peroxiredoxin catalysis for various 
physiological roles. Biochemistry 2014, 53(49):7693-7705. 
41. Matsumura T, Okamoto K, Iwahara S-I, Hori H, Takahashi Y, Nishino T, Abe Y: 
Dimer-oligomer interconversion of wild-type and mutant rat 2-Cys peroxiredoxin. 
Journal of Biological Chemistry 2008, 283(1):284-293. 
42. Ogusucu R, Rettori D, Munhoz DC, Netto LES, Augusto O: Reactions of yeast 
thioredoxin peroxidases I and II with hydrogen peroxide and peroxynitrite: Rate 
constants by competitive kinetics. Free Radical Biology and Medicine 2007, 
42(3):326-334. 
43. Hall A, Parsonage D, Poole LB, Karplus PA: Structural evidence that Peroxiredoxin 









Chapter Six: Conclusions and suggestions for future work 
 
The ability of proteins to associate into 3D functional entities is unparalleled when compared 
to synthetic analogues. [1-3] Their functional complexity, shape, and the different modes of 
assembly are all encoded in the amino acid sequence. It is therefore possible to predict 
systems that will drive controlled association, making proteins attractive tools for the 
formation of nanomaterials using the bottom-up approach. The aim of this study was to 
increase the repertoire of available protein building blocks from which these structures could 
form.  
Using proteins that had the ability to assemble in nature meant that the interfaces that guided 
assembly were already in place. Additionally, selecting proteins that had in-built functions 
was also seen as beneficial for the formation of functional nanomaterials.  The different 
modes of oligomerisation were examined for three different proteins, Lsr2, Nterm-Lsr2 and 
HsPrx3.  All three proteins displayed features that aligned them with the goals of this work. 
Throughout this study, novel and tailorable methods were developed to form protein tectons 
that associated upon a specific switch. The relatively simple modes of assembly allowed the 
study of additional routes of exerting control over these systems. Using a range of different 
environmental factors (protein concentration, pH, ionic strength, and metal chelation) it was 
possible to develop assembly systems that produced materials of a controlled size.  These 
systems could be utilised in the development of functional nanomaterials in future work. 
 
6.1 Oligomerisation of Lsr2 and its derivatives 
Lsr2 was identified as a potential protein tecton due to a number of native modes of assembly 
that had been identified in the associated literature. [4-7] The ability of this small, basic, 
histone-like protein to organise DNA into bacterial nucleoids and nucleoprotein fibres also 
aligned well with the idea of developing protein building blocks with in-built function. [6, 8, 
9] During the purification process it was noted that the protein bound to significant amounts 
of genomic DNA. Due to the fact it was not possible to remove the DNA using the methods 




employed in this thesis, the controlled assembly of the N-terminal dimerisation domain was 
explored instead. 
 
6.1.1 Assembly in response to an enzymatic switch 
Nterm-Lsr2 undergoes assembly in response to enzymatic cleavage at Lys
4
.  [4, 10] This 
facilitates the formation of an inter-dimer β-strand, which enables the assembly of single 
dimeric units into HMW oligomers.  The system, first described by Summers et al., was 
successfully reproduced in this study, with a protein tecton forming upon proteolysis with 
1:500 (w/v) trypsin:Nterm-Lsr2. However, using trypsin to initiate the assembly of Nterm-
Lsr2 brought with it inherent problems. Unwanted proteolysis at additional lysine and 
arginine residues within the protein meant that the system was never optimal.  High initial 
protein concentrations were needed to assemble large structures, and the identification of the 
oligomeric state was made difficult by the inclusion of hydrolysed products into the 
assemblies. This was seen both in solution (SEC) and on TEM, with the large “spaghetti-like” 
structures being masked by a significant amount of protein aggregate. The assembly system 
was significantly improved with the addition of a specific enzyme recognition site.  
Enteropeptidase digest was used to create a protein tecton that assembled into complex 
“spaghetti- like” structures at pH 7.4.  Characterisation of the Ent-Nterm tecton showed that it 
was the same single unit that was formed during trypsin cleavage.  Without the unwanted 
proteolysis, the system was able to perform at optimal levels.  
 
6.1.2 Controlling tecton assembly 
Through studying variations in environmental conditions it was possible to exert additional 
control over the assembly system.  The sizes of the oligomers increased with increasing 
protein concentration. This was unsurprising for two reasons. First, the concentration used 
during the initial trials in this study was lower than that used by Summer et al, [4] resulting in 
smaller oligomers consistent with a concentration dependence on oligomer size. [10] The 
second reason is related to the mode of assembly. Each tecton has two oligomerisation sites 
located on either side of the 2-fold symmetry axis. The assembly system is “open” as a result 
and, with no capping mechanism, the oligomerisation can continue up to the point of protein 
saturation. [3] From the concentration variation experiments a model of assembly was 




proposed whereby the LMW (tetramer) and MMW oligomers were in fast equilibrium, and 
the HMW oligomer only formed once the MMW oligomer population had reached a critical 
concentration.  Additional equilibrium experiments corroborated this hypothesis.  
Increasing the pH from 7.4 to 9.0 caused the oligomers to disassemble into a tetramer.  This 
was attributed to the deprotonation of the N-terminal lysine α-amine (pKa 8.95), which had 
been identified in the crystal structure as forming salt-bridges with negatively charged 
residues, and backbone carbonyl oxygen atoms on the neighbouring dimer (fig 6.1 B).  It was 
hypothesised that the removal of these interactions resulted in a less stable interface. Protein 
concentrations higher than those used in this study would therefore be needed to drive 
oligomerisation into the HMW form.  Further concentration analysis, and a crystal structure 
of the tecton at pH 9.0, could definitively confirm this hypothesis. 
 
6.2 Controlled assembly of HsPrx3-6his 
 
HsPrx3 is emerging as a useful building block for the formation of protein nanomaterials. 
[11, 12] This family of proteins has the ability to assemble into many different oligomeric 
states in response to environmental variations. [13-15]  
 
6.2.1 HsPrx3-6his is a stable protein tecton 
For the typical 2-Cys Prx1 subfamily, the switch between dimer and toroid (decamer or 
dodecamer) usually occurs upon formation of the active site disulfide bond (Cysp – Cysr). 
[16-18] However, the addition of the histidine tag in this study resulted in a marked increase 
in stability of the dodecamer form. The active site disulfide bond was still able to form, as 
visualised by the SDS stable dimer, indicating that additional variations in the protein 
structure were the cause of the stability. When comparing the crystal structure of BtPrx3 with 
the cryo-EM reconstitution of HsPrx3 tubes at pH 4.0, it was noted that there were significant 
differences between geometries of the structures. [12] The root mean square deviation 
(RMSD) of residues at the A and B-type interface were measured. RMSD at the A-type 
interface was significantly greater than at the B-type interface (1.3 Å and 2.1 Å respectively). 
[12] The BtPrx3 contains an N-terminal histidine tag and is also stable under oxidation 




conditions. [19, 20] Additionally, the placement of residues at the A-type interface is 
important for toroid stabilisation. [18, 21, 22] Specific differences between the HsPrx3-6his 
and HsPrx3-WT at this interface could be the origin of the toroid stability. To confirm this, a 
crystal structure of the HsPrx3-6his would need to be acquired under both reducing and non-
reducing conditions. The A-type interface would be studied to show any variations that may 
occur in response to the active site disulfide bond formation. A further structure of the native 
protein (without the tag) would then be compared to the tagged structures to note any 
significant differences between the two. 
Histidine residues at the A-type interface of AcePrx1 are involved in the native decamer 
stability. [23] The imidazole side chains of His
107
 can interact via π-π stacking of the 
aromatic rings, along with H-bonding to backbone oxygen atoms on the adjacent monomer. 
This particular residue has been identified in another, similar, stable decameric form of Prx 
(HsPrx4). [24] It is possible that the histidine residues within the current system (HsPrx3-
6his) are engaging in similar interactions. The crystal structure would be useful to corroborate 
this hypothesis, although the interactions may be dynamic in nature, as seen by the flexibility 
of the tag and linker in the bovine structure. [19] Additionally, the original histidine tag 
variation constructs, HsPrx3-4his and HsPrx3-2his, could be used to analyse this hypothesis. 
A reduction in toroid stability with decreasing histidine content would indicate that the toroid 
stabilisation was in response to direct interactions between the histidine residues and 
protein/additional tags within the ring. 
 
6.2.2 Tubes and stacks formed within the physiological pH range 
The formation of a stable toroid resulted in an ideal tecton from which larger assemblies 
could form. It has been noted in many studies that typical 2-Cys Prxs have the propensity to 
form stacks at the R-type interface. [12, 25-29] In fact, their geometry and symmetry are 
remarkably well suited for the formation of tubes. [30] There are a number of complementary 
residues that appear to enable this interaction, namely the backbone carbonyl groups on α2 
with the protonated lysine and histidine residues on α6, as well as interactions between lysine 
and aspartic acid of β2 on adjacent subunits. [12, 31] It has been suggested that the HMW 
stabilisation may be due to changes in the environment and a switch in the enzyme function. 
[26, 27] However, some studies have noted that it may be possible for Prxs to interact at the 




R-type interface in a dynamic manner at physiological pH, and in the peroxidase active form. 
[32]  
With this is mind, the influence of the tag and linker sequence on the oligomeric state of 
HsPrx3 was investigated. The most notable difference between this construct and the WT 
recombinant construct was that the pH sensitivity increased dramatically. The tubes, seen at 
pH 4.0 with HsPrx3-WT, [11] began to form at much higher pH values with HsPrx3-6his. A 
MW corresponding to two or three rings was seen at pH 7.6 on SEC and AUC, with TEM 
confirming that these were indeed stacks of Prx and not random aggregates. At pH 7.4, the 
rings had associated into tubes. These tubes were stable in solution with the oligomers eluting 
at V0 on gel filtration, showing structures greater that the column MW limit (660 kDa). AUC 
further confirmed that the oligomers were stable in solution, and TEM analysis showed that 
the tubes were unusually uniform, when compared to other Prx tubes. [11, 33, 34] The length 
was further influenced by small changes in pH values. At pH 7.2 elongated tubes formed, 
with the most populated MW being around 5 x dodecamer in solution (AUC), increasing to 
15 x dodecamer on TEM. The concentration was shown to have a notable effect on the MW 
of HsPrx3-6his at pH 7.2, with the size increasing from 0.5 mg/mL to 5 mg/mL. This 
suggests a similar open helical symmetry to the tubes formed from HsPrx3-WT at pH 4.2. 
[12] This could also be the reason why longer tubes were always seen on TEM, with the 
concentration increasing rapidly upon drying during TEM grid preparation. 
Like many Prxs, the primary interactions at the R-type interface of are electrostatic in nature. 
[12, 26, 35] The tubes at pH 7.4 were subjected to a range of salt concentrations (NaCl) and 
analysed on SEC. As expected for electrostatic interactions the salt had a detrimental effect, 
with the HMW oligomers dissociating at 600 mM NaCl and above. The electrostatic 
interactions that had been noted in the native structure [12] were probed by substituting 
Lys
23
, located on β2 at the R-type interface, with either His, Arg or Ala. While substitution 
for a neutral residue (HsPrx3-K23A) led to a decrease in the proportion of HMW oligomers 
the association was not completely disrupted, suggesting the involvement of additional 
residues. 
The points of potential charge within the non-native sequence are the histidine residues in the 
tag. Increasing the number of histidine residues (PRX3E and PRX3F, with 8 and 10 histidines 
respectively) led to an increase in the size of the assemblies, both in solution studies and on 
TEM. While the exact pKa of these residues is unknown, it is possible to postulate a route 




towards assembly. Histidine residues within a tag have varying pKa values, depending on 
their proximity to the N-terminal amine. [36] It was hypothesised that the number of charged 
histidine residues within the tag increases with decreasing pH. The positively charged tag 
would be able to interact with the large area of negatively charged backbone carbonyl oxygen 
atoms on α2 of the adjacent ring. [26] This type of interaction has been seen at the A-type 
interface of other typical 2-Cys Prxs. [37] It has been suggested that Prxs rings have the 
potential to dynamically interact without the need for native structural changes in response to 
extreme environmental variations (for example high H2O2 concentration, [29] or acidic pH 
[11]). [32] As these interactions are normally short lived, and therefore not often noted, it is 
likely that the addition of the tag provides the stability needed for the tubes to form. To 
confirm this hypothesis, it would be beneficial to calculate the pKa values of the histidine 
residues in the tag. With recent developments in cryo-EM allowing for the solution of 
structures to the near atomic level, [38] it may also be possible to elucidate the structure of 
the tubes formed from HsPrx3-6his.  [12]  This could aid the identification of the exact points 
of contact at the R-type interface, which would likely confirm the mode of assembly. 
 
6.2.3 Metal ion coordination 
Metal ion coordination was also utilised in this study to initiate the onset of protein assembly. 
The imidazole side chains in the tag presented the ideal ligand to coordinate to divalent metal 
ions. [33, 39-41] It was found that Ni
2+
 produced the most stable oligomer, which is 





). [39] The largest oligomer seen under all conditions was 
stacks of four dodecamers. This was less than had been seen in previous studies using a 
similar mode of assembly. [33] It was noted during the course of this study that the Prx used 
in the previous study, SmPrx1, had additional metal chelating residues within the tag (the 
aspartic acid residues within the enteropeptidase cleavage site). One of the constructs 
designed during this project also had the same sequence of residues in the tag (PRX3D). Due 
to time constraints it was not possible to examine this protein under metal chelating 
conditions. This remains an area of potentially informative future work. 
 




6.2.4 The length of the linker influences the oligomeric state 
The influence of the length of the linker was also examined. This was due to the hypothesis 
that a disordered peptide within the toroid lumen may be instigating a chaperone response.  
Prxs have the ability to behave as holdase chaperones, preventing the aggregation of unfolded 
and partially unfolded proteins in response to cell stress conditions. [29, 35, 42] HsPrx3-WT 
had been identified as a putative chaperone due to the large hydrophobic surface area within 
the toroid lumen. [12] Variations in the linker length did influence the quaternary structure of 
the protein, with stacks forming at pH 8.0 non-reducing conditions.  The proteins analysed 
included the presence of an additional 6-histidine tag and linker sequence that was not within 
the original construct design. It is important to note that the increased number of histidines 
within the tag may have aided additional interactions between the linker sequence and the 
native protein (π-π stacking, H-bonding).  That said, a significant number of Prx rings were 
visualised with electron density within the dodecamer on TEM.  This was reminiscent of 
other Prx holdase chaperones. [42] Furthermore, the construct with the lowest peroxidase 
activity, PRX3B, also had the largest proportion of these chaperone-like species on TEM. It 
is possible that the drop in peroxidase activity was related to a switch in function, as there 
was no apparent trend in the activity and the degree of assembly. A crystal structure of these 
constructs would be useful in determining the exact reason behind the stacking. This may 
also provide insight into the loss in peroxidase activity. In addition, the structure could be 
compared to other known Prx chaperones to assess any similarities. A chaperone activity 
assay could also be completed to investigate whether there is a trend between the peroxidase 
and chaperone activity of these constructs. 
 
6.3 Functionalisation opportunities for the novel protein building-blocks 
 
The aim of this study was to develop novel assembly systems to be used in the formation of 
functional biological nanomaterials. As a result of the work on Nterm-Lsr2, it was possible to 
design proteins that assembled upon a specific cleavage event.  The enteropeptidase 
recognition site is found in many recombinant expression systems, [43, 44] and is already 
encoded into the protein sequence from the expression plasmid.  This makes it an ideal target 
for use in other protein assembly systems, providing a means for oligomerisation on demand.  




Ent-Nterm assembles into long “spaghetti-like” structures. The amino acid content of these 
structures means there is a wealth of surface functionalisation sites. [45] Using the methods 
developed by Sasso et al. (Chapter 1 at 1.4.3) it may be possible to add functional entities to 
these structures. These functional assemblies could be used in a range of different fields, from 
biosensors to high surface area catalysts. [45], [46] 
The water soluble tubes formed from the human protein HsPrx3-6his could be developed for 
the use in biomedical applications. Protein nanotubes are gaining interest within this field due 
their open-ended structure (which is ideal for drug delivery and storage), the longevity in 
which they can exist in the body, their biocompatibility, and the large surface area available 
for functionalisation on both the interior and exterior of the tube. [47] The stability of 
HsPrx3-6his 1D tubes at pH values around physiological pH values lends further credence to 
their potential use within this field. 
Proteins have been shown to rapidly adsorb on gold surfaces due to interactions between Au 
and cysteine, aspartic acid, and glutamic acid residues found on the surface of many proteins.  
[48] While the cysteine residues in HsPrx3-6his are buried within the protein interior, there 
are still a number of available residues that can interact with gold. [49] The system of 
HsPrx3-6his HMW oligomerisation, developed during this study, has been used to investigate 
the interaction of the protein with Au (111) gold terraces. (Laura Domigan, unpublished 
work). Scanning tunnelling electron microscopy (STEM) was used to image the arrangement 




Figure 6.1: STEM of HsPrx3-6his bound to a Au(111) surface at pH 7.2.  The 
protein, at ~ 2 nm in height along the D6 axis, is aligned as an array of rings upon the 
gold surface. 





The influence of pH on the assembly was further probed using quartz crystal microbalance 
with dissipation (QCM-D). This technique measures the resonance frequency and dissipation 
in response to adsorption onto a sensor surface. [50, 51] The mass of adsorbed particles is 
given by the change in the frequency, and changes in dissipation provide information about 
the viscoelasticity of the absorbed layer. The mass calculated from ΔF showed the adsorption 
of a monolayer of HsPrx3-6his at pH 8.0 (fig. 6.2 i), and a greater adsorption mass at pH 7.2 
due to the oligomers formed at this pH (fig. 6.2 ii). The dissipation was also greater for the 
protein at pH 7.2 (fig. 6.2 i and ii). It is believed this is due the heterogeneous nature of these 
oligomers, leading to a less ridged and structured surface layer.   
 
 
Figure 6.2: Change of ΔD dissipation plotted as a function of change in 
frequency ΔF at (i) pH 8.0 and (ii) pH 7.2. The change in frequency is less at pH 
8.0, showing a lower mass of adsorbed protein. At pH 7.2 the adsorption appears to 
occur in two stages.  The first stage is the protein binding to the gold, and the second 
stage is the oligomerisation of the protein in response to the low pH. 
 
The results from this study provide a proof of principle that the sizes and properties of 
HsPrx3-6his layers on a gold surface can be manipulated by the pH sensitivity. The control 
over the adsorption could aid the formation of ordered protein arrays on a gold surface. The 
metal bound tags within the lumen could be further utilised to bind to additional nanoparticles 
to form complex nanoscale systems with a variety of different functions. 
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Appendix: Chapter Three 
 
 
Appendix 3.1: Western blot of Lsr2 fraction for IMAC. Only visible band is the Lsr2 
monomer indicating that other band seen on SDS-PAGE is an impurity that does not contain 




























A: SEC of Lsr2, 1 M NaCl 
 
                                          B: Agarose gel of DNAse digest 
 
Appendix 3.2:  Analysis of different conditions to try and remove DNA from full length 
Lsr2. BPL stands for base pair ladder. (A) SEC of Lsr2 in high salt buffer (50 mM NaPi, 1 M 
NaCl, pH 7.4).  Peak is still at the void showing that Lsr2 is still bound tightly to DNA.  (B) 
agarose gel of DNAse digest.1, 2, 3, 4, 5, 6 and 7 - samples left at room temperature for 5, 10, 
15, 30, 60, 120 and 240 minutes respectively.  There is no visible digest of the genomic DNA 

































                                    A:Lsr2-R97A 
 
                                     B: LSr2-R97AR99A 
 
Appendix 3.3: SDS-PAGE analysis of DNA binding mutants. (A) Lsr2- R97A mutant 
agarose gel, 1 – crude lysate, 2 – insoluble crude, 3 – soluble crude, 4 – IMAC flow through, 
5 – IMAC peak 1, 6 – IMAC peak 2, 7 – IMAC peak 3 (all IMAC peaks contain Lsr2-R97A). 
(B) Lsr2-R97AR99A mutant agarose gel, 1 – crude lysate, 2 – insoluble crude, 3 – soluble 





































Appendix 3.4: SDS showing the fractionation of Nterm-Lsr2 due to unwanted trypsin 
cleavage.  1 - the protein fragment peak.  
 
         A: 4.3 mg/mL                                                   B: 1.8 mg/mL                               
 
  
Appendix 3.5: Equilibrium of HMW assemblies of Nterm-Lsr2: (A) Equilibrium of 30-
mer from 4.3 mg/mL oligomerisation of Nterm-Lsr2; (B) Equilibrium of tetradecamer from 






















































































































































































































































Oligomerised Nterm (1.8 mg/mL)
            A: 4.3 mg/mL                                                B: 1.8 mg/mL                 
  
Appendix 3.6:  Equilibrium of MMW assemblies of Nterm-Lsr2: (A) Equilibrium of 
octamer from 4.3 mg/mL oligomerisation of Nterm-Lsr2; (B) Equilibrium of heptamer from 
1.8 mg/mL oligomerisation of Nterm-Lsr2. 
 
        A: 4.3 mg/mL                                                     B: 1.8 mg/mL 
  
Appendix 3.7: Equilibrium of LMW assemblies of Nterm-Lsr2. (A) Equilibrium of 
tetramer from 4.3 mg/mL oligomerisation of Nterm-Lsr2; (B) Equilibrium of tetramer from 





















































































































































































































































































         A: pH 6.0                                                        B: pH 8.0 
Appendix 3.8: Oligomerisation at varying pH. (A) pH 6.0 and (B) pH 8.0  There is a small 
change in the extent of oligomerisation with the MMW oligomer being the largest formed. 
 
 
Appendix 3.9: Oligomerisation of Nterm-Lsr2 in tris buffer at pH 7.4.  There is no 















































































































Appendix: Chapter Four 
        A: 10 mM EDTA O/N                                         B: 50 mM EDTA O/N                  
 
      C: 10 mM EDTA + 20 mM imidazole               D: low protein concentration      
Appendix 4.1:  HsPrx3-6his in non-reducing conditions.  A: increased dissociation time 
from one hour to O/N in EDTA,  b: Increased EDTA concentration, c: additional chelating 
agent EDTA and imidazole, d: low protein concentration (0.4 mg/mL).  Non of the different 
conditions led to the dissociation of the decamer into dimers. 
 
 
Appendix 4.2: AUC of HsPrx3-6his in reducing conditions. There is a single species at the 






























































































A: pH 7.8 
 
 
B: pH 7.6 
 
 
C: pH 7.4 
 
D: pH 7.2 
 
 
Appendix 4.3:  SEC of oligomerisation of HsPrx3-6his with decreasing pH in reducing 
conditions. (A) pH 7.8, (B) pH 7.6,(C) pH 7.4 and (D) pH 7.2.  The switch between single 
rings and HMW oligomers occurs between pH 7.6 and 7.4.  The oligomerisation is slightly 












































































         A: pH 7.8                                                  B: pH 7.6 
Appendix 4.4:  HPLC trace of the concentration dependence on the size of oligomers at 
pH (A) 7.8 and (B) 7.6. blue: 0.5 mg/mL; red: 1 mg/mL, green: 3 mg/mL and purple : 5 
mg/mL. The oligomer mass is the equivalent of a double stack at pH 7.6 but there is no 




Appendix 4.5:  HPLC trace of the concentration dependence on the size of oligomers at 
pH 7.2, blue: 0.5 mg/mL; red: 1 mg/mL, green: 3 mg/mL and purple : 5 mg/mL.   Increasing 




















































































      B: (NH4)2SO4 
 
 
Figure 4.6: Influence of salt concentration on the concentration of HsPrx3-6his over 
time. (A) NaCl and (B) (NH4)2SO4.  Blue: no salt; red: 100 mM; green: 200 mM and purple: 
300 mM.  While there is very little variation in the protein concentration with NaCl there is a 
significant decrease in concentration in the presence of > 100 mM (NH4)2SO4. For this reason 




Appendix 4.7: Increasing salt concentration disrupts HMW oligomerisation. The 


































































                  A: K23A                                                                       B: K23H 
 
                                                           C: K23R 
 
Appendix 4.7: SDS-PAGE analysis of the purification of the Lys
23
 mutants. (A) HsPrx3-
K23A. 1: crude lysate; 2: insoluble crude 1; 3: soluble crude; 4: IMAC flow through; 5: 
IMAC imidazole eluted fraction; 6: SEC peak 1; 7: SEC peak 2;  8: SEC peak 3. (B) HsPrx3-
K23H. 1: crude lysate; 2: insoluble crude 1; 3: soluble crude; 4: IMAC flow through; 5: 
IMAC imidazole eluted fraction; 6: SEC peak 1; 7: SEC peak 2; 8: SEC peak 3, 9: SEC peak 
4. (C) HsPrx3-K23R. 1: crude lysate; 2: insoluble crude 1; 3: soluble crude; 4: IMAC flow 
through; 5: IMAC imidazole eluted fraction; 6: SEC peak 1; 7: SEC peak 2;  8: SEC peak 3. 
 
 





















Appendix: Chapter Five 
 
Protein LCMS (m/z) Calculated mass (kDa) 
PRX3A 25309 26073 
PRX3B 25950 26065 
PRX3C 24530 24623 
PRX3D 25528 25644 
PRX3E 26805 26904 
PRX3F 27801 27174 
 




Appendix 5.2: Differential scanning fluorimetry of the histidine tag varying and 
HsPrx3-6his: red: 6-histidine; blue: 10-histidine and green: 8-histidine.  The relative 
fluorescent unite (RFU) increases with increasing unfolding as the dye (sypro-orange) binds 
to the hydrophobic regions of the protein. By plotting  -d(RFU) dt against temperature it is 
possible to calculate the melting temperature of the protein.  The melting temperature for all 3 
proteins was 63 
o
C showing that there was no decrease or increase in the protein stability with 

































































                                  HMW    dodecamer 








Appendix 5.3: SEC traces of 8-histidine (PRX3E) and 10-histidine tagged (PRX3F) 
HsPrx3 at pH 7.4.  The longer histidine tagged constructs, (A) PRX3E and (B) PRX3F, 
where dialysed into pH 7.4 buffer and run on SEC.  This was to check if they had the same 
response to pH changes as HsPrx3-6his.  Both constructs assemble into HMW oligomers at 











































































































































































































































        A: PRX3A IMAC                                                B: PRX3B IMAC 
           C: PRX3C IMAC                                           D: PRX3D IMAC                        
Appendix 5.4: Elution of linker variation constructs from IMAC. (A) PRX3A, (B) 
PRX3B, (C) PRX3C and (D) PRX3D elution from a Ni
2+
 IMAC column upon increasing 
imidazole concentration. Black: absorbance at 280 nm (mAU); grey: percentage 
concentration of 0.5 M imidazole buffer (%).  All constructs were expressed and purified 

























































































                                  HMW  dodecamer 









Appendix 5.5:  SEC traces of linker variation constructs at 600 mM NaCl. High 
concentration of salt was added to the protein sample (1 mg/mL) in non-reduced buffer pH 
8.0. (A)PRX3A, (B) PRX3B, (C) PRX3C and (D) PRX3D all show a mixture of HMW and 
LMW oligomers. Increasing the salt concentration from 150 mM to 600 mM does not disrupt 
the interactions that are driving HMW assembly. Integrated values are shown in table 5.6. 







































A: western blot                                              B: SDS-PAGE 
 
 
Appendix 5.6: SDS-PAGE (A) and western blot of linker variations.  Wells 1 – 4 contain 
HsPrx3-6his with varying amounts of TEV, related to another experiment, wells 5, 6, 7 and 8 
contain PRX3A, PRX3B, PRX3C and PRX3D respectively.  There are a small amount of 













































































































































          A: PRX3A                                                      B: PRX3B                      
      C: PRX3C                                                            D: PRX3D   
       E: PRX3E                                                           F: PRXF 
G: HsPrx3-6his 
 
Appendix 5.7: Activity assay analysis. All 7 constructs were analysed using the protocol 
from the methodology (2.4.1). kPrx was calculated by plotting  
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